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Primary rhegmatogenous retinal detachment (RRD) is one of the most 
common ophthalmic emergencies. RRD is caused by a full thickness break in 
the retina which initiates separation of the neurosensory retina from the 
underlying retinal pigment epithelium. The subsequent accumulation of fluid 
within this potential space extends the area of detachment and causes visual 
loss.  
Previous assessments of RRD incidence have demonstrated large differences 
in case definition and methodology, with incidence estimates varying 3-fold 
geographically and in different time periods. To date there have been no 
systematic or prospective incidence estimates of primary RRD in the U.K. In 
this thesis I present the findings of a 2-year epidemiology study that 
prospectively aimed to recruit all incident cases of primary RRD diagnosed in 
Scotland. Case recruitment from consenting participants comprised a 
detailed questionnaire and a blood sample. In this thesis, I present the 
findings of the Scottish retinal detachment study that examined the 
incidence, demographic features, temporal incidence trends, as well as 
clinical and socio-economic associations of primary RRD in Scotland. From 
the clinical and genetic resource I assembled, I calculated the first 
population based estimate of the sibling recurrence risk ratio for RRD and 
designed and assisted in the analysis of the first case-control genome wide 
association study of this condition. 
Results from this study have estimated the annual incidence of primary RRD 
in Scotland to be 12.05 per 100,000 population. Based on this estimate, 
there are approximately 7,300 new cases annually in the United Kingdom. 
RRD incidence increases with age, is more common in men and right eyes, 
and is strongly associated with socio-economic affluence. In addition, using 
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hospital episode data, the overall age-standardised incidence of RRD in 
Scotland was shown to be steadily increasing since 1987 with an average 
annual increase of 1.9%. 
Analysis of the clinical findings highlighted that the majority of RRD cases 
are caused by more than one retinal break; an important consideration for 
appropriate surgical management. Ocular trauma, previous cataract surgery, 
family history, and retinal degeneration are important predisposing features. 
In addition, over a 2 year period approximately 7% of individuals will suffer 
a RRD in the fellow eye representing an important risk of bilateral visual 
loss.  
Furthermore, I demonstrate that the risk of having an affected sibling with 
RRD is increased 2-fold given that one sibling has had the condition, 
substantiating a genetic component to the pathogenesis of this condition. In 
the final aspect of this thesis I will present the design and analysis of a two 
stage case-control genome-wide association study examining the role of 
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Primary rhegmatogenous retinal detachment (RRD) is the most common 
ophthalmic emergency. RRD is caused by a full thickness break in the retina 
which initiates separation of the neurosensory retina from the underlying 
retinal pigment epithelium. The subsequent accumulation of fluid within this 
potential space (the subretinal space) extends the area of detachment and 
causes visual field loss.(D'Amico 2008) Most cases of RRD present when the 
macula is affected and require intervention to restore vision or prevent 
further visual loss. The mainstay of RRD treatment is surgical, accounting for 
an important proportion of ophthalmic hospital in-patient admissions at an 
annual cost of over £1.3million in the U.K.(Patel et al. 2004)  
 Previous assessments of RRD incidence have demonstrated large 
differences in case definition and methodology, with incidence estimates 
varying 3-fold geographically and in different time periods. To date there 
have been no systematic or prospective incidence estimates of primary RRD 
in the U.K. In addition, despite a known familial component to RRD, there 
have been no published genome-wide association studies  on RRD. Common 
genetic variants which predispose to developing this common and potentially 
blinding condition are therefore unknown. 
 This thesis presents the findings of a 2-year epidemiology study that 
prospectively aimed to recruit all incident cases of primary RRD diagnosed in 
Scotland. Based on this clinical and genetic resource my aim was to calculate 
the incidence of primary RRD, to explore clinical associations within the 





CHAPTER 1- Anatomical considerations 
1.1 The retina  
The retina contains the receptors for vision and is the innermost layer of the 
eye. It functions to transform visual light stimuli into neural signals which 
are transmitted and interpreted in the brain. The retina is bounded 
externally by Bruch’s membrane and the choroid and internally by the 
vitreous. It is a transparent membrane being thickest at the posterior pole 
(0.56mm) and thinning towards its anterior extension, (0.1mm) the ora 
serrata. It is continuous posteriorly with the optic nerve and anteriorly with 
the epithelium of the ciliary body. (Snell R & Lemp M 1998)  It consists of 
two layers, an outer pigmented layer (RPE) and an inner neurosensory layer 
(NSR) between which there is a potential space important in 
rhegmatogenous retinal detachment pathology, the sub-retinal space. Based 
on light microscopy and principally for descriptive purposes, the retina 
consists of ten layers. These are designated (from posterior to anterior): The 
retinal pigment epithelium (RPE), the rods and cones, the outer limiting 
membrane, the outer nuclear layer, the outer plexiform layer, the inner 
nuclear layer, the inner plexiform layer, the ganglion cells, the nerve fibre 
layer and the inner limiting membrane (ILM). The outer nuclear layer 
contains the nuclei of the rods and cones and the inner nuclear layer 
contains the nuclei of the horizontal cells, bipolar cells, Muller cells and 
amacrine cells. The outer plexiform layer contains the synapses between the 
rods and cones and the bipolar, horizontal and amacrine cells. The inner 
plexiform layer is contains the synaptic connections of the bipolar, amacrine 
and ganglion cells. The ganglion layer consists of the nerve fibres of the 
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ganglion cells converging towards the optic disc. Muller cells are neuro-glial 
support cells abundant in the retina. They have long processes and that 
extend radially across the retina. The outer limiting membrane is made up of 
a layer of zonulae adherents between the photoreceptor cells and the radial 
processes of the Muller cells. At the vitreous surface, the Muller cells have 
expanded terminations covered by a basement membrane. This layer forms 
the retinal aspect of the vitreo-retinal interface, which has an important role 
in vitreo-retinal pathology and is known as the inner limiting membrane. 
(Michels RG et al. 1990; Forrester et al. 1996) 
 1.1.1 The cells that limit the sub-retinal space 
The NSR contains the photoreceptors and nerve fibre layer. The RPE is a 
single layer of cells extending from the optic nerve head to the ora serrata 
which have numerous functions in metabolism, photo-transduction and 
adhesion to the neurosensory layer. Between these two layers is a potential 
space, the sub-retinal space. When the retina detaches, the sensory retina 
separates from the RPE, and the RPE remains attached to Bruch’s membrane 
and the underlying choroid.(Michels RG et al. 1990) 
1.1.2 Photoreceptors 
Photoreceptors are one of three principal neuron cells types (along with 
ganglion and bipolar cells) in human retina responsible for phototransduction 
and the relay of impulses generated by light. In the human eye, two types of 
photoreceptor predominate: rods and cones, which are situated in the outer 
aspect of the neurosensory retina. There are approximately 115 million rods 
and 6.5 million cones in the human retina. Rods are responsible principally 
for sensing contrast, brightness and motion, whereas cones function to 
sense fine resolution, spatial resolution and colour vision. The density of 
rods and cones varies topographically. The peripheral retina is rod-
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dominated with an average density of 30,000 rods per mm2. The cone 
density increases towards the macula (150,000mm2) and the fovea contains 
cones only.  
 Anatomically rods and cones consist of a long slender cell with an 
inner and outer segment joined by a connecting stalk. The inner segment 
joins with the cell nucleus and nerve fibre axons which pass into the outer-
plexiform layer of the retina where they form synaptic terminals (cone 
pedicle or rod spherule) with bipolar cells and other inter-neurons. The outer 
segments of rods and cones are different in structure anatomically and in 
function physiologically but they both contain the visual pigments 
responsible for light absorption and for initiation of a neuro-electrical 
impulse.(Forrester et al. 1996) 
 
Rod Cells   
Rods are long (~100μm) cells whose outer segment contains a visual 
pigment, rhodopsin within membrane bound lamellae or disks (up to 1,000 
per cell and 10-15nm thick) that are enclosed by a single membrane. The 
disks are formed at the base of the outer segment and over a period of 10 
days they travel to the tips of the outer segment where they are 
phagocytosed by the microvilli of the RPE in a circadian manner. The rods 
are separated from the RPE by a modified extra-cellular ground substance 
called the inter-photoreceptor matrix. 
Cone Cells 
Cones are shorter than rods (~70μm) and are usually divided into three 
types depending on the wavelength of maximal sensitivity (blue, green, red 
corresponding to short, medium and long wavelength). Cone outer segments 
tend to be shorter than rods and conical in shape. The lamellae in cones are 
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not surrounded by a membrane as in rods, but are in free communication 
with the inter-photoreceptor matrix. Cones have a longer lifespan than rods, 
they are not produced in the same manner as rods and do not undergo 
phagocytosis by the RPE.(Forrester et al. 1996) 
1.1.3 Retinal pigment epithelium 
The RPE is a monolayer of columnar/cuboidal epithelial cells extending from 
the margin of the optic nerve head to the ora serrata, where it is continuous 
with the pigment epithelial layer of the pars plana. The basal aspect of the 
RPE lies on Bruchs membrane and the apical surface is intimately associated 
with the photoreceptor outer segments. The number of RPE cells in each eye 
is approximately 4.2-6.1 million. The RPE has many functions which are 
critical in maintaining normal visual function. (Forrester et al. 1996; Green & 
Sebag 2006) 
1.1.4 Geographic regions of the retina 
The clinical and anatomical structure of the retina is clearly defined into 
several topographic regions (See Figure 1.1) (Michels RG et al. 1990): 
- The posterior pole (macula or area centralis)(blue circle):  This is a 5-
6mm diameter circular zone of retina situated between the superior and 
inferior temporal retinal arteries. This region is cone dominated. 
- The fovea (yellow circle): This is a 1.5mm diameter area in the posterior 
pole, 3mm lateral to the optic disc. It is partly yellow due to carotenoid 
pigments contained in the cone axons. The foveal region is on the optical 
axis, so that light fixed by an observer falls directly on the fovea. 
- The fovea centralis (foveola) (red circle): This is a 0.35mm area in the 
centre of the macula consisting of a depression surrounded by slightly 
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thickened margins. Cone receptors are maximally concentrated here. 
The foveola is avasular and depends entirely on the underlying 
choriocapillaris for nutritional support. 
- The peripheral retina is the remainder of the retina outside the posterior 
pole. The distance from the optic disc to the ora serrata is 23-24mm 
temporally and 18.5mm nasally. The peripheral retina thins as it extends 
anteriorly and possesses only one layer of ganglion cell bodies. 
- The ora serrata is the dentate-like anterior margin of the NSR. At this 
transition region, the NSR is continuous with the layers of the ciliary 
body epithelial cells. The ora serrata extends 1-2mm more anteriorly on 
the nasal side. 
For descriptive purposes, the retina is divided into nasal and temporal 
halves by a vertical line through the fovea. The optic nerve head is used 
as a central point to describe the four quadrants of the retina – supero-
temporal, supero-nasal, infero-temporal and infero-nasal. The area of 




Figure 1.1 – Illustrating the geographic features of the central retina- 
Macula(blue circle); fovea (yellow); foveola (red). STA- Superior temporal 
artery; ITA- Inferior temporal artery 
 
 
1.2 The vitreous 
 Normally, the vitreous is a homogenous gel-like structure, with 
several distinct anatomical regions including the vitreous body, the vitreous 
base and the vitreous cortex.(Michels RG et al. 1990) The central vitreous 
comprises the main bulk of the vitreous body and is traversed by an 
embryonic vascular remnant (Cloquet’s canal), which extends posteriorly as 
the space of Martegiani present over the optic nerve head. Within the central 
vitreous, collagen fibrils are low in concentration and run in an antero-
posterior direction inserting into the vitreous base anteriorly and the 
vitreous cortex posteriorly. Anteriorly, the vitreous gel is concave and is 
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attached to the posterior surface of the lens capsule (Weigert’s 
ligament).(Green & Sebag 2006; Sebag & Balazs 1985) 
 The vitreous cortex is a thin layer of vitreous (100μm-300μm) 
surrounding the vitreous body. It may be distinguished from the vitreous 
body by the higher concentration of collagen fibrils.  The anterior aspect of 
the vitreous cortex extends from the vitreous base anteriorly and across the 
posterior surface of the lens. The anterior limit is known as the anterior 
hyaloid face. This region is in direct contact with the aqueous humour 
providing a potential diffusion surface. The posterior vitreous cortex lines the 
surface of the retina behind the vitreous body. The vitreous cortex is absent 
over the optic disc and thinned over the macula. The fibrils of the cortex 
extend parallel to the retina and are thought to insert indirectly into the 
inner limiting membrane of the retina.(Le Goff & Bishop 2008; Foos 1972b; 
Balazs 1975)   
 The vitreous base is an annular zone, straddling the ora serrata. It 
extends 1-2mm anterior to the ora serrata and 3-4mm posterior to the ora 
serrata on the retina. The vitreous in this region is characterised by dense 
collagen fibrils which are strongly adherent to the anterior retina and the 
non-pigmented ciliary epithelium of the pars plana forming an unbreakable 
adhesion.(Foos 1972b; Bishop 2000) 
 1.2.1 Vitreous attachment 
The vitreous is attached to all contiguous structures, but the firmness of 
attachment varies, which has important implications in vitreo-retinal 
pathology: 
Vitreous base- The vitreous base is the firmest zone of attachment between 
the vitreous gel and surrounding structures. Collagen fibres in this region 
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have a radial orientation and are densely interwoven with basement 
membranes from the adjacent retinal and ciliary epithelial cells. Anterior to 
the ora serrata, the fibres insert directly into ‘crypts’ and invaginations in the 
retinal basement membrane or into the plasmalemma of Muller cells.(Foos 
1972a) Posterior to the ora serrata, Foos originally described progressive 
changes in the structure of the vitreous base with age, where interdigitations 
develop between the collagen filaments of the vitreous base and the basal 
layer of the retina. This results in a gradual posterior migration of the 
posterior edge of the vitreous base.(OKUN 1961; Foos 1972a; TENG & CHI 
1957) Vitreous base fibres inserting anterior to the ora serrata are known as 
the anterior loop fibres which play a role in anterior proliferative 
vitreoretinopathy membrane formation and transmission of traction to the 
peripheral retina and ciliary body.(Green & Sebag 2006) 
Optic nerve head – The vitreous cortex is adherent to the periphery of the 
optic nerve head, with vitreous fibrils intermingling with thickened basement 
membranes of Muller cells. The adhesion at this site is strong in young 
people and weakens with age.(Michels RG et al. 1990; GRIGNOLO 1952)  
Lens and Parafoveal area- The cortical vitreous is also moderately adherent 
around the posterior aspect of the lens capsule, the posterior pole and 
margin of the fovea. 
Retinal vasculature - Firm attachments are also present to the retinal vessels 
in the mid-periphery. The attachment to these vessels accounts for the 
bleeding which can occur during a posterior vitreous detachment. The 
cortical vitreous may also be attached to the retina around other areas of 
pathology such as chorio-retinal scars, lattice degeneration and cystic retinal 
tufts.(Michels RG et al. 1990) Figure 1.2 highlights the anatomy of the 




Figure 1.2 – Schematic diagram demonstrating the anatomy of the 
vitreous. 
 
1.3 Vitreous biochemistry 
The vitreous is an acellular extra-cellular matrix consisting mainly of water 
(98%) and contains macromolecules with complementary properties 
responsible for structure and function. The fibrillar macromolecules of an 
extra-cellular matrix provide the shape, strength and flexibility, and the 
charged carbohydrates, (principally gycosaminoglycans) by attracting water 
and counter-ions, provide a swelling pressure that spaces the fibrillar 
proteins and resists compressive forces. The principal fibrillar component 
providing structure to the vitreous is collagen and the principal 
glycosaminoglycan (GAG) is hyaluron (HA).(Bishop 2000; Le Goff & Bishop 
2008)The collagen fibrils provide a scaffold-like structure that is ‘inflated’ by 
the HA.(Sebag 2004) If collagen is removed, the remaining HA forms a 
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viscous solution, if HA is removed, the gel shrinks but is not 
destroyed.(Comper & Laurent 1978) 
 1.3.1 Collagen 
Collagen molecules are formed from 3 polypeptide (alpha) chains which fold 
in a characteristic triple helical formation. This consists of an amino acid 
repeat structure which requires that each 3rd amino acid residue is a glycine 
so that the configuration is (Gly-X-Y), where X and Y can be any amino acid. 
The presence of different amino acids allow for glycosylation or intra-
molecular cross-linking. Vitreous consists of rope like structures composed of 
collagen type II, a hybrid of types V/XI and type IX collagen in a molar ratio 
of 75:10:15.(Bishop 2000; Le Goff & Bishop 2008; Sebag 2004)  
 Type II Collagen 
This accounts for 75% of total collagen. It is secreted as procollagen with 
terminal extensions N-propeptide and C-propeptide. These terminal 
extensions are cleaved by specific enzymes which reduce the solubility of the 
collagen and allow it to participate in fibril formation. The N-propeptide 
undergoes alternative splicing at the mRNA level, where exon 2 is included 
(IIA procollagen) or is not (IIB procollagen). Type IIA predominates in adult 
vitreous, and has been shown to have properties in binding growth 
factors.(Bishop et al. 1994a; Bishop et al. 1994b; Zhu et al. 1999) 
Type V/XI Collagen 
Vitreous contains a hybrid of type V and type XI collagen. This type of 
collagen comprises between 10-20% of vitreous collagen and co-assembles 
with type II collagen to form the fibril core.(Le Goff & Bishop 2008) The N- 
terminal of type XI collagen is retained on the surface and plays an 
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important role in regulating fibril diameter. Collagen V it thought to be 
important in initiating collagen fibril formation.(Blaschke UK et al. 2000; 
Gregory et al. 2000; Wenstrup et al. 2004) 
Type IX Collagen 
Type IX collagen represents approximately 20% of vitreous collagen. It 
covalently links to the surface of the fibrils in a regular periodicity; however 
it cannot form fibrils in isolation. Type IX collagen is a non-fibrillar collagen 
and belongs to the family of fibril-associated collagens with interrupted triple 
helices, which also includes type XII, XIV, and XVI collagen. Type IX 
collagen can exist in a proteoglycan and non-proteoglycan form. In the 
vitreous it is synthesized in proteoglycan form.(Le Goff & Bishop 2008; 
Bishop et al. 1994a; Bos et al. 2001) 
Type VI Collagen 
Recently, Bishop et al have demonstrated that type VI collagen has been 
found in bovine and human vitreous. It is not thought to be a component of 
the collagen fibrils but forms separate micro-fibrils. It has also has a role in 
binding of fibrillar collagen and hyaluronan.(Bishop et al. 1996; Kielty et al. 
1992) Figure 1.3ab illustrates the macro-molecular structure of the vitreous 
in the youthful and aged eye. 
 1.3.2 Non-collagen structural proteins 
Fibrillin 
Fibrillin containing microfibrils have been demonstrated in the vitreous. 
These are a family of glycoproteins present as isolated microfibrils in 
vitreous. (ie. They do not associate with the heterotypic collagen fibrils 
present in abundance.) They tend to be associated with elastin in many body 
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tissues, but this does not appear to occur in the vitreous. The major 
component of these microfibrilins in the eye is fibrillin-1, which contains a 
number of calcium binding epidermal growth factor-like domains. A mutation 
in the gene coding for fibrillin-1 (Ch. 15q21) causes Marfan syndrome, which 
carries an increased risk of RRD. However, it is not known if the changes in 
vitreous structure confer this increased risk or if the risk is related to other 
ocular phenotype features such as myopia and lens dislocation.(Bishop 
2000; Le Goff & Bishop 2008; Mayne et al. 1991; Ren et al. 1991) 
Opticin 
Opticin is a leucine-rich repeat protein which has shown to be a dominant 
extra-cellular protein that binds the heterotypic collagen fibrils of vitreous. It 
is thought to be secreted by the non-pigmented ciliary epithelium and has 
been immunolocalised to the ILM, lens capsule as well as cortical and basal 
vitreous. Opticin may have a role in vitreo-retinal adhesion, associating with 
type XVII collagen/endostatin found at the ILM and it also binds growth 
hormone and several GAGs including heparin sulphate and chondroitin 
sulphate.(Le Goff & Bishop 2007; Sanders et al. 2003; Ramesh et al. 2004) 
Other collagen binding macromolecules of unknown significance have also 
been found including VIT-1 and fibroncetin.(Mayne et al. 1999; Menasche et 
al. 1997)   
Glycosaminoglycans 
Glycosaminoglycans (GAGs) are extracellular molecules composed of long 
chains of repeating disaccharide units, all GAGs except HA are bound to a 
protein core (forming proteoglycans) and undergo varying degrees of 
modification. The vitreous contains HA and small amounts of chondroitin 




Hyaluronan (HA) is the predominant GAG in vitreous and is found in its 
highest concentration in the vitreous cortex. Its’ concentration has been 
shown to increase with age, peaking at 20 years, before increasing again 
after 70 years. HA is a highly hydrated polyanion which forms space filling 
networks and has visco-elastic properties. HA chains can be long and can 
associate with several other chains through entanglement. The entangled 
gel-like nature of the polysaccharide is highly hydrophilic. This water binding 
capacity gives a high optical clarity to the vitreous and also prevents rapid 
movement of water into or out of the vitreous acting to resist large changes 
in the globe volume.(Le Goff & Bishop 2008; Foulds 1987; Sebag 2004; 
Balazs 1975) 
Chondroitin sulphate 
The vitreous contains two CS proteoglycans, collagen IX and versican. Of 
these, versican is present in large quantities. The C-terminal region of 
versican contains several domains and the N-terminal binds to HA supported 
by a link protein. By binding HA at its N-terminal, versican may also interact 
with several other components through its C-terminal. In has been shown 
that versican interacts with microfibrillar proteins fibulin-1 and fibulin-2. 
Mutations altering the CS domains of versican have been implicated in 
Wagner syndrome.(Bishop et al. 1994a; Miosge et al. 1998; Reardon et al. 
1998; Le Goff & Bishop 2008; Bishop 2000; Kloeckener-Gruissem et al. 
2006) 
Heparan Sulphate 
HS proteoglycans are major components of basement membranes and have 
been found on the ILM of the retina. HS is found in higher concentrations in 
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the vitreous during development and concentrations are very low post-
natally.(Halfter et al. 2005; Le Goff & Bishop 2008)(Table 1.1) 
Principal structural proteins in human vitreous 
 
Composit
ion Structural features Distribution 
Collagens 
   
Fibrillar 
collagens 






70% of vitreal collagen; type IIa 
predominates; binds growth factors TGF-β1 













Co-assembles with type II forming fibril core; 
role in regulating fibril diameter and 
initiating fibril formation(Blaschke UK et al. 














Lateral association with type II; binds GAGs; 
role in maintaining regular fibril spacing(Bos 












Lateral association with type I, II and 
hyaluronan; may surround vitreous cortex 
and mediate adhesion between vitreous 
cortex and ILM(Bishop et al. 1996; 





Potential role in anchoring vitreous 
matrix(Ponsioen et al. 2008) ILM 





Forms a two-dimensional network; principal 
component of basement 
membranes(Ponsioen et al. 2008) ILM 









Contributes to vitreous structural support 











Binds heterotypic collagen fibrils; role in 
assembly of collagen fibrils and preventing 
fibril aggregation(Le Goff et al. 2003; Le Goff 





    
    Glycosaminoglycans(GAGs)   - Repeating disaccharide: D-glucuronic 







Major vitreous component; highly 
hydrated; forms space filling 








Complexes with hyaluronan stabilising 
vitreous structure; interacts with ECM 















Table 1.1 – The structural features and known vitreoretinal distribution of 
the principal structural components of the vitreous and vitreoretinal 
interface. (ECM- Extra-cellular matrix)  
 
 
1.4 Vitreo-retinal adhesion 
 1.4.1 Vitreous cortex and inner limiting membrane 
The basement membrane of the Muller cells forms the principal component 
of the inner limiting membrane of the retina.(Green & Sebag 2006) The ILM 
consists of 3 layers, whose thickness varies topographically and increases 
with age – the lamina rara, immediately adjacent to the Muller cells is 0.03-
0.06μm thick and demonstrates no topographic or age related 
changes.(Malecaze et al. 1985) The middle layer, lamina densa is thinnest at 
the fovea and disc (0.01-0.1μm), remaining thin at the vitreous base and 
equator, but thickens at the posterior pole to 0.5μm to 3.2μm. The lamina 
rara externa is the innermost layer, contiguous with the vitreous 
cortex.(Foos 1972b; Foos 1974; Matsumoto et al. 1984; Sebag 1992) The 
vitreal surface of the human ILM is smooth, and the posterior aspect is 
irregular, filling the spaces formed by the underlying irregular membranes of 
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the sub-retinal glial cells. This feature is most marked at the posterior pole.  
At the rim of the optic nerve head, the thickened posterior ILM ends abruptly 
and continues as a thin basement membrane thought to be the basal lamina 
of the astroglial cells in the optic nerve head. (known as the inner limiting 
membrane of Elsching). Over the central portion of the optic nerve head, the 
membrane thins to 20nm and is composed of GAGs and no collagen. (known 
as the central meniscus of Kuhnt) The thinness and chemical composition of 
these areas are thought to account at least in part for the frequency of 
pathological proliferative changes and abnormal cell migration occurring 
around the optic nerve head. Similarly in the foveal area, the density of the 
Muller cell processes decreases significantly and the ILM becomes markedly 
attenuated (10-20nm thick).(Matsumoto et al. 1984; Russell et al. 1991; 
Sebag 1992; Anderson 1970; Heegaard et al. 1988) 
Unlike the dense attachment at the vitreous base, collagen fibrils of the 
cortical vitreous do not appear to insert into the lamina rara externa of the 
ILM, but are orientated parallel to it.(Matsumoto et al. 1984)The particular 
mode of adhesion between the ILM and vitreous cortex remains unknown, 
but the unifying concept is that these two anatomically distinct entities 
adhere together via an extra-cellular matrix ‘glue.’(Green & Sebag 2006)  
Immunocytochemical studies have confimed that laminin, fibronectin and 
collagen type IV are present in human ILM. Collagen type XVIII has been 
identified in the chick and mouse ILM, the absence of which causes 
vitreoretinal separation in mice.(Halfter et al. 1998; Fukai et al. 2002) Type 
IV collagen forms a scaffold-like network that stabilises the ILM and laminin 
molecules form an independent scaffold and can interact with membrane 
receptors.(Timpl 1996; Timpl & Brown 1996) Fibronectin is present on the 
surfaces of most cells and in many extracellular matrices throughout the 
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body. It is an extracellular glycoprotein which binds with high affinity to 
interstitial collagens, proteoglycans, and HA.(Yamada & Olden 1978; 
Pearlstein et al. 1980) Laminin is restricted primarily to basement 
membranes and binds strongly to type IV collagen of epithelial cells.(Timpl 
et al. 1979)  Topographic and age-related variation in the distribution of ILM 
constituents has been noted in human retina.(Kohno et al. 1987; Halfter et 
al. 2000) Immunoflourescent studies of the ILM have shown a bi-laminar 
pattern of fibronectin and laminin in thickened ILM at the posterior pole of 
older eyes. Young eyes did not demonstrate this bi-laminar pattern. This 
association also varies topographically, being weakest at the equator and 
strongest at the posterior pole. (Kohno et al. 1987) There was no correlation 
between the presence of laminin and fribronectin and the occurrence of 
posterior vitreous detachment (PVD), suggesting that changes in the 
biochemical composition of ILM is a prerequisite to PVD.  
Transmission electron microscopy of primate ILM demonstrated the presence 
of carbohydrate rich, Alcian blue staining, non-collagenous material that 
surrounded cortical vitreous and may have a role in fibrillar attachment to 
the lamina rara externa of the ILM.(Matsumoto et al. 1984)Further 
histochemical studies have demonstrated specific binding of lectin 
compounds in neural retinal, as well as an age specific high affinity binding 
in the ILM of young eyes which was absent in older eyes, perhaps 
accounting for the decreased vitreo-retinal adhesion seen in older eyes. 
(Russell et al. 1991) Figure 1.4 highlights the structure of the vitreo-retinal 





1.4.2 Degenerative remodeling 
A spectrum of changes has been observed in the ILM of normal eyes which 
have been termed ‘degenerative remodelling.’ Foos initially described 
changes at the vitreous base, equator and peri-papillary region of the ILM. 
These changes include discontinuity of the ILM, cleft formation and 
separation of Muller cells. In more severe instances, vitreous strands may 
adhere to these degenerative clefts or to the cell membrane of Muller cells 
devoid of basal lamina. Further studies have added evidence to these 
findings, particularly in the equatorial region, where collagen fibrils may 
adhere to widened intercellular spaces between Muller cells and 
morphological reports of “tubuli” and “spiculae” arising from the ILM and 
inserting into the vitreous cortex have added support to this 
concept.(Dunker et al. 1997) Similarly, evidence for a dynamic vitreous base 
has been demonstrated by Wang J. et al where age-dependant intra-retinal 
synthesis of collagen was shown to penetrate the ILM and splice with cortical 
vitreous expanding the width of the vitreous base.(Wang et al. 2003) More 
recently, intra-retinal collagen type II packages have been found in the pre-
equatorial region associated with Muller cells, and this is thought to be the 
result of a process of interactive remodelling where breakdown and 
synthesis of vitreous and ILM collagens takes place, a process similar to that 
which occurs in other extra-cellular matrix components subject to 
mechanical stress (eg. Bone and cartilage).  It thought that the development 
of these regions of abnormal adhesion may predispose to retinal tear 
formation during PVD.(Green & Sebag 2006; Ponsioen et al. 2005; Malecaze 




Figure 1.3ab – Figure 1.3a(above)- Illustrates the collagen (C) structure in 
youthful vitreous, where parallel bundles of collagen fibrils are regularly 
spaced apart (by chondroitin sulphate side chains – thin black lines) in a 
hydrophilic glycosaminoglycan matrix composed primarily of hyaluronan 
(grey background) which ‘inflates’ the collagen structure. The collagen 
bundles form an interconnecting network by branching between bundles.  
With age (figure 1.3b -below), there is loss of the regular collagen spacing 
and aggregation of collagen fibrils, which results in visually perceivable 





Figure 1.4ab – Schematic representation of the vitreo-retinal 
interface(M=Muller cell). Outside the vitreous base (Figure 1.4a-above), the 
dense collagen fibrils of the vitreous cortex are orientated parallel to the 
retina and are thought to be opposed to the retina by a molecular ‘glue’. In 
contrast, at the vitreous base (Figure 1.4b-below), the very dense collagen 
fibres of the vitreous cortex are orientated radial or perpendicular to the ILM 
(inner limiting membrane) of the retina and insert directly into the lamina 





1.5 Ageing changes in the vitreous 
Human vitreous undergoes an age-dependant process of liquefaction.  
Balazs and Denlinger demonstrated that by the age of 14-18 years, 20% of 
the total vitreous volume is liquid. After the age of 40 years, there is a 
steady increase in liquid vitreous and a simultaneous decrease in gel 
volume. By 80-90 years, more than half of the vitreous is liquid.(Balazs & 
Denlinger J.L. 1982) Myopia is associated with more rapidly progressive 
vitreous liquefaction.(GOLDMANN 1964; Foos & Wheeler 1982; Akiba 1993) 
During this process, the collagen fibrils remain as the bulk component of the 
gel vitreous and the hyaluron concentration does not change.(Sebag & 
Balazs 1989) Eisners initial studies and several others since then have 
demonstrated that liquefaction begins in the central vitreous with the 
appearance of macroscopic fibres in the central vitreous. (Sebag & Balazs 
1989; Eisner 1975b; Eisner 1975a; Sebag 1987)  Low power microscopic 
studies have demonstrated that vitreous liquefaction initially occurs in 
pockets (lacunae) which then coalesce. (Sebag 1987; Foos & Wheeler 
1982)EM studies have confirmed that the macroscopic fibres seen in the 
vitreous during this process are bundles of aggregated collagen fibrils which 
are thought to result from the breakdown of the HA/collagen 
macromolecular structure of the vitreous.(Sebag & Balazs 1989)  
 1.5.1 Pathogenesis of vitreous liquefaction 
The youthful homogenous vitreous consists of bundles of collagen fibrils 
dispersed throughout the gel, with individual collagen fibrils spaced apart. 
Two progressive changes occur in the ageing vitreous: synchysis – 
progressive increase in liquefied spaces and syneresis – an increase in 
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optically dense structures.(Foos & Wheeler 1982; Balazs & Denlinger J.L. 
1982; Foos 1972a; Oksala 1978) Several mechanisms are thought to be 
contributory to the progressive liquefaction and aggregation of collagen 
fibrils observed in the aging eye. Ultrastructural studies suggest there is 
progressive lateral fusion of collagen fibrils, resulting in visually perceivable 
aggregates. The fusion of these fibrils results in a redistribution of the 
collagen fibrils, with an increased concentration in the residual gel but a 
decreased concentration of fibrils in other areas, resulting in liquefaction. 
(Sebag & Balazs 1989) Further TEM evidence suggests a reduction in the 
quantity of collagen and  possible enzymatic (in the form of matrix 
metalloproteinases) fragmentation of the collagen fibrils is important in the 
process of liquefaction.(Los et al. 2003) Bishop et al showed that 
progressive age-related changes on the surface of collagen fibrils may play 
an important role in the formation of these aggreagates.(Bishop et al. 2004) 
They found an age-dependant decrease in type IX collagen, which by virtue 
of its chondroitin sulphate side chains may have a role in shielding type II 
collagen from exposure on the fibril surface. This age dependant decline in 
type IX collagen and increased surface exposure of type II collagen was 
thought to predispose to fusion of collagen fibrils on contact. Structural age-
related changes in type II collagen with an increase in molecular weight  and 
size of the alpha-chain have been found in bovine and human eyes.(Akiba et 
al. 1993) Similarly, light-induced free-radical damage to the vitreous has 
caused insolubilization of the vitreous and degradation of HA which may 
contribute to liquefaction.(Akiba et al. 1994) The changes underlying 
vitreous liquefaction are complex, involving age-dependant structural 
changes in the vitreous components and the loss of normal macromolecular 




 1.5.2 Age related changes at the vitreo-retinal interface  
In young eyes, there is an extensive and strong adhesion between the 
posterior vitreous cortex and the ILM of the retina. With age, this adhesion 
weakens and this is likely due to biochemical changes at the vitreo-retinal 
interface.(Sebag 1991) At birth, the vitreous base is at the ora serrata. An 
age dependant increase in the width of the vitreous base has been 
demonstrated in aged human vitreous.(TENG & CHI 1957; Wang et al. 2003) 
This increased migration of the posterior border of the vitreous base (up to 
3.7mm) is more prominent on the nasal aspect and is significantly higher in 
males.  Wang et al suggest that the extension of the vitreous base into the 
peripheral retina is due to the synthesis of ‘new’ vitreous collagen by retinal 
cells. Some of this newly synthesised collagen breaks through defects in the 
ILM and intertwines with pre-existing cortical vitreous, creating new 
adhesions and extending the vitreous base posteriorly. This has important 
implications for the pathogenesis of peripheral retinal breaks and sites of 
increased vitreo-retinal traction during PVD. (Wang et al. 2003)Recently, 
advanced glycation end products have been demonstrated in the aged 
vitreous and they may have a role in the structural alteration of the vitreous 
gel and the predisposition to PVD.(van et al. 2009) 
 There exists an age-dependant thickening in the ILM at the posterior 
pole.(Kohno et al. 1987) This thickening may affect the ability of Muller cells 
to maintain the components of the extra-cellular matrix, thus weakening 
vitreo-retinal adhesion.(Sebag 1991) Similarly, the coating of 
macromolecules may allow collagen fibrils in the cortical vitreous to stick to 
the ILM. Changes in the structural components of  the aged vitreous may 




1.6 Neurosensory retina and retinal pigment epithelium  
The loss of structural interaction between the neurosensory retina (NSR) and 
underlying RPE causes visual loss in patients with RRD. The mechanisms of 
interaction between the neural retina and the RPE  are complex and involve 
mechanical and metabolic factors.  
The RPE is a polarized monolayer of epithelial cells resting on Bruchs 
membrame between the choriocapillaris and the NSR. The apical surface of 
the RPE has a complex anatomical relationship with the outer segments of 
the photoreceptors.(Campochiaro et al. 1986) The RPE microvilli extend and 
interdigitate the photoreceptor outer segments, they play a crucial role in 
disc pahgocytosis and renewal but their role in adhesion is uncertain.(Fisher 
S.K. & Lewis G.P. 2006) They may provide a frictional resistance or an 
electrostatic force that opposes separation but the magnitude of this is 
unknown.(Marmor M.F. 2006) 
The interphotoreceptor matrix (IPM) is a viscous material composed of 
glycoproteins, proteoglygans and GAGs.(Adler & Klucznik 1982; Porrello & 
LaVail 1986) The IPM has component structures that play a role in adhesion. 
Cones and rods are surrounded by a specialized matrix that binds peanut 
and wheatgerm agglutin respectively. This matrix remains attached to both 
RPE and cones and stretches markedly to maintain this attachment when the 
NSR is peeled from the RPE, suggesting a strong bond. The evidence for this 
is strongest with respect to cones but is exists for rod photoreceptors 
also.(Hollyfield et al. 1989; Hageman & Johnson 1986; Johnson et al. 1986; 
Hageman et al. 1995)  Other evidence suggesting the importance of the IPM 
in adhesion is gleaned from experimental studies where enzymes degrading 
proteoglycans have been given intra-vitreally or directly into the IPM and 
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have resulted in marked loss of adhesion in primate eyes.(Yao et al. 1990; 
Yao et al. 1994; Marmor et al. 1994)  
Although the mechanical adhesion may largely be maintained through the 
IPM, post mortem and primate studies have also demonstrated the 
importance of active metabolism and continuous oxygenation in maintaining 
the adhesive strength.(Marmor et al. 1994; Yao et al. 1994; Marmor & Yao 
1995; Kim et al. 1993) 
The RPE actively transports water from the subretinal space to the choroid. 
This active transport, as well as dehydrating the sub-retinal space, is an 
important factor in maintaining adhesion. Drugs interfering with this active 
transport have shown to reduce retinal adhesiveness.(Marmor & Maack 
1982; Marmor & Negi 1986; Hughes et al. 1984)Intra-ocular pressure and 
high retinal flow resistance through the impermeable RPE exert an outward 
hydrostatic force applying continual pressure on the ocular layers.(Toris et 
al. 1990; Marmor M.F. 2006)Osmotic pressure also plays a role in 
maintaining retinal adhesion. This is supported by in vivo studies where 
intravenous injections of Mannitol have increased retinal adhesion by 
50%.(Kita & Marmor 1991)The combination of these factors maintain retinal 
adhesion under normal conditions. Once RRD occurs, these mechanisms of 
normal adhesion become compromised causing loss of adhesion with 
consequential visual loss. 
 
1.7 Posterior vitreous detachment (PVD) 
 Foos originally noted the relationship between vitreous liquefaction 
and PVD. He noted a strong correlation between the extent of vitreous 
syneresis and the prevalence of PVD, showing that only a certain amount of 
liquefaction can be tolerated until the residual vitreous gel collapses causing 
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a PVD.(Foos & Wheeler 1982) PVD results from weakening of the vitreous 
cortex and ILM adhesion in conjunction with progressive liquefaction so that 
liquefied vitreous passes through the vitreous cortex into the ‘retro-hyaloid’ 
space dissecting the vitreous body from the ILM. The PVD progresses to 
detach anteriorly as far as the vitreous body, where strong attachments 
prevent further progression.(Michels RG et al. 1990) In order for a PVD to 
occur without clinical complications, the extent of liquefaction and weakening 
of vitreo-retinal adhesion must occur concurrently and to a similar 
extent.(Sebag 2004) Sebag describes a unifying concept of an anomalous 
PVD, where the extent of liquefaction exceeds the degree of weakening 
vitreo-retinal adhesion resulting in traction at this interface responsible for 
clinical complications such as retinal tears and RRD. In this framework, an 
incomplete PVD with sites of persistent vitreoretinal adhesion are need to 
precipitate a retinal break.(Sebag 2004)  
 1.7.1 Incidence of PVD   
The incidence of PVD in normal populations is age dependant and varies with 
the method employed in examining the vitreous. Biomicroscopic examination 
reveals an overall incidence of 28% increasing to 53% in people of 50 
years.(PISCHEL 1952)Autopsy studies demonstrated the presence of PVD in 
one eye in 27% of people aged 60-69 years and in 63% of people over 70 
years.(Foos & Wheeler 1982) More recent ultrasonography studies support 
the higher frequency of PVD in the elderly, but found an overall lower 
incidence where 46% had a complete PVD in the 80-89 year age 
group.(Weber-Krause & Eckardt 1997)The incidence of PVD is higher after 
certain surgical procedures. One year after uncomplicated 
phacoemulsification only 41.4% of eyes did not have a PVD.(Mirshahi et al. 
2009) It has also been noted that PVD occurs earlier in life and more 
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frequently in females than in males.(Foos & Wheeler 1982; Yonemoto et al. 
1996)  
 1.7.2 Relationship between PVD and RRD 
A posterior vitreous detachment is the most common cause of a retinal tear, 
which is the critical event in RRD formation.(Coffee et al. 2007) The reported 
incidence of retinal tears in patients with acute symptomatic PVD varies 
between 8-46%.(Tasman 1968; Murakami et al. 1983; Novak & Welch 
1984; Byer 1994) A recent meta-analysis indicating that the rate of retinal 
break after symptomatic PVD is 21.7%.(Coffee et al. 2007) Discovery of 
retinal tears is important in preventing retinal detachment. Risk factors for 
developing a retinal tear with a symptomatic PVD include myopia, trauma, 
previous cataract surgery, lattice degeneration, previous retinal detachment 
in the fellow and a family history of retinal detachment.(Dayan et al. 1996; 
Boldrey 1994; Tielsch et al. 1996) Approximately one half of eyes with a 
symptomatic retinal tear and persistent vitreoretinal traction will go on to 
develop RRD.(Davis 1974; Shea et al. 1974) In contrast, asymptomatic 
retinal breaks in phakic eyes show a very low progression to clinical retinal 
detachment (<1%).(Byer 2001; Byer 1998) 
 1.7.3  Relationship between PVD and myopia 
PVD and RRD in myopes occurs more frequently and at a younger 
age.(Akiba 1993) Development of vitreous liquefaction is more extensive 
and occurs earlier in these eyes and is significantly correlated with an axial 
length of >30mm.(Morita et al. 1995)Several studies have addressed the 
relationship between vitreous liquefaction and high myopia demonstrating an 
earlier onset of rheologic changes in the vitreous with large lacunae 
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formation and extensive syneresis.(Green & Sebag 2006; Morita et al. 1995; 
Grossniklaus & Green 1992)  
 
1.8  Rhegmatogenous retinal detachment 
 The invention of the Ophthalmoscope by Hermann von Helmholtz in 
1850 enabled physicians to visualise the retina. Further developments of the 
ophthalmoscope led to the discovery of retinal breaks by Albrecht von 
Graefes in the latter part of the 19th century. However, their association with 
rhegmatogenous retinal detachment (RRD) remained unknown for many 
years. So pessimistic was the morale at the time that in 1904, at the 
International Congress in Paris, retinal detachment was declared 
untreatable. Motivated by this declaration, a Swiss Ophthalmologist, Jules 
Gonin performed extensive studies into the pathogenesis of RRD and came 
to the conclusion that RRD is caused by small breaks in the peripheral 
retina. He is credited with performing the first intervention to close these 
retinal breaks and treat RRD - a principal which is still in use in surgical 
procedures today.(Sodhi et al. 2008; Gonin J. 1930; Wolfensberger 2003)  
 It has been estimated that one in 300 people will develop a 
rhegmatogenous retinal detachment in their lifetime.(Haimann et al. 1982b) 
In west Scotland, Ireland and southwest England up to 2% of blind and 
partial sight registrations are due to RRD.(Bamashmus MA. et al. 2004; Grey 
RH et al. 1989; Munier A et al. 1998)At present treatment modalities for 
RRD are predominantly in-patient surgical procedures.  In-patients admitted 
with RRD may comprise up to one in five ophthalmology in-patients in 
specialised centres.(Li 2003)  
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1.9 Pathogenesis of rhegmatogenous retinal 
detachment 
Rhegmatogenous retinal detachment (RRD) is characterized by the presence 
of a full thickness retinal break. This break is held open by vitreoretinal 
traction that allows accumulation of liquefied vitreous under the retina 
separating it from the RPE. Therefore, the precursors to RRD are liquefied 
vitreous, tractional forces that can produce and maintain a retinal break, and 
a break through which fluid gains access to the subretinal space. (Ghazi & 
Green 2002; Wolfensberger 2003) 
 Most eyes with retinal breaks do not develop RRD because the 
physiological forces attaching the NSR to the RPE are sufficient to hold the 
retina in place. However, when the opposing forces involved in RRD 
pathogenesis (vitreo-retinal traction, currents within the vitreous, 
gravitational forces) overwhelm the forces of attachment and liquefied 
vitreous fluid passes into the sub-retinal space at a faster rate than can be 
removed by the RPE, RRD results.(Michels RG et al. 1990)  
 A retinal break occurs when the vitreous detaches posteriorly and 
reaches a point of firmer attachment of the vitreous to the retina causing 
traction at that point. This commonly occurs around areas of exaggerated 
vitreo-retinal adhesion, such as the posterior margin of the vitreous base, 
areas of lattice degeneration or other vitreoretinal degenerations and around 
equatorial blood vessels. As the process of vitreous detachment continues 
and the vitreous remains attached to the flap of the tear, a horse-shoe tear 
(HST) will result. On the other hand, if the vitreous traction is strong enough 
to cause avulsion of the retinal tear at its base, a round hole (RH) results 
and the traction resolves. These are the two most common type of breaks 
causing RRD.(Michels RG et al. 1990; Ghazi & Green 2002; Machemer 1984)  
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 An RRD is typically defined as a full thickness break in the retina that 
allows liquefied vitreous to enter the subretinal space and extend for 2 disc 
diameters.(Schepens 1951) Depending on the location of this pathology RRD 
can be equatorial, oral or macular. Equatorial RRD is the most common, 
occurring with myopia, horse-shoe tears, round holes and lattice 
degeneration. Oral RRD is seen in dialysis, giant retinal tears and trauma. 
Macular RRD is seen in high myopia and traumatic macular holes.(Ghazi & 
Green 2002) 
 The incidence of retinal tears in clinical series has been noted 
between 1-7.8%.(Halpern 1966; Byer 1967; Rutnin & Schepens 1967; 
Smith & Ganley 1972) In post-mortem studies, this has varied between 3.3-
27%.(Foos et al. 1983; Foos 1975; Barishak & Stein 1972; Foos 1974) The 
incidence of retinal tears is much higher than RRD and Byer noted a 
prevalence of RRD and retinal breaks in a ratio of 83 to 1, with long-term 
studies of asymptomatic retinal breaks rarely progressing to symptomatic 
retinal detachment.(Byer 1967; Byer 1982; Byer 1974b) 
 As well as a retinal break, sustained traction and movement of 
liquefied vitreous are necessary for the development of RRD. Gravitational 
forces on superior retinal breaks can cause sustained traction and increase 
the progression to RRD. Rotary eye movements and shifting of the vitreous 
gel cause flow currents to develop in the liquid vitreous. Recent 
biomechanical studies demonstrate that even slight rotary eye movements 
can cause significant flow currents to develop in the liquid vitreous.(Repetto 
et al. 2005) When the eye rotates, the inertia of the detached vitreous 
causes it to lag behind the rotation of the eye and retina, and exerts a 
tractional force perpendicular to the site of vitreoretinal adhesion, which can 
cause or extend a retinal break. The sustained traction and currents in the 
vitreous allow the passage of liquefied vitreous through the retinal break, 
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dissecting the NSR away from the RPE and extending the area of 
detachment.(TENG & CHI 1957; Rosengren & Osterlin 1976; Michels RG et 
al. 1990) 
  
IDIOPATHIC RETINAL DIALYSIS 
Idiopathic retinal dialyses are known to account for 1.8% of RRD in large 
series.(Kinyoun J.L & Knobloch W.H 1984) They are defined as 
circumferential tears along the ora serrata with vitreous attachment to their 
posterior margin. They are often found inferotemporally and in a high 
proportion bilaterally.(Hagler 1980) Some authors suggest a developmental 
abnormality in their pathogenesis; others believe almost all are due to an 
unremembered trauma.(Verdaguer et al. 1975; Ross 1991) Retinal dialyses 
are slowly progressive and often show signs of chronicity such as 
demarcation lines or intraretinal cysts at presentation.(Michels RG et al. 
1990; Kanski J & Menon J 2003)  
GIANT RETINAL TEARS (GRT) 
Giant retinal tears are responsible for up to 2% of RRD in large 
series.(Ashrafzadeh et al. 1973) Most tears are idiopathic.(Ang et al. 2010) 
GRTs occur more commonly in males, are associated with myopia and with 
certain collagen disorders, primarily Stickler syndrome. GRT is may be due 
to blunt trauma and in these cases there is usually avulsion of the vitreous 
base throughout the length of the tear.(Freeman et al. 1974) Giant retinal 
tears are defined as circumferential retinal breaks of 90 degrees or more. 
The tear is usually along the posterior margin of the vitreous base and rarely 
they may occur at the anterior margin in the ciliary epithelium. As a direct 
result of circumferential extension, GRTs tend to adopt a  rolled or inverted 
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edge and can require complex surgical repair.(Michels RG et al. 1990; 
Kanski 1975) 
MACULAR HOLE (MH) 
Macular holes are an uncommon cause of RRD. In the West their incidence is 
estimated between 0.5 – 1% being higher in Asian countries. Macular hole 
RRD occurs more frequently after blunt trauma or in highly myopic 
eyes.(Zhang & Hu 1982; Leaver & Clearly 1975) 
1.10  Clinical Features of rhegmatogenous retinal 
detachment 
SYMPTOMS 
Symptoms of RRD are not reliable indicators of RRD. Most patients with RRD 
notice a variety and often a combination of symptoms including floaters 
(60%)  or flashes (55%) often followed by a shadow and loss of vision in up 
to 80% of cases. Over 75% of patients may present with sudden painless 
loss of vision. Other symptoms include dyschromatopsia, ocular pain and 
diplopia. A small proportion (7%) of patients may be 
asymptomatic.(Polkinghorne & Craig 2004a; Kanski J & Menon J 2003) 
SIGNS 
An acute RRD typically has an opaque, convex configuration and undulates 
freely with eye movements with a loss of underlying choroidal pattern. There 
may be pigmented cells in the anterior vitreous (Schafer’s sign), vitreous 
hemorrhage and PVD (seen as a Weiss ring on biomicroscopy). The intra-
ocular pressure is usually lower in the affected eye and if extensive, there 
may be a relative afferent papillary defect. Long-standing or chronic RRD 
may show retinal thinning, the presence of intra-retinal cysts (if present for 
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over 1 year) or subretinal demarcation lines. These subretinal demarcation 
lines are caused by the proliferation of RPE cells at the junction of the 
attached an unattached retina, and my take several months to 
develop.(Kunimoto DY et al. 2004; Kanski J & Menon J 2003) 
PROLIFERATIVE VITREORETINOPATHY (PVR)   
PVR is an anomalous scarring condition caused by cellular proliferation and 
contraction of membranes on the posterior surface of the detached hyaloid 
membrane, the inner retinal membrane (epiretinal membrane) and the outer 
retinal membrane (subretinal membrane). This membranous proliferation 
causes tractional bands within the vitreous, retinal folds (star folds) and 
increased retinal rigidity. It the commonest cause of surgical failure in RRD 
and can complicate surgery if present preoperatively. It is thought to be 
present in approximately 7% of RRD cases and is much more likely if several 
features are also present: GRT, multiple retinal tears, uveitis, aphakia or 
vitreous hemorrhage. The classification of PVR is defined by the American 
Academy of Ophthalmology and varies in severity from Grade A (minimal) to 
Grade D (massive).(Pastor 1998; Girard et al. 1994; 1983)   
1.10.1   Treatment of rhegmatogenous retinal detachment 
The management of asymptomatic RRD is controversial, with studies 
supporting conservative (observation) management and surgical treatment 
in high-risk cases or cases with likely progression to involve the macula. 
Symptomatic RRD is an indication for surgical repair.   
PROPHYLAXIS 
No defined guidelines exist for preventative treatment of RRD in patients 
with predisposing retinal degenerations. Recent evidence supports 
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prophylactic treatment for symptomatic retinal tears, retinal breaks 
threatening progression, high risk fellow eyes of non traumatic GRT and 




Scleral buckling surgery involves an inward indentation of the sclera using a 
‘buckle’ explant. These may be radial, partially circumferential or encircling. 
The principal is to close the retinal break by apposing the RPE to the 
neurosensory retina and to reduce dynamic vitreoretinal traction at the site 
of the break. It is the method of choice for uncomplicated RRD, has proven 
long-term effectiveness in retinal attachment and current evidence suggests 
a final anatomic success rate of 94%.(Schwartz et al. 2002; Kanski J & 
Menon J 2003; Sodhi et al. 2008)  
Pars Plana Vitrectomy (PPV) 
Initially used in complicated cases of RRD pars plana vitrectomy is becoming 
an increasingly performed procedure for all cases of RRD. PPV is a 
microsurgical procedure which aims to remove the posterior hyaloid face, 
relieve vitreoretinal traction, manipulate and reattach the retina and create 
space for internal tamponade. Numerous agents can be used for internal 
tamponade including gas (sulphur hexafluoride, perfluoropropane), heavy 
liquid (perfluorocarbon) and silicone oil. The instrumentation and techniques 
used for PPV are continually being advanced and improved. PPV holds 
numerous advantages over scleral buckling including better visualisation of 
the posterior pole as well as the ability to remove and manipulate opacities 
and proliferative membranes. PPV has a high final success rate of up to 95% 
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in RRD complicated by PVR, pseudophakia or multiple breaks.(Sodhi et al. 
2008; Kanski J & Menon J 2003; Schmidt et al. 2003) 
Pneumatic retinopexy 
This technique was initially described in 1986. It involves the injection of an 
intra-vitreal gas tamponade without PPV or scleral buckling. It is useful in 
selected cases; uncomplicated RRD caused by small closely clustered retinal 
breaks in a narrow area of the superior retina. It has the advantage of being 
minimally invasive with reduced recovery time, however because it does not 
relieve vitreo-retinal traction, a re-detachment risk persists. Primary success 
rate is 64%, and final success rate is 91%. (Hilton & Grizzard 1986; Sodhi et 
al. 2008; Kanski J & Menon J 2003)  
 1.10.2    Visual outcome after RRD surgery 
 Macular attachment at presentation is one of the most important predictors 
of final visual outcome. Despite advances in surgical treatment functional 
results after RRD repair remain poor with visual acuity of >20/40 (6/12) 
only achieved in 28.4% of cases where the macula is detached.(Pastor et al. 
2008)This finding is further supported by Minihan et al, who demonstrated 
that both primary and final anatomic success rates were similar in two 
studies conducted 20 years apart (80-84% in 1979 and 89-94% in 
1999).(Minihan M. et al. 2001) There has been much controversy over which 
surgical method should be used to treat RRD.(Sodhi et al. 2008) However 
there has only been one large randomized multi-centre trial which 
demonstrated no difference in final visual acuity between PPV and scleral 
buckling in pseudophakic cases but an improved final visual outcome with 





1.11  Risk factors influencing RRD development 
 1.11.1   Myopia 
Myopia is an error of refraction primarily caused by increased axial length 
but may also be caused by corneal or lenticular changes. Myopia and 
especially high myopia have been established as one of the major risk 
factors for RRD.(C.L.Schepens 1961; Cambiaggi 1964; Druault-Toufesco S 
1922) High myopia is defined as a spherical equivalent of -6.0 dioptres (D) 
or an axial length (AL) of at least 26mm.(Curtin BJ 1985) Myopic eyes are 
more likely to develop retinal tears after PVD than non-myopic eyes.(Grand 
2003; Byer N.E 1979) It has been reported that an eye with a spherical 
equivalent refractive error of between -1 to -3 D has a fourfold increased 
lifetime risk of RRD compared to a non myopic eye, increasing to tenfold 
with a refractive error of >-3D. (Austin et al. 1990; The Eye Disease Case-
Control Study Group 1993) Furthermore, an increase in axial length of 1mm 
increases the risk of RRD by a hazard ratio of 1.3.(Ninn-Pedersen & Bauer 
1996) Myopic patients are more likely to have RRD at a younger age and 
more likely to develop bilateral RRD. (Burton et al. 1983; Michels RG et al. 
1990; The Eye Disease Case-Control Study Group 1993; Burton 1989; Li 
2003; Yonemoto et al. 1994) 
Myopia predisposes to RRD through increased vitreous liquefaction, PVD at a 
younger age and an increased incidence of predisposing vitreoretinal 
degenerations such as lattice degeneration. The presence of specific factors 
and biochemical changes which weaken vitreo-retinal adhesion in myopic 
eyes remains to be resolved. It has been postulated that compromised 
Muller cell function may play a role in weakening adhesion as is 
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demonstrated by abnormal b-wave amplitude in high myopes on 
electroretinogram.(Sebag 1991; Morita et al. 1995) Age related changes 
such as ILM thickening cannot account for the early onset of RRD noted in 
these patients. Developmental studies where myopia was induced in newly 
born chicks demonstrated an increase in the volume of vitreous in myopic 
compared to non-myopic eyes, indicating that perhaps a developmental 
factor may influence early liquefaction in highly myopic eyes.(Pickett-Seltner 
et al. 1992) In humans, this is supported by connective tissue disorders such 
as Stickler syndrome and Wagner syndrome exhibiting vitreous degeneration 
and varying degrees of myopia, suggesting that a type of developmental 
dysgenesis of the vitreous in myopic eyes may have an important role in 
conferring this increased risk. 
 1.11.2    Trauma  
Blunt trauma is an important cause of retinal breaks and subsequent RRD. A 
blunt contusion is thought to cause a change in the in the antero-posterior 
diameter of the eye followed by a sudden compensatory lengthening. This 
causes marked vitreo-retinal traction and can result in retinal breaks such as 
peripheral dialysis, avulsion of the vitreous base, macular holes and horse-
shoe shaped tears at the posterior margin of the vitreous base or equator. 
These breaks usually occur at the time of impact and can progress 
slowly.(Ghazi & Green 2002; Sodhi et al. 2008; Cox et al. 1966)Penetrating 
ocular injury may directly cause RRD and these tend to have a poor 
prognosis.(Cox & Freeman 1978) 
 1.11.3    Cataract surgery 
Uncomplicated cataract extraction regardless of method employed increases 
the risk of retinal detachment. This is thought to be due to a higher rate of 
PVD after cataract extraction as a result of more tractional forces after lens 
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removal and a lower concentration of hyauronic acid contributing to vitreous 
collapse.(Ghazi & Green 2002) The long-term incidence of retinal 
detachment after cataract extraction varies with the method of cataract 
surgery - studies have estimated this at  0.4-3.6% for intra-capsular 
cataract extraction, 0.55-1.65% for extra-capsular cataract extraction and  
0.41%- 1.65% for phacoemulsification. (Lois & Wong 2003; Boberg-Ans et 
al. 2003) The incidence is much higher if cataract surgery is complicated by 
posterior lens capsule rupture (up to 7%).  Up to half of RRDs after cataract 
extraction will occur within the first year after the initial surgery.  The 
cumulative risk of RRD post cataract surgery increases linearly with time. 
(Javitt et al. 1994; Norregaard et al. 1996)The cumulated six year risk of 
RRD is increased by a factor of 6 to 8 after cataract surgery and this risk 
continues to increase for at least eight years after surgery, possibly up to 20 
years postoperatively. (Norregaard et al. 1996),(Erie et al. 2006) (Boberg-
Ans et al. 2006)  
 1.11.4    Posterior capsulotomy 
Posterior capsule opacification occurs in 20-30% of eyes after cataract 
surgery and is the most common post-cataract surgery complication. The 
treatment of choice for this is Nd:YAG capsulotomy (Nd:YAG). The incidence 
of RRD after Nd:YAG is reported between 0-4.1% after a four year follow 
up.(Lois & Wong 2003) Few studies have estimated the risk of Nd:YAG as a 
risk factor independent of cataract surgery, however, Javitt et al found the 
relative risk of RRD in patients who underwent Nd:YAG compared to those 
who didn’t was 3.9.(Javitt et al. 1992) It is thought that an alteration in 
vitreous structure, or disruption of the anterior hyaloid membrane may be 
responsible for this increased incidence. Changes in energy used and size of 
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capsule disruption did not appear to influence risk of RRD.(Dardenne et al. 
1989; Koch et al. 1989; Rickman-Barger et al. 1989) 
1.12  Peripheral retinal degeneration  
 There are several peripheral retinal lesions which cause anomalies in vitreo-
retinal adhesion predisposing to RRD. These include lattice degeneration, 
oral bays, meridional folds, retinal tufts, white without pressure and 
pavestone degeneration. 
 1.12.1    Lattice degeneration 
Lattice degeneration was first described by Gonin in 1930 as “brilliant white 
trellis” and is now known to be the most common vitreo-retinal 
degeneration.(Gonin J. 1930) Lattice degeneration occurs early in life and 
the peak prevalence is in the second decade. The prevalence of lattice 
degeneration is similar in worldwide reports:  In the US it is seen in 6-8% of 
normal eyes (Byer 1965; Straatsma BR et al. 1974) and in Japan in 
9.5%.(Shiomi Y 1981) It is frequently associated with myopia and is the 
most important peripheral retinal degeneration predisposing to RRD.(Lewis 
2003) The prevalence of lattice increases with increasing myopia from 4.3% 
in emmetropia to 14% in myopia of >-3D. Its prevalence is also associated 
with increasing axial length being present in 15% of eyes with an axial 
length of at least 30mm and in less than 7% of eyes with axial lengths less 
than 27mm. (Burton 1989; Michels RG et al. 1990; Ashrafzadeh et al. 1973) 
Lattice degeneration is bilateral in up to 48% of affected cases. Lattice 
lesions are usually numerous with the average between 2 and 24 lesions. It 
is found most commonly in the vertical meridian and inferotemporal retinal 
quadrants.(Byer 1965; Byer N.E 1979) Lattice degeneration has numerous 
morphological features, but the pathogenesis remains largely unknown. 
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Lattice degeneration often exhibits pockets of overlying cortical vitreous 
liquefaction. Foos examination of eyes at autopsy demonstrated that this is 
not associated with the central progressive liquefaction occurring as a 
natural process of ageing, indicating that PVD is not the basis for the higher 
rate of RRD in these eyes.(Foos & Simons 1984) EM studies have 
demonstrated several retinal and vitreous abnormalities in regions of lattice 
degeneration. These include alterations in ILM and absence of basement 
membranes over the surfaces of lesions as well as an increased presence of 
astrocytes.(Straatsma BR et al. 1974; Streeten & Bert 1972)   
  Clinically, lattice degeneration is a circumferentially distributed, 
sharply demarcated, elliptical area of peripheral retinal thinning with variable 
pigmentation. These lesions are often described as lattice-like white lines or 
shiny snail track variations associated with ovoid pigmented craters. They 
are often characterised by a criss-crossing network of hyalinised vessels with 
exaggerated vitreoretinal attachments along the edge of the lesion.(Byer 
1975; Byer N.E 1979) Tractional retinal tears associated with lattice are 
frequent, noted in 64-83% of clinical series.(Byer N.E 1979) The most 
common cause of RRD associated with lattice is due to tractional retinal 
tears which can occur at the lateral and posterior margin of a lattice lesion 
during PVD due to strong retinal adhesion. However, secondary atrophic 
retinal holes within areas of lattice can be present in up to 30% of eyes and 
can cause a localised detachment which may become progressive.  
Radial perivascular lattice is a ‘lattice-like lesion’ predisposing to RRD. It is 
distinct from lattice degeneration. It is usually found post-equatorially and is 
characterised by broad ill-defined lesions. There is a high incidence of retinal 
tears associated with this lesion, and it typically occurs with Stickler 





 1.12.2    Lattice degeneration and the risk of RRD 
Although lattice degeneration is a risk factor for RRD, the large majority of 
patients with lattice do not develop RRD. The incidence of RRD from atrophic 
holes and tractional tears associated with lattice is estimated between 0.3-
0.5%. Hyams and Byers followed a group of patients with lattice 
degeneration for up to 10 years and found that only 1.4% progressed to 
RRD. Progression to RRD is more likely in young myopic eyes with lattice 
degeneration due mainly to round holes within areas of lattice degeneration. 
(Byer 1974a; Byer N.E 1979; Straatsma BR et al. 1974; Hyams et al. 1974) 
At present there is no scientific evidence to suggest beneficial prophylactic 
treatment of eyes with lattice with or without associated retinal breaks and 
prophylaxis is considered on a case per case basis.(Lewis 2003),(Michels RG 
et al. 1990; Byer 1974a)  
 1.12.3    Oral bays 
Oral bays are areas of retinal indentation near the ora serrata and may be 
completely surrounded by retinal tissue (enclosed) or incompletely 
surrounded by retinal tissue (partially enclosed). Oral bays are present in 
3% of eyes in a large autopsy series. Enclosed oral bays are more significant 
for RRD development as they mimic retinal holes.  In a series of 1000 
autopsy eyes, a retinal tear was associated with an oral bay in 17% of 
cases.(Michels RG et al. 1990; Spencer et al. 1970a) 
 1.12.4    Retinal tufts 
Retinal tufts may be non-cystic, cystic or zonular. Non-cystic tufts are not 
associated with retinal detachment. Cystic tufts are congenital projections of 
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fibroglial tissue into the vitreous cavity and may be associated with up to 6% 
of retinal holes. Cystic tufts are frequently located around the equator; they 
are unilateral in 80% of cases and are present in 5% of the population. They 
represent areas of strong vitreoretinal adhesion and are associated with 
retinal tears. Tears around areas of cystic tufts have been reported as being 
responsible for up to 10% of RRD. However the longterm risk of RRD from a 
cystic retinal tuft is 0.28%.(Byer 1981; Lewis 2003; Murakami-Nagasako & 
Ohba 1982) 
Zonular tufts are anterior projections of fibroglial tissue which are 
continuous with the lens zonlules. Zonular tufts are present at birth, bilateral 
in 15% and usually located in the nasal quadrant. They provide a means 
whereby direct zonular manipulation can cause retinal traction and rarely 
may be associated with RRD after cataract extraction.(Ghazi & Green 2002; 
Foos 1969)  
Meridional folds and complexes are found in 12% and 20% of normal eyes 
respectively. Meridional folds are elevated radial retinal folds with the 
majority emerging from dentate processes. Histologically, they are areas of 
thickened retina with cystic degeneration and may have vitreous 
attachment. Meridional complexes describe the presence of a dentate 
process in the same meridian as a ciliary process.  Through abnormal 
vitreous attachment, both may be associated with an increased incidence of 
retinal breaks, however the association with risk of RRD is weak.(Spencer et 
al. 1970b; Michels RG et al. 1990; Ghazi & Green 2002) 
 1.12.5    Degenerative retinoschisis 
Retinoschisis describes a splitting of the neurosensory retina into two layers, 
an inner (vitreous) layer and an outer (choroidal) layer. Degenerative 
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retinoschisis is associated with retinal detachment in 2-6% of 
cases.(McPherson et al. 1981) First delineated by Straatsma and 
Foos(Straatsma & Foss 1973), there are two types of degenerative 
retinoschisis based on the type of pre-existing cystoid degeneration that 
progresses to cause  retinoschisis. Degenerative retinoschisis is preceeded 
by peripheral cystoid degeneration of the retina which can be either typical 
(flat) or reticular (bullous). Typical cystoid degeneration is usually bilateral 
and results in cystic retinal spaces which coalesce at the ora serrata and 
extend circumferentially and posteriorly. The cystic spaces develop between 
the outer plexiform and inner nuclear layers of the retina. Typical cystoid 
degeneration is not associated with any pathological lesions or anatomical 
variations. Reticular cystoid degeneration is less common than the typical 
form and is frequently nasal and in the inferotemporal quadrant. Reticular 
cystoid degeneration is the more severe form, causing loss of ganglion cells 
and the development of cystic spaces bounded by the inner plexiform layer 
and the thin internal limiting membrane. Typical retinoschisis is present in 
1% of autopsy eyes, is bilateral in 33%, associated with a hypermetropic 
refractive error in up to 80% and is usually located inferotemporally. 
Reticular retinoschisis is slightly more common (1.6%), extends posterior to 
the equator in nearly all cases and is also located 
inferotemporally.(Straatsma & Foss 1973; Michels RG et al. 1990) 
There are 2 types of RRD associated with degenerative retinoschisis. The 
first is a localized, relatively stable RRD which occurs when there is a hole in 
the outer layer only. This is the most common form of RRD associated with 
retinoschisis and is found in 6.4% of clinically followed up eyes.(Byer 1968) 
Rarely, progressive symptomatic RRD can occur from retinoschisis and 
retinal breaks in both the outer and inner layers. Data on the proportion of 
cases that develop this complication varies significantly, but is thought to be 
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quite low (0.5%). Treatment for RRD associated with retinoschisis is usually 
limited to patients who develop symptomatic, progressive RRD.(Lewis 2003) 
 1.12.6    Pavingstone degeneration 
Sometimes referred to as ‘chorioretinal atrophy’ or ‘cobblestone 
degeneration,’ pavingstone degeneration are lesions of flat, pale and well 
demarcated appearance in the retinal periphery anterior to the equator. First 
described in 1855 these lesions are seen in 35% of over 80 year 
olds.(Michels RG et al. 1990) They are bilateral in the majority of myopes 
(57%) and are present in over 50% of eyes with an axial length greater than 
28mm.  Histologically they show absence of underlying choriocapillaris and 
loss of RPE. The pathology of these lesions is linked to choroidal vascular 
insufficiency. Pavingstone degeneration does not predispose to RRD but if 
involved in an area of retinal detachment, a secondary break may occur 
which can be difficult to identify clinically.(O'MALLEY et al. 1965) 
 1.12.7    White without pressure 
The terms “white with pressure” (WWP) and “white without pressure” 
(WWOP) refer geographic areas of white discolouration in the peripheral 
retina. The former occurring with sclera indentation, the latter, considered to 
be more important, is apparent without indentation. These areas are 
circumferentially orientated usually in the temporal quadrants and extend for 
a variable distance posteriorly with an irregular sharply defined 
border.(Lewis 2003) WWOP is found in 15-22% of normal eyes. It is much 
more common in young myopes, with reports indicating that over 30% of 
young individuals with an axial length of greater than 33mm have 
WWOP.(Pierro et al. 1992; Shukla & Ahuja 1982) Histologically, there is 
localised atrophic change, and loss of the ILM with some authors speculating 
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that WWOP may be an earlier stage of another degeneration.(Curtin BJ & 
Karlin DB 1971; Pierro et al. 1992) WWOP is not thought to confer a 



















CHAPTER 2 The epidemiology of 
rhegmatogenous retinal detachment 
 
2.1 Comprehensive review of RRD epidemiology  
 
In this section I present a comprehensive review of previous population 
based studies examining the epidemiology of rhegmatogenous retinal 
detachment. 
I conducted a Medline database search from January 1970 to January 2009 
using search terms ‘incidence,’ ‘population,’ ‘epidemiology’ and 
‘rhegmatogenous,’ ‘retinal detachment’ in different combinations. The search 
engine Google Scholar was also used to identify relevant articles published in 
books, journals and websites. Further articles were identified by tracking the 
references of relevant publications. Studies were eligible if they were 
observational and designed to estimate RRD incidence. Paediatric studies 
were excluded. Articles published in other languages were included and if 
needed translated. Articles published as letters or abstracts were excluded. 
(see Figure 2.1)      
The titles and abstracts of all articles found were reviewed. I developed a 
checklist (Appendix A), based on the STROBE recommendations,(von et al. 
2008) and each article was given a methodology score out of 20. A 
consensus on inclusion criteria was agreed with a second investigator (BWF) 
and studies meeting the following criteria were included:  
-Recruitment period of at least 1 year 
-Clear case inclusion criteria 
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-Clear statistical data and an effort to report 95% confidence intervals for 
incidence rate 




Figure 2.1 – Flowchart of literature search on population based studies of 
RRD. 
 
If necessary, the 95% confidence intervals of incidence rates were calculated 
from demographic data assuming Poisson distribution. The age and sex-
specific incidence and geographic distribution of incidence estimates were 
examined.  
Selected studies 
A total of 14 studies were included (see Figure 2.1). Eight were retrospective 
assessments from hospital records (5) or ICD coded data (3). Four studies 
established prospective recruitment from treatment centres. One was a 
questionnaire survey and another, a local population survey. Only 2 studies 
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achieved the maximum methodology score. All studies principally report the 
incidence of RRD cases attending hospital services for diagnosis or 
treatment. 
 
2.2 Epidemiology of rhegmatogenous retinal 
datachment 
2.2.1 Incidence and geographic variation 
The first comprehensive population-based estimates of RRD were conducted 
in Iowa and Minnesota.(Haimann et al. 1982a; Wilkes et al. 1982) The 
former was based on a hospital register and a questionnaire to all 24 
ophthalmologists in Iowa city and surrounding regions. The latter study 
involved a database search for all patients presenting to hospitals in 
Rochester, Minnesota between 1970 and 1978. Despite a large difference in 
case size and methodology, both reported an overall annual incidence of 
approximately 12 per 100,000.  
At a similar time in Europe, two studies reported differing annual incidences 
of 6.9 and 10.6 per 100,000 in Finland and Sweden.(Laatikainen et al. 1985; 
Tornquist et al. 1987a) The Finnish study was an operative series from 
Helsinki University Hospital between 1978 and 1981. The Swedish study 
included all patients admitted with RRD to a medical centre over ten years 
(1971-1981). From the data, it is unclear why the reported incidences vary 
by 40%. Excluding aphakia, the reported incidence of RRD varies between 
5.4 and 8.5 per 100,000 of population.  
Epidemiological analyses of RRD have also used large centralised computer 
databases – The Rochester Epidemiology Project identified Olmstead county 
residents admitted with RRD over 20 years (1976-1995), giving the highest 
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reported overall incidence of 17.9 per 100,000.(Rowe et al. 1999) One 
Swedish study established a complex, computer based national register and 
analysed over 1,000 patients with RRD reporting an overall incidence of 14 
per 100,000.(Algvere et al. 1999) The first Asian study reviewed 1,126 
Singapore residents having operative repair of RRD over four years reporting 
a constant annual incidence of 10.5 per 100,000. (Wong et al. 1999) 
Overall, centralised databases may provide higher case capture, however 
previous reports have demonstrated a large (~2-fold) variation.   
Two Chinese studies (Li 2003; Zou et al. 2002) have estimated differing 
annual incidences between 7.98 and 14.4 per 100,000, with the proportion 
of myopia being high (between 66-68%) in both studies. In Beijing, patients 
were recruited bimonthly from 35 centres. The Shanghai study included 
hospital cases and out-patients from the local health network, showing an 
annual increase in incidence over the four year study period, from 11.3 to 
17.9 per 100,000 of population. Similarly, a five year review of patients 
undergoing surgical repair showed the incidence of two regions only 8 miles 
apart varied between 11.3 per 100,000 (Wolverhampton) and 6.3 per 
100,000(Walsall). (Mowatt et al. 2003) 
The reported incidence, study design, case inclusion and relative sample size 
of population based epidemiological analyses of RRD is summarised in table 
2.1 and figure 2.2, demonstrating the wide range reported. Of the 
prospectively conducted studies, only 2 have attempted to include out-
patient cases.(Li 2003; Zou et al. 2002) Several studies have a small sample 
size introducing a potential for sampling error. Examining the eight studies 
with a sample size >300 cases reveals a median annual incidence rate of 
10.5 (IQR 8.1 - 13.2) per 100,000 of population. However, the inclusion of 
trauma and re-operations differs between all reports, with 7 of 14 studies 
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not specifying if re-operations were included. Excluding all other cases and 
examining non-traumatic phakic cases only reveals a similar variation 
between 5.3 and 12.6 cases per 100,000 of population. (see figure 2.3)  
 
Figure 2.2 – Overall reported total incidence rates (per 100,000 of 
population) and associated confidence intervals of RRD in previous 
population based epidemiology studies ordered by sample size. 
 
Figure 2.3 – Overall reported incidence rates and associated confidence 
intervals of non-traumatic phakic RRD in previous population based studies 





2.2.2 Age Distribution  
RRD develops from retinal breaks occurring at physiologic or pathologic sites 
of firm vitreo-retinal adhesion during posterior vitreous detachment 
(PVD).(Ghazi & Green 2002) The prevalence of PVD increases with age; 
occurring in 11% of 60-69 year olds, 46% of 80-89 year olds and occurring 
earlier in myopes. (Weber-Krause & Eckardt 1997) 
 The largest annual incidence rate of RRD is seen in the elderly with 
studies supporting a bimodal distribution and a secondary peak in younger 
ages (20-30 years) attributed to highly myopic patients.(Polkinghorne & 
Craig 2004b; Li 2003; Wong et al. 1999; Sasaki et al. 1995; Haimann et al. 
1982a) The highest incidence rate of RRD was found in the 60-69 age group 
with rates varying between 19 and 27 per 100,000, (Haimann et al. 1982a; 
Sasaki et al. 1995; Mowatt et al. 2003; Zou et al. 2002; Li 2003) however 
unexplained incidence rates as high as 40 and 70 per 100,000 have been 
reported.(Rowe et al. 1999; Polkinghorne & Craig 2004b; Limeira-Soares et 
al. 2007) (Figure 2.4)The strongest association was noted between 
advancing age and non-traumatic phakic RRD.(Haimann et al. 1982a; Li 
2003; Sasaki et al. 1995; Mowatt et al. 2003; Ashrafzadeh et al. 1973) After 
60 years the risk of developing RRD can be 17-20 times greater than a 
cohort under 30 years.(Tornquist et al. 1987a) The incidence rate of RRD in 
under 20 year olds was the lowest noted; <3 per 100,000, similar to 
previous paediatric series. (Rosner et al. 1987; Wong et al. 1999; Li 2003; 
Limeira-Soares et al. 2007; Haimann et al. 1982a; Polkinghorne & Craig 
2004b)  
Despite a similar distribution of over 60 year olds in study populations, the 
incidence of RRD in this age group has also shown variation. (See table 2.2)  
In Beijing and Finland 14% and 15.2% of the population were over sixty and 
the incidence rates were comparable at 7.98 and 6.9 per 100,000.(Li 2003; 
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Laatikainen et al. 1985) However, in Singapore and Brazil, the proportion of 
the population over sixty was <10%, but the reported incidences in this 
group differed more than two-fold, suggesting other influencing 
factors.(Wong et al. 1999; Limeira-Soares et al. 2007)  
 2.2.3 Gender 
While some reports indicate a sex distribution corresponding with that of the 
general population,(Haimann et al. 1982a),(Laatikainen et al. 1985) most 
indicate a preponderance of males,(Mowatt et al. 2003; Ivanisevic et al. 
2000; Rosman et al. 2001; Polkinghorne & Craig 2004b; Limeira-Soares et 
al. 2007)(Male-to-Female Ratio-1.3:1 to 2.3:1)and a minority find that 
females predominate in the phakic non-traumatic group. (Male-to-Female 
Ratio– 1:1.16 to 1:1.4) (Tornquist et al. 1987a; Sasaki et al. 1995) A large 
Singapore study found that males are twice as likely to require surgery. This 
may be related to an inherent gender risk, though an increased rate of 
ocular trauma was contributory. (Wong et al. 1999) Furthermore, in myopic 
populations’ males tend to predominate, although with age, this gender 
based refractive difference may be less significant. (Schepens & Marden 
1966; Hirsch & Ditmars 1969; Hirsch M.J. 1953; Bourne et al. 2004; 
Dandona et al. 2002; Sawada A et al. 2008; Attebo et al. 1999) 
Nonetheless, the higher proportion of myopia in young males may partly 
explain the imbalanced gender distribution in some studies. 
  2.2.4 Seasonality  
Seasonal variation in RRD incidence with a summer peak and winter trough 
has been reported.(Thelen et al. 1997; Ghisolfi et al. 1986; Paavola et al. 
1983; Laatikainen et al. 1985) The effect of light and temperature on the 
vitreous has been implicated.(Thelen et al. 1997) In some studies, no 
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seasonal variation was found,(Tornquist et al. 1987a; Zou et al. 2002; 
Ivanisevic et al. 2002) and others note a winter peak and a summer 
trough.(Al Samarrai 1990) 
 2.2.5 Ethnicity 
Of the few studies performed, ethnic variation significantly affects RRD 
incidence. The reason for this is unknown. In Singapore, RRD incidence in 
Chinese is three times higher than in Indians (11.6 per 100,000 and 3.9 per 
100,000) (Wong et al. 1999) despite minimal variability of risk factors 
(myopia, lattice degeneration, previous intra-ocular surgery and trauma). A 
UK study noted a 3-fold lower incidence in Asians compared to 
Caucasians.(Mowatt et al. 2003) Numerous reports suggest the incidence of 
RRD in Blacks is lower than Caucasians.(Av-Shalom et al. 1967; Weiss & 
Tasman 1978; BROWN & THOMAS 1965; Kaimbo et al. 1986; Peters 1995; 
Aboise A 1979; Yorston & Jalali 2002) However, to date there have been no 
population-based studies of RRD incidence in developing countries. (Yorston 
& Jalali 2002) Despite reported variations, post mortem studies have not 
demonstrated racial variation in the prevalence of predisposing ocular 
factors to RRD. (Foos et al. 1983) 
 
2.3 Clinical associations 
 2.3.1 Trauma 
Traumatic RRD shows a male predominance affecting younger age groups. 
Series in Finland, Sweden, Beijing and Iowa found between 6.3 and 12.2% 
of RRDs were traumatic with the majority being young males. (Tornquist et 
al. 1987a; Haimann et al. 1982a; Li 2003),(Laatikainen et al. 1985) In New 
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Zealand 16.4% of RRDs were associated with ocular trauma with nearly 90% 
under the age of fifty.(Polkinghorne & Craig 2004b) In the majority of 
studies, the incidence range of traumatic RRD has been consistently low 
(between 0.6–2 per 100,000 – see table 2.1). 
 2.3.2 Peripheral retinal degeneration and RRD 
Areas of abnormal vitreo-retinal adhesion (oral bays, meridional complexes, 
retinal tufts) can predispose to retinal breaks during PVD, however efforts at 
characterising these lesions indicate they are uncommonly associated with 
RRD and carry a low risk of progression (<2%).(Ghazi & Green 2002) 
Similarly, most peripheral retinal degenerations are poorly characterised in 
epidemiology studies. The association with lattice degeneration is better 
known. Lattice degeneration is a vitreo-retinal degeneration of unknown 
pathogenesis. The prevalence increases with myopia from 4.3% in 
emmetropia to 14% in myopia of >-3 diopters (D).(Burton 1989) RRD 
patients with lattice are younger and more myopic than those without. Of 
Swedish patients with RRD and lattice (29.7%), one quarter had a refractive 
error of >-5D compared with 15.7% in eyes without lattice. (Tornquist et al. 
1987a)  A clinical report from India showed that 26.8% of eyes had lattice 
and a similar proportion were also myopic (31.3%).(Jalali et al. 2005) A 
higher proportion of lattice degeneration was found in Japanese studies (60-
65%) with refractive error in these cases showing a myopic deviation away 
from the mean of >2D.(Sasaki et al. 1995),(Shimizu H 1989) Depending on 
population characteristics, lattice degeneration appears to be an important 
factor associated with RRD in myopic eyes. 
2.3.3 Macular status 
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Macular attachment at presentation is an important prognostic indicator of 
visual outcome. Western studies support a macula off detachment rate of 
40-60%(Laatikainen & Tolppanen 1985a; Rowe et al. 1999), compared to a 
higher rate of 86.8% in developing countries.(Jalali et al. 2005) Schepens 
noted a macula off presentation in 65.1% of phakic RRDs in 1973, compared 
to a largely unchanged rate of 69% in the UK in 1997.(Ashrafzadeh et al. 
1973),(Sullivan PM et al. 1997)  
2.3.4 Refraction and RRD  
Myopia and especially high myopia are major risk factors for 
RRD.(C.L.Schepens 1961; Cambiaggi 1964; Druault-Toufesco S 1922) 
Independent of age, an eye with a spherical equivalent refractive error of -1 
to -3D has a fourfold increased risk of RRD compared to an emmetropic eye, 
increasing to tenfold with a refractive error of >-3D. (Austin et al. 1990; The 
Eye Disease Case-Control Study Group 1993) Myopia predisposes to RRD 
through increased vitreous liquefaction, earlier PVD and higher incidence of 
vitreo-retinal degeneration.(Ghazi & Green 2002) Myopic patients are more 
likely to have RRD at a younger age and bilateral RRD.(Burton et al. 1983; 
The Eye Disease Case-Control Study Group 1993; Burton 1989; Li 2003; 
Yonemoto et al. 1994) 
 In Scandanavia, myopic detachments (>-2D) composed 40% and 50.3% of 
all phakic detachments in young age groups. This was 4-6 times higher than 
myopia prevalence in contemporary estimates. (Laatikainen et al. 
1985),(Tornquist et al. 1987a) In Croatia 46.9% of all phakic detachments 
were myopic (>-0.75D) compared with 22.8% of the general population. 
(Ivanisevic et al. 2000) A higher rate of low myopia (66-68%)  was seen in 
Beijing and Shanghai.(Zou et al. 2002; Li 2003)  In New Zealand, myopia of 
>-6D increased the risk of early RRD by 90%.(Polkinghorne & Craig 2004b) 
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The strong association between myopia and RRD in young age groups is 
evident, however ethnic differences are likely to underlie the reported 
variation, as myopia prevalence in Asian countries is known to be 1.5 to 2 
fold higher than Caucasian populations of similar age. (Ling SK et al. 
1987),(Sperduto RD et al. 1983; Sasaki et al. 1995)  
2.4 Variation, bias and the need for further research 
The overall variation reported in these studies is large and likely to be due to 
differences in study design and population examined. However, this variation 
persists when examining non-traumatic phakic cases only and in reports 
from regions of comparable myopia prevalence and elderly population 
distribution, suggesting a potential (undiscovered) underlying influence. The 
methodology employed in 8 of 14 studies described were retrospective 
reviews, which may provide an accurate incidence estimate of the population 
studied, but are often limited by the precision of diagnostic and operational 
coding. While studies examined define RRD clinically, their inclusion with 
regard to re-operations, trauma, non-operated cases and out-patient cases 
differ. No studies have attempted to apply capture-recapture methodology 
to estimate under-ascertainment rates or have estimated the proportion of 
non-operated or out-patient cases. Similarly, few recent estimates of RRD 
incidence have used large samples sizes; most reporting < 500 cases.  A 
detailed national or international register may allow for longitudinal studies 
and a more inclusive estimate of RRD incidence and its’ variation over time. 
As out-patient procedures and day-case surgery become increasingly 
widespread, reliance on in-patient operative records to estimate RRD 
incidence are likely to become insufficient. A clear consensus on case 




2.5 Clinical characteristics of RRD 
 In this section I review the characteristics of RRD presented both in 
previously published epidemiology studies as well as in natural history 
studies.   
 2.5.1 Cataract extraction and pseudophakia 
The risk of RRD after cataract extraction varies with the surgical method 
employed. This is due to a higher rate of PVD after cataract extraction and a 
lower hyaluronic acid concentration causing vitreous collapse.(Boberg-Ans et 
al. 2003; Ghazi & Green 2002) The cumulated six year risk of RRD after 
cataract surgery is increased by a factor of 6 to 8, increasing linearly for 20 
years.(Javitt et al. 1994; Norregaard et al. 1996),(Boberg-Ans et al. 
2006),(Erie et al. 2006) In the 1950s clinical series found a quarter of all 
RRDs were aphakic.(Ashrafzadeh et al. 1973) Over time the reported 
proportion of aphakia has declined, (42.7% in 1976; 18.6% in 1981; 4.7% 
in 1990; < 10% in 2000)  (Haimann et al. 1982a; Tornquist et al. 1987a; 
Sasaki et al. 1995; Li 2003)  reflecting cataract surgery trends.  
Studies from Minnesota revealed 26.6% and 19% of RRD cases had previous 
cataract surgery.(Wilkes et al. 1982),(Rowe et al. 1999) Between 1971-81, 
18.6% of RRD cases had prior cataract extraction in Sweden. Twenty years 
later, the Swedish RRD register reported that 30.8% of over 1,000 detached 
eyes had prior cataract surgery.(Algvere et al. 1999; Tornquist et al. 1987a) 
By contrast, the combined proportion of aphakia and pseudophakia in China 
has been reported as only 10%,(Li 2003) and further UK and South 
American studies have supported this observation.(Mowatt et al. 2003; 
Limeira-Soares et al. 2007) More recently, a New Zealand study reported a 
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high rate (33%)of pseudophakia.(Polkinghorne & Craig 2004b) As a 
consequence of changing trends in cataract surgery and poorly reported 
rates, an accurate comparison of the incidence of pseudophakic RRD in 
previous studies is difficult. However, of the available data, reports in the 
last decade indicate a slightly higher incidence of pseudophakic RRD than 
the preceding decade. (see Table 2.1)  
 2.5.2 Increased rate of cataract surgery 
Higher life expectancy and advances in cataract surgery has seen the 
proportion of pseudophakic individuals in developed countries rise.  The 
Rochester  Epidemiology Project reported a linear rise in cataract surgery 
rates between 1980 and 1994.(Baratz et al. 1997) The estimated prevalence 
of unilateral pseudophakia in North Carolina increased from 7.6% to 9.8% 
between 1998 and 2002, with the prevalence of bilateral pseudophakia more 
than doubling.(Williams A et al. 2006) Between 1986 and 1990 the number 
of cataract operations in Sweden rose from 227 to 328 per 100,000 of 
population and in the UK, the rate of cataract surgery increased 3.7-fold 
between 1989 and 2004.(Ninn-Pedersen et al. 1994; Keenan et al. 2007a)  
The overall incidence of RRD has not shown this linear rise, however, the 
proportion of pseudophakia in RRD series appears to be increasing. A vitreo-
retinal centre in London analysed cases of RRD in 1980 and again in 1999 
finding that pseudophakia rose from 0.8% to 24%. Other UK reports support 
this large increase.(Minihan M. et al. 2001; Ah-Fat et al. 1999)In a series of 
4,203 primary RRD cases in France the proportion of pseudophakia rose 
from 13% to 33% between 1989 and 2000.(Ducournau D.H. & Le Rouic JF. 
2004)   Strikingly, a comparison between the proportion of pseudophakic 
RRD in Minnesota between 1970 -78 and 1976-95 showed no significant 
difference, despite a four-fold rise in the rate of cataract extraction between 
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1980-94 in the same region.(Rowe et al. 1999; Wilkes et al. 1982; Baratz et 
al. 1997) 
 2.5.3  Type and frequency of retinal break 
Tractional, PVD induced retinal tears or atrophic retinal holes can cause 
RRD.(Ashrafzadeh et al. 1973) Clinical  studies observe a higher frequency 
of tractional tears in phakic RRD: India(186/395 vs 116/395)(Jalali et al. 
2005), America (880/1,353 vs 578/1,353)(Ashrafzadeh et al. 1973), Helsinki 
(217/352 vs 61/352)(Laatikainen & Tolppanen 1985a) Round hole 
detachments occurred mainly in myopic eyes with lattice degeneration. 
Multiple breaks were more likely in young eyes with lattice degeneration. 
(Laatikainen & Tolppanen 1985b)Tears were more frequent in non-myopic or 
moderately myopic phakic patients over forty.(Tornquist et al. 1987b) In two 
US studies, atrophic holes accounted for 3% and 14% of 
detachments.(Morse & Scheie 1974; Tillery WV & Lucier AC 1976) In Japan, 
of patients with lattice degeneration, 40% of RRDs were caused by tractional 
tears and 20% by atrophic holes. A Finnish study stratified breaks by age of 
onset noting that in the under 20 year olds, dialysis was the most common, 
between 20 and 40 years horse-shoe tear and round holes were equally 
common and over the age of 40, the most common causative break was a 
PVD associated horse-shoe shaped tear. (Sasaki et al. 1995; Laatikainen & 
Tolppanen 1985b) Giant retinal tears and retinal dialysis are uncommon, 
accounting for 0.6%-7.7% of phakic RRD.(Ashrafzadeh et al. 1973; 
Laatikainen & Tolppanen 1985b; Jalali et al. 2005; Sasaki et al. 1995) 
Macular hole RRD is uncommon in European(Laatikainen & Tolppanen 
1985a) and American(Margherio RR & Schepens CL 1972) series (0.5% and 
1.7%) but accounts for 8.9% and 21.1% of RRDs in more myopic 
series.(Sasaki et al. 1995),(Zhang & Hu 1982)   
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 2.5.4 Area of detachment and location of retinal breaks 
Clinical series have found that the most frequent site of peripheral retinal 
tears are in the supero-temporal quadrant, followed by the infero-temporal 
quadrant. Taking these into account, between 61.6-96% of horse-shoe 
shaped retinal tears are found in the temporal retina. Round holes are more 
commonly associated with young age, myopia and lattice degeneration and 
are commonly in the infero-temporal region. One large series noted that HST 
in high myopia is often found in the supero-nasal quadrant. (Laatikainen & 
Tolppanen 1985b; Tornquist et al. 1987b)Retinal dialysis are often 
associated with trauma (>77%) and the majority are located in the infero-
temporal quadrant.(Laatikainen & Tolppanen 1985b)A higher incidence of 
nasal retinal break have been found in clinical series examining aphakic 
retinal detachments.(Ashrafzadeh et al. 1973) Further clinical studies 
indicate that in between 52- 66% of cases, there are less than 2 quadrants 
(or six clock hours) of retina detached. Total RRD was noted to be present in 
17.2%. Myopic RRD was often localised with a higher majority (75%) limited 
to <2 clock hours of detachment.(Laatikainen & Tolppanen 1985b; Tornquist 
et al. 1987b) 
 
 
2.6 Bilateral RRD 
Bilateral RRD affects between 3–33% depending on case inclusion and study 
duration.(Gupta & Benson 2005) Earlier large clinical studies noted a high 
rate (473/2,016 and 1,642/5,270) of bilateral RRD including re-detachments 
over ten years.(C.L.Schepens 1961; Ashrafzadeh et al. 1973) Over one year, 
62 
 
rates of bilateral RRD vary between 3.5 and 5.82%, (Sasaki et al. 1995; Li 
2003; Polkinghorne & Craig 2004b; Haimann et al. 1982a) increasing to 9-
10% over a four year period.(Laatikainen et al. 1985; Laatikainen & 
Tolppanen 1985a; Zou et al. 2002) In Sweden over ten years and Minnesota 
over 20 years, 11.2%(34/538) and 6%(18/293) of subjects had bilateral 
RRD.(Tornquist et al. 1987a; Rowe et al. 1999) In all series, RRD has 
affected a proportion of both eyes indicating over time fellow eye 








* Includes aphakic cases  
N/S – Not specified 
^Mean refraction of all cases under 50 years (95% CI) 
^^Mean refraction and SD of all cases 
 
 
Table 2.1 –Reported  incidence of RRD (per 100,000 of population), clinical characteristics and inclusion criteria as reported in previous population based epidemiology studies ordered by sample size. 













































Singapore(Wong et al. 
1999) 1999 
Singapore  ICD-9 (15) 4 2,705,115 1126 10.5 (10.2-10.9) N/S N/S N/S N/S N/S N/S N/S No 
Stockholm and 
surrounding 
counties(Algvere et al. 
1999) 1999 
Sweden  Prospective; 
diagnosis by 
clinician (12) 
1 1,744,330 1116 14 N/S N/S N/S 52.3% -4.16 (-5 to -3.3D)^ N/S N/S No 
Orebro and 
Varmland(Tornquist et 
al. 1987a) 1987 
Sweden  Prospective; 
diagnosis by 
clinician (16) 
10 N/S 590 10.6(9.8-11.4) 7.97 1.97* 0.66 N/S 25% (>-2D) 11.2% Yes Yes 
Beijing(Li 2003) 2003 China  Prospective; 
diagnosis by 
clinician (20) 
1 6,589,000 526 7.98(7.3-8.67) 6.25(5.65-6.86) 0.8*(0.59-1.02) 0.93 (0.69-1.16) N/S 66.5% (>-1D) 5.8% Yes No 
Iowa County(Haimann 
et al. 1982a) 1982 
U.S.A  Questionnaire 
survey (13) 
1 2,824,500 361 12.4(11.5-14.2) 6.1(5.4-7.3) N/S 1.4(1-2) N/S N/S 3.4% Yes N/S 
Sao Paolo(Limeira-
Soares et al. 2007) 
2007 
Brazil  ICD-10 (16) 1 3,389,294 313 9.2(8.2-10.3) 7.1(6.3-8.1) 1(0.7-1.4) 0.9(0.6-1.3) N/S N/S N/S Yes No 
Olmstead County, 
Minnesota(Rowe et al. 
1999) 1999 
U.S.A  ICD-9 (15) 20 106,470 311 17.9(15.9-19.9) 12.6(10.9-14.3) 3.4(2.46-4.16)* 1.3(0.8-1.7) 41% N/S 6% Yes N/S 
Helsinki(Laatikainen et 
al. 1985) 1985 
Finland  Retrospective 
assessment (16) 
4 1,121,955 310 6.9(5.5-8.7) 5.4(4.3-7) N/S 0.8(0.4-1.6) 56.5% 40% (>-1D) 9.9% Yes N/S 
Split-Dalmatia 
County(Ivanisevic et al. 
2000) 1999 
Croatia  Retrospective 
assessment (7) 
11 465,947 272 N/S 5.3(4.1-6.2) N/S N/S N/S 46.9% (>-0.75D) 2.2% No N/S 
Kumamoto(Sasaki et al. 
1995) 1995 
Japan  Retrospective 
assessment (17) 
1 1,840,300 192 10.4(9-12) 9.8(8.5-11.4) N/S 0.2(0-0.5) N/S -3.7 +/- 5D^^ 4.2% Yes N/S 
Auckland(Polkinghorne 






1 1,205,694 146 11.8(9.8-13.7) 6.1(4.7-7.6) 4.1(3-5.4) 2(1.3-3) N/S 23% (>-6D) 3.5% Yes No 
Wolverhampton(Mowatt 
et al. 2003) 2003 
U.K.  Retrospective 
assessment (15) 
5 248,600 140 11.3(9.48-13.3) 9.7(8-11.4) 1.2(0.68-2) 0.7(0.34-1.38) N/S N/S N/S Yes N/S 
Walsall(Mowatt et al. 
2003) 2003 
U.K.  Retrospective 
assessment (15) 
5 259,517 83 6.3(5.1- 7.92) 5.4(4.28-6.9) 0.9(0.48- 1.62) 0.5(0.22-1.12) N/S N/S N/S Yes N/S 
Shanghai(Zou et al. 
2002) 2002 
China  Prospective; 
population survey 
(13) 
4 108,132 61 14.4(10-18.6) N/S N/S 6.5(2.6-13.3) N/S 68.8% (>-3D) 9.8% Yes No 
Rochester, 
Minnesota(Wilkes et al. 
1982) 1982 
U.S.A  Retrospective 
assessment (14) 




Wol – Wolverhampton 
Wal - Walsall 
*65+ yrs      
** 65-74 yrs     
Study Location 
 
Incidence of RRD per 














Singapore(Wong et al. 
1999) 
 
21.9 (19-24.8) 9.1% 
 
Orebro, Sweden(Tornquist 



























Brazil(Limeira-Soares et al. 
2007)  
49.9 38.7 8.9% 
 
Olmsted County, 
Minnesota, U.S.A(Rowe et 
al. 1999) 
 
70 50 N/S 
 
Finland(Laatikainen et al. 
1985) 
21.8 15.2% 
Croatia(Ivanisevic et al. 
2000)† 
22.1 15.8 15.8% 
Japan(Sasaki et al. 1995) 22.7 18.9 22% 
New Zealand(Polkinghorne 
& Craig 2004b) 
49.7 32.6 13.8% 
 
West Midlands, 
U.K.(Mowatt et al. 2003) 
 
Wol       
27.4 Wal   
**42.4 
29.1 
    ***69.5 
39.9%∆  
 
Shanghai, China(Zou et al. 
2002) 
17.5  (12.9-22) 18.9% 
Rochester, Minnesota, 






 ***75-84 yrs 
∆ 40-79 yrs 
†Non-traumatic phakic only 
N/S – Not specified 
 
Table 2.2 –Age specific incidence of RRD in over 60 year olds as reported in 
previous epidemiology studies (ordered by sample size) and the 






















































Figure 2.4 – Mean and 95% confidence intervals of RRD incidence in 























CHAPTER 3 Temporal trends in the rate of RRD 
and cataract surgery in Scotland 
3.1 Introduction 
An accurate epidemiology study requires high case ascertainment from a 
stable, well defined population that actively seeks medical care. Because of 
this, few studies have systematically examined the changes and influences 
on the incidence rate of RRD across different time periods in a well defined 
geographic area. There are six vitreo-retinal surgical sites in Scotland which 
are responsible for diagnosing and managing all RRD cases (Ayr, Glasgow, 
Edinburgh, Dundee, Aberdeen and Inverness). The stable population 
structure and well defined referral and treatment patterns make Scotland an 
ideal region to conduct an epidemiology study. 
This chapter examines the trends in RRD incidence in Scotland between 
1986 and 2007, taking into account changes in the size and composition of 
the population and examines the changes in cataract surgery rates over this 
period.  
 3.2 Methodology 
 3.2.1 Data Source-Information Services Division Scotland 
The Information and Statistics Division of the Scottish Executive (ISD) is 
Scotland's national organisation for health information and statistics. They 
are responsible for National Health Service (NHS) hospital episode statistics 
data which comprise administrative, demographic and medical information 
on all inpatient and day-case procedure hospital episodes in all general and 
acute wards in Scotland. Private patients are not included in this database. 
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These data are collected in hospital by trained clerical staff who assign 
diagnostic codes for each admission at the time of patient discharge. The 
information is transferred to the Information and Statistics Division of the 
Scottish Executive who collate and analyse the data. 
Since 1987 these data have been linked to successive episodes of care for 
each person, so that individuals can be traced through multiple episodes of 
care. This record linkage is done through a probability matching algorithm. 
Firstly, to determine which record pairs belong to the same person, the 
records are matched by a Soundex/NYSIIS code (a name compression 
algorithm), first initial, sex, and date of birth. If there is a discrepancy in any 
one of these, the records will not be matched. Secondly, probability weights 
are calculated and applied to determine the likelihood that the records are 
from the same individual. This logarithmic weighting is based upon 
demographic criteria including surname, maiden name, sex, date of birth, 
residential postcode and other correspondence criteria such as date of 
admission and date of discharge. Once the probability weights are ordered, 
the threshold (defining linkage) is set, usually at the 50/50 point. This is an 
automated process, with larger groups of records contributing to a higher 
false positive rate. Clerical monitoring of record pair batches estimate both 
the false positive and false negative rates from this process to be 
approximately 3%.(2008)      
We obtained all first diagnosis of RRD and first operation for cataract for 
patients in Scotland between 1987 and 2006 based on diagnostic and 
procedural coded data derived from the ISD. The diagnostic codes used to 
identify patients with RRD were 361.0 – 361.9 and 362.4 in the International 
Classification of Disease 9th edition (ICD-9) and H33.0 -33.5 in ICD-10. The 
operative codes used to identify patients undergoing cataract surgery from 
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were 173 to 178 in the Office of Population, Censuses and Surveys: 
Classification of Interventions and Procedures, 3rd edition (OPCS-3) and C71-
C75 in OPCS-4. Over the analysis period, coding of RRD changed between 
ICD-9 and ICD-10, however no corresponding change in hospital admission 
rates was noted during this changeover period (between 1994 and 1995). 
Similarly, the OPCS procedural coding system has undergone several 
revisions, but no corresponding significant or stepwise change in CSR was 
noted. (Table 3.2a+b) 
  
3.2.2 Statistical Methods  
I first used a log-linear regression model to examine the trends in RRD 
incidence and the cataract surgery rate over time, and calculated an average 
annual percent change (AAPC) in incidence rate over the study period. I 
added a quadratic trend term (year2) to examine for possible non-linear 
trends in RRD incidence. 
I then used age-period-cohort modeling to explore the effects of 
chronological age, time period, and birth cohort on RRD incidence trends. 
Individual data was grouped into eighteen 5-year age groups from 0-4 years 
through to 85+ years, four 5-year calendar periods from 1987-1991 through 
to 2002-2006 and twenty derived birth cohorts. Assuming a Poisson 
distribution of cases of RRD, a log-linear regression model was used to 
estimate the changes in RRD incidence by age, period and birth cohort. (R 
v2.10.1) The Poisson model used took the form of: 
 -log(rate) = μ +αi + βj + γk + εijk    
Where αi is the age effect, βj is the period effect and γk is the cohort effect. 
The term εijk is the random error term. The parameter estimates were 
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calculated as maximum likelihood estimates. The first period (1987-1991) 
and last age group (85+) were assigned as reference groups. Based on this 
general form, I examined 5 models in sequence: a one-factor age model, a 
two-factor age-drift model, age-cohort model, age-period model, and an 
age-period-cohort model. The drift term in the age-drift model represents a 
temporal change in incidence rate not identifiable as a period or cohort 
effect. I calculated goodness of fit (R-squared) statistics based on model 
differences in deviance and degrees of freedom, to determine the model 
accounting for the most variability. The full age-period-cohort model had the 
lowest residual deviance and an R2 of 0.96 and was used in the 
analysis.(Table 3.1) 
 Age and sex-specific incidence rates of patients admitted with a first 
diagnosis of RRD and those undergoing cataract surgery in Scotland were 
calculated annually. Annual incidence rates were calculated on the basis that 
the first admission only counted toward the episode rate, so that recurrent 
individual admissions with the same diagnostic code were not counted after 
12 months from the first admission. This method aims to eliminate re-
operations on RRD cases; however, consecutive bilateral RRD cases will only 
have been counted once. Age and sex standardised rates were calculated by 
a direct method using the European Standard Population as a reference.  
Annual population data was obtained from the General Register Office for 
Scotland from the Scottish population censuses since 1987. Using the 1987 
age specific RRD incidence rate and the 2006 population census, I calculated 
the expected standardised incidence rate for each age group in 2006 and 
compared this to the observed incidence rates in 2006.  
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 3.2.3  Data Quality  
Retrospective hospital episode statistics data which I have used to estimate 
disease incidence have some limitations,(2007a; Milburn et al. 2007) 
including insufficient clinical details, incorrect diagnostic coding, duplicate 
entries and incomplete population coverage. Thus the use of HES to 
estimate disease incidence is by necessity an approximation and often limits 
the ability of the investigator to examine other influencing aspects of 
disease, such as in this case, the prevalence of myopia or ocular trauma. 
However HES remain a useful indicator of changing incidence trends, 
particularly where the study population is a stable one actively seeking 
medical care and the disease under investigation requires hospital admission 
for treatment.  
The ISD Data used in this study is derived from hospital episode statistics, 
the accuracy of which is dependent on appropriate and exact coding. A 
recent quality control audit of surgical specialties (excluding general 
surgery) indicates coding for main condition is accurate in 88.5% 
(95%CI:86.3-90.7) and for main operation in 93% (95%CI: 91.2-
94.8).(2007a)  Inappropriate record linkage of hospital episode statistics can 
be up to 3%.(2008) The proportion of RRD cases treated in private sector is 
unknown, however I expect this number to be very low, as elective eye 
operations in England and Wales in 1998 (excluding cataract extraction) 
accounted for only 1.8% of all eye operations performed in NHS 
hospitals.(Williams et al. 2000)This relevant proportion is likely to be lower 
in Scotland as RRDs diagnosed and followed-up privately will be operated on 





3.3.1 Temporal trends in cataract surgery in Scotland  
The annual and age standardised cataract surgery rate (CSR) in Scotland 
between 1987 and 2006 are shown in figure 3.1 and 3.2. The CSR in 
Scotland rose from 145 per 100,000 in 1987 to 575 per 100,000 in 2006, 
representing an overall increase of 296%. There was no significant gender 
difference in the increase in CSR over the calendar years. Figure 3.3a and 
3.3b demonstrate a significant and dramatic rise in CSR in males and 
females aged over 60 years across 4 time periods in Scotland. From the age 
of sixty years and onwards, there was a steady rise in the CSR, with a peak 
for both genders in the 80-89 year age group. Women had a higher overall 
CSR than men across 4 time periods. Using a linear regression model, the 
average annual percent change in each health board region in Scotland was 
calculated. (Table 3.3) Across all health board regions combined, there was 
an average annual increase in CSR of 6.6% (95%CI 6.08-7.14), with 
virtually all regions demonstrating a significant annual increase of between 5 
to 11% between 1987 and 2006. 
 
 
3.3.2 Temporal trends in RRD incidence in Scotland  
 
The age specific and age standardised annual RRD incidence rate between 
1987 and 2006 is shown in table 3.4. (Table 3.5a(males); Table 
3.5b(females)) The crude incidence rate of RRD for all ages and both 
genders rose steadily from 10.06 per 100,000 (95%CI: 9.19-10.93 per 
100,000) in 1987 to 15.28 per 100,000 (95%CI: 14.21-16.35 per 100,000) 
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in 2006. The incidence of RRD was higher in males of all age groups, and the 
temporal rise in incidence was more marked in males. The age standardised 
male:female incidence ratio rose from 1.40 in 1987 to 1.76 in 
2006.(p<0.001) Figure 3.4 demonstrates the age standardised incidence 
and associated 95% confidence intervals in men and women. Figure 
3.5(a+b) and figure 3.6 (a+b) demonstrate the age and sex specific RRD 
rates for men and women between 1987 and 2006. Both genders showed a 
significant rising trend in the highest incidence age groups (60-79 years). In 
men, the strongest rising trend in incidence was found in younger age 
groups between 40 to 59 years, a pattern which was absent in females. 
The average annual percent change (AAPC) in RRD incidence increased 
annually by 1.9% overall in the 20 year period. Significant increases were 
noted in nearly all age groups with the exception of those under 20 years 
and in the 30-39 year age group. (Table 3.6) The second order quadratic 
trend term did not demonstrate a significant change in incidence, with the 
exception of the over 80 year age group.  
I calculated the expected age specific incidence rate in 2006 using the 1987 
age specific rate standardised to the 2006 Scottish population and compared 
this to the observed age specific rate in 2006. (Table 3.7) The observed rate 
in 2006 was significantly higher than the expected rate in all age groups 
over 40 years.  
Figure 3.7 demonstrates the combined age-period-cohort effects on RRD 
incidence. Chronological age demonstrates a bimodal distribution in 
incidence with a peak in the sixth decade, as well as a secondary smaller 
peak in the 3rd decade. No significant period effects were found. No 
significant birth cohort effects were found in cohorts since 1940. Prior to this 
there was a reduction in risk ratio (0.25-0.86) as fewer parameters were 























































































Figure 3.1 – Annual cataract surgery rates (CSR) in Scotland between 1987 























































A ge standardised rate in men
A ge standardised rates women
Age standardised CSR in Men and Women
 
Figure 3.2 - Age standardised (direct method) CSR in men and women 
between 1987 and 2006 demonstrating a linear increase in CSR. No 







































































































































































































   Age-drift 1216.9(125) 74.47(1) < 0.001 
 Age-Cohort 1039.82(106) 177.08(19) <0.001 0.87 
Age-Period 1214.19(123) 2.71(2) 0.25 0.98 
Age-Period-Cohort 1034.1(104) 5.72(2) 0.044 0.96 
Table 3.1 – Summary statistics comparing the goodness of fit for different 










OPCS 4 OPCS 3 
  
C71.1        Extracapsular 
extraction of lens simple linear 
extraction of lens 
  
173 Extra-capsular Extraction of 
Cataract (no further subdivisions) 
C71.2        Extracapsular 
extraction of lens 
phakoemulsification of lens 173 (no further subdivisions) 
C72.1        Intracapsular 
extraction of lens forceps 
extraction of lens 
1741 Intra-capsular forceps extraction 
of cataract 
C72.2        Intracapsular 
extraction of lens suction 




C72.3        Intracapsular 
extraction of lens cryoextraction 
of lens 
1745 Intra-capsular cryo-extraction of 
cataract 
C72.8        Intracapsular 
extraction of lens other specified  
1742, 1743 Intra-capsular linear (1742) 
and chymotrypsin (1743) extraction of 
cataract 
C72.9        Intracapsular 
extraction of lens unspecified  174 Intra-capsular extraction of cataract 
C74.1        Other extraction of 
lens curettage of lens  
176 Other extraction of lens, not 
elsewhere classified (no further 
subdivisions)  
C74.2        Other extraction of 
lens discission of cataract 176 (no further subdivisions) 
C74.3        Other extraction of 
lens mechanical lensectomy  176 (no further subdivisions) 
C74.8        Other extraction of 
lens other specified  176 (no further subdivisions) 
C74.9        Other extraction of 
lens unspecified  176 (no further subdivisions) 
C75.1        Prosthesis of lens 
insertion of prosthetic 
replacement for lens 
1781 Insertion of intra-ocular aphakia 
implant 
C75.2        Prosthesis of lens 
revision of prosthetic replacement 
for lens no equivalent code  
C75.3        Prosthesis of lens 
removal of prosthetic replacement 
for lens 
1782 Removal of Intra-ocular aphakia 
implant  
C75.8        Prosthesis of lens 
other specified  178 Intra-ocular aphakia implant  
C75.9        Prosthesis of lens 
unspecified  178 Intra-ocular aphakia implant  
Table 3.2a – Selected codes for cataract surgery in the Office of Population, 







ICD - 10 ICD-9 
H33.0 - Retinal Detachment with 
retinal break  
361.0 - Retinal detachment with 
retinal defect  
H33.1 - Retinoschisis and retinal 
cysts  
361.1 - Retinoschisis and retinal 
cysts  
H33.3 - Retinal breaks without 
detachment  
361.3 - Retinal defects without 
detachment  
H33.5 - Other retinal detachments  
361.8 - Other forms of retinal 
detachment  
Also consider:  361.9 - Unspecified  
H35.7 - Separation of retinal layers 
362.4 - Separation of the retinal 
layers 
Table 3.2b – Selected codes for rhegmatogenous retinal detachment based 
on International Classification of Disease ( ICD-9 and ICD-10). 
 
 
Region AAPC (%) LOWER 95% CI UPPER 95% CI P-value 
All Scotland 6.61 6.08 7.14 <0.001 
Ayrshire 9.31 8.44 10.29 <0.001 
Borders 8 5.02 10.51 <0.001 
Dumfries and Galloway 11.07 9.97 12.12 <0.001 
Fife 5.23 4.29 6.18 <0.001 
Forth Valley 8.33 7.25 9.53 <0.001 
Grampian -2.18 -5.16 0.9 0.144 
Glasgow and Clyde 6.61 6.18 7.14 <0.001 
Highland 9.64 8.98 10.4 <0.001 
Lanarkshire 7.68 6.6 8.65 <0.001 
Lothian 5.97 4.5 7.46 <0.001 
Orkney 7.36 5.34 9.41 <0.001 
Shetland 5.87 4.19 7.47 <0.001 
Tayside 5.55 4.92 6.18 <0.001 
Western Isles 9.09 7.578 10.52 <0.001 
Table 3.3 – Analysis of average annual percent change (AAPC) in cataract 

















Table 3.6 – Age specific average annual percent change (AAPC) of RRD 











Table 3.7 – The age specific expected and observed incidence of RRD in 
2006 calculated using the 1987 age specific incidence standardised with the 






(A)  Linear model Quadratic trend term  
 Age AAPC (%) p-value Sign of 2nd order term p-value 
 0-9 +1.1 0.588 + 0.066 
 10-19 -1.2 0.166 + 0.194 
 20-29 +1.1 0.051 - 0.176 
 30-39 +0.2 0.619 + 0.782 
 40-49 +1.2 0.04 - 0.047 
 50-59 +2.6 <0.001 - 0.915 
 60-69 +1.9 <0.001 - 0.474 
 70-79 +1.6 0.001 - 0.951 
 80+ +1.9 0.019 - 0.001 
 All ages +1.9 <0.001 - 0.334 
(B)  Incidence per 100,000 population 
(95% Confidence Interval) 
 Age Expected 2006 Incidence   Observed 2006 Incidence 
 0-9 0.91(0.3-2.1) 1.64(0.8-3.1) 
 10-19 4.45(2.9-6.4) 3.14(1.9-4.8) 
 20-29 6.92(5.1-9.3) 6.77(4.9-9.1) 
 30-39 7.98(6-10.4) 9.12(7-11.6) 
 40-49 7.40(5.6-9.6) 13.28(10.9-16.1) 
 50-59 12.49(10-15.5) 27.64(23.8-31.9) 
 60-69 22.94(19-27.4) 34.42(29.6-39.8) 
 70-79 30.72(25.4-36.8) 35.18(29.5-41.7) 
 80+ 13.56(9.1-19.5) 18.24(13-24.9) 





Figure 3.4– Age standardised incidence of RRD in men and women. A rising 
trend was noted for both genders, but was much stronger in men.  
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 Incidence per 100,000 population 
Age Group 
Age standardised Incidence(100,000) 
































































































Table 3.4 – The annual incidence of RRD by age group and the age standardised incidence in men and women between 1987-2006. This 
table highlights the increasing incidence of RRD and demonstrates the much higher age standardised incidence in men.  
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Incidence per 100,000 
Age Group 
 




Year           
1987 0.91 5.89 8.97 8.94 9.60 17.49 21.26 35.93 9.33 11.12 
(9.80-
12.44) 
1988 1.51 8.95 5.95 9.29 12.96 22.34 29.02 30.93 22.46 12.85 
(11.43-
14.27) 
1989 1.81 5.19 9.59 12.69 14.61 18.60 34.76 30.03 12.94 13.63 
(12.17-
15.09) 
1990 1.21 4.13 10.64 10.79 14.38 20.85 32.20 25.66 23.16 13.26 
(11.81-
14.70) 
1991 0.91 6.02 7.57 8.39 14.43 18.74 29.37 27.32 18.38 12.15 
(10.77-
13.53) 
1992 0.91 4.91 9.92 12.05 16.40 17.23 33.84 33.23 31.74 14.11 
(12.62-
15.60) 
1993 1.21 4.67 9.58 12.10 14.12 25.94 36.56 30.31 27.04 14.74 
(13.22-
16.27) 
1994 0.91 5.95 11.09 11.09 11.29 20.13 31.12 40.51 20.89 13.90 
(12.42-
15.37) 
1995 0.00 5.33 8.80 10.41 19.96 22.53 30.72 38.69 31.40 14.84 
(13.31-
16.36) 
1996 0.93 6.88 7.72 12.19 17.70 23.03 30.81 33.95 38.59 15.00 
(13.46-
16.53) 
1997 1.25 5.27 10.69 10.83 19.69 25.57 29.88 38.07 38.68 15.89 
(14.31-
17.47) 
1998 0.95 6.12 9.96 11.86 17.33 23.55 39.53 32.07 24.14 15.79 
(14.21-
17.36) 











2000 0.33 3.06 7.64 10.72 16.45 30.71 34.93 37.95 40.40 16.12 
(14.52-
17.71) 
2001 0.67 3.06 10.94 8.97 13.64 24.06 37.47 31.96 28.32 14.75 
(13.23-
16.28) 
2002 1.38 7.92 8.13 13.16 17.33 33.51 34.80 39.99 23.93 17.81 
(16.13-
19.48) 
2003 2.10 5.16 9.15 12.32 18.71 34.71 48.58 40.86 28.08 19.51 
(17.76-
21.27) 
2004 0.71 6.04 12.64 9.52 13.79 29.09 44.79 46.72 31.70 18.23 
(16.54-
19.92) 
2005 1.77 4.56 10.11 12.41 16.78 37.22 43.17 39.39 26.35 19.10 
(17.37-
20.82) 















Year           
1987 0.96 2.78 4.83 6.90 5.17 7.90 24.48 27.25 14.91 9.08 
(7.93-
0.23) 
1988 0.64 2.61 4.61 7.20 7.93 16.54 22.08 18.02 14.48 9.30 
(8.14-
10.47) 
1989 0.32 2.10 4.37 4.27 8.41 18.29 22.49 24.73 13.25 9.56 
(8.38-
10.74) 
1990 0.63 1.23 3.40 6.98 7.98 19.07 24.68 31.03 14.73 10.54 
(9.30-
11.78) 
1991 0.00 1.26 3.41 8.48 6.04 14.35 28.60 24.12 17.66 9.93 
(8.73-
11.13) 
1992 0.32 2.24 4.44 6.43 9.57 17.19 24.47 23.04 11.85 9.92 
(8.72-
11.12) 
1993 0.95 1.94 4.26 7.33 7.71 17.06 32.76 27.34 21.84 11.50 
(10.21-
12.79) 
1994 0.32 0.97 4.10 5.37 10.56 20.71 30.75 32.63 11.57 11.48 
(10.19-
12.77) 
1995 0.32 0.97 6.05 7.02 8.10 19.63 30.13 28.41 18.23 11.51 
(10.22-
12.80) 
1996 0.65 1.29 4.61 8.43 6.28 19.54 22.81 24.00 15.95 10.17 
(8.95-
11.38) 
1997 0.65 1.92 7.33 4.18 6.62 16.88 27.71 33.53 15.34 11.02 
(9.75-
12.28) 
1998 0.33 0.63 4.98 4.65 6.59 16.81 32.14 24.37 24.86 10.80 
(9.55-
12.06) 
1999 0.67 2.85 6.03 5.38 8.79 12.70 26.17 27.72 19.70 10.62 
(9.38-
11.87) 
2000 1.03 1.59 5.84 5.89 8.66 15.96 26.58 25.31 18.30 10.76 
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2001 0.35 1.59 5.32 3.94 5.75 17.53 33.82 35.59 19.27 11.78 
(10.47-
13.10) 
2002 0.36 1.91 6.42 6.24 8.58 16.74 33.88 25.92 24.05 12.12 
(10.79-
13.46) 
2003 0.37 1.91 5.53 7.13 8.64 19.29 29.06 26.41 15.22 11.63 
(10.32-
12.93) 
2004 0.37 1.27 5.84 7.03 7.41 18.14 27.98 33.84 17.92 11.93 
(10.61-
13.25) 
2005 0.37 1.91 3.83 7.23 6.76 18.18 30.07 30.05 12.08 11.33 
(10.05-
12.62) 








Figure 3.5a+b –  Age specific annual admission rates of RRD in men and 
women over four time periods. In men, over the four time periods, a 
progressively higher incidence was noted in men of younger age. This 










Figure 3.6a – Age sepcific and standardised incidence of RRD in men. A 
signficant rising trend was found in all age groups combined(χ2 
trend=154.96, p-value < 0.001) and in age groups 40-59years (χ2 







Figure 3.6b - Age sepcific and standardised incidence of RRD in women. A 
signficant rising trend was found in all age groups combined (χ2 
trend=27.84, p-value < 0.001) and in age group 60-79years only (χ2 








Figure 3.7 - Age-period-cohort plot of parameter estimates and associated 
95% confidence intervals of RRD incidence in Scotland. This figure highlights 
the increasing incidence of RRD with age, demonstrating a peak in the 6th 
decade and a smaller secondary peak in the 3rd decade. No significant period 















The CSR in Scotland has climbed linearly and increased 4 fold since 1986. 
This is not surprising, as recent cataract surgery initiatives in the UK have 
increased surgical capacity and estimates from other developed countries 
have indicated a similar trend; in the United States, the estimated 
prevalence of pseudophakia or aphakia is 5.1% of those over forty 
(6.1million), and this is expected to rise (to 9.5million) by 2020. (Ninn-
Pedersen & Bauer 1996; Dua et al. 2009; Congdon N et al. 2004)This rise in 
the CSR has prompted questions about the overuse of cataract surgery, and 
as uncomplicated cataract surgery remains a risk factor for RRD 
development(Austin et al. 1990; Lois & Wong 2003), this rise in CSR may 
have important implications in the increase in RRD incidence noted in 
Scotland.  
 
The overall crude incidence rate of RRD worldwide from studies of adequate 
methodology has been reported between 6.3 and 17.9 per 100,000 of 
population(Mitry et al. 2009a; Algvere et al. 1999; Li 2003; Haimann et al. 
1982a; Limeira-Soares et al. 2007; Rowe et al. 1999; Laatikainen et al. 
1985; Polkinghorne & Craig 2004b; Zou et al. 2002; Wilkes et al. 1982), 
however, many studies do not report the standardised incidence rates and 
have not examined incidence trends over a long time period, making it 
difficult to determine if the rise in incidence noted in Scotland is also present 
in other populations. Based on HES data, the estimated age standardised 





Over 20 years in Scotland, there is an average annual percent increase in 
RRD incidence of 1.9%.  
A proportion of this increase in incidence is attributable to temporal changes 
in the Scottish population and the rising proportion of elderly individuals. 
However, the statistically significant difference noted between the expected 
and observed incidence rates in 2006 suggests that there are other factors 
which may have influenced the trend observed. The proportion of myopia, 
previous cataract surgery, ocular trauma and the socio-economic status of a 
study population can all  affect RRD incidence.(Saidkasimova et al. 2009; 
Austin et al. 1990) Temporal changes in the prevalence of these risk factors 
in Scotland are likely to also contribute to the observed trend in incidence. 
Furthermore, the advances in vitreo-retinal surgery and the expansion of 
specialist vitreo-retinal services in Scotland between 1987 and 2006, may 
have increased the number of operable cases and subsequently contributed 
to the rise in disease incidence noted.  
 
The incidence of RRD in both men and women peaks in the 6th decade with a 
secondary peak in the 3rd decade, which is widely supported by previous 
population based estimates.(Algvere et al. 1999; Li 2003; Haimann et al. 
1982a; Limeira-Soares et al. 2007; Rowe et al. 1999; Laatikainen et al. 
1985; Polkinghorne & Craig 2004b; Zou et al. 2002; Wilkes et al. 1982) 
Examining sex-specific RRD rates over 20 years, I found a higher incidence 
in males in virtually all age groups with an age standardised male:female 
incidence ratio varying between 1.31:1 to 1.82:1. The higher incidence in 
men has been reported in previous studies with male:female incidence ratios 
varying between 1.3:1 to 2.3:1.(Mowatt et al. 2003; Ivanisevic et al. 2000; 
Rosman et al. 2001; Polkinghorne & Craig 2004b; Limeira-Soares et al. 
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2007) This gender imbalance in RRD incidence in our study cannot be 
explained by the underlying gender distribution of the Scottish population 
and a higher rate of traumatic RRD in men or an inherent increased risk in 
males may be contributory.(Wong et al. 1999; Sheu et al. 2007)  
 There is also a temporal trend towards an earlier age of onset in 
males. There is a significant increase in RRD incidence in males of younger 
age groups (40-59 years) across the 20 year study period when compared 
to females of similar age. The reason for this is uncertain, but may be due to 
differences in the levels of myopia between genders or due to lifestyle 
differences, where males may under-report ‘minor’ ocular trauma. Previous 
studies have indicated that in younger myopic populations, males tend to 
predominate(Hirsch & Ditmars 1969; Hirsch M.J. 1953; Bourne et al. 2004; 
Dandona et al. 2002; Sawada A et al. 2008; Attebo et al. 1999), and in 
certain populations the influence of myopia, axial length and cataract 
surgery in males confers a higher risk for RRD development when compared 
with females.(Sheu et al. 2007) 
        An accurate estimate of disease incidence is an important first step in 
assessing the related healthcare burden. These results from national hospital 
data in Scotland over a 20-year period indicate a higher age standardised 
incidence in males and an increasing incidence of primary RRD in both 
sexes. The increase in RRD incidence may be partly attributed to the aging 
population in Scotland over the study period but other contributing factors 
may also exist. The increase in overall RRD incidence during the study 
period was more notable in males with a trend towards an earlier age of 
onset. Despite accounting for temporal changes the Scottish population, the 
reason for this imbalanced gender distribution is unclear.  With the changes 
in population structure and a longer living population, it is likely that RRD 




CHAPTER 4 Genetics of RRD, Myopia and 
associated vitreoretinopathy 
 
4.1 The Heritability of RRD  
4.1.1  Evidence for the heritability of RRD  
There is now significant evidence that ocular and retinal disorders related to 
RRD carry an important genetic component. Risk factors strongly associated 
with development of RRD such as myopia and lattice degeneration aggregate 
significantly in families. An eye with a spherical equivalent refractive error of 
between -1 to -3 dioptres(D) has a fourfold increased lifetime risk of RRD 
compared to a non myopic eye, increasing to tenfold with a refractive error 
of >-3D. (The Eye Disease Case-Control Study Group 1993)  Multiple familial 
studies support a high genetic effect for myopia and  heritability estimates 
calculated from twin studies are as high as 0.8.(Teikari et al. 1991; Teikari 
et al. 1988a) Lattice degeneration, implicated in up to two thirds of cases is 
the most prevalent vitreoretinal degeneration predisposing to 
RRD.(Straatsma BR et al. 1974) Family pedigrees have demonstrated 
autosomal dominant and recessive modes of inheritance, with a three-fold 
higher prevalence of lattice degeneration in first degree relatives.(Everett 
1968) 
 A positive (first degree relative) family history in patients with RRD 
not associated with other ocular or non-ocular findings has been reported 
between 1 – 8.2% in large population studies.(Wilkes et al. 1982; Zou et al. 
2002; CUENDET et al. 1975) A hereditary predisposition to rhegmatogenous 
retinal detachment was initially suggested over 40 years ago and recently an 
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autosomal dominant gene mutation with variable penetrance for RRD has 
been identified in a genetic linkage study. (FRANCOIS 1968; Francois J & 
Verbraeken H 1975; CUENDET et al. 1975)Inherited vitreoretinopathies 
associated with RRD such as Stickler syndrome, Wagner syndrome and 
familial exudative vitreoretinopathy(FEVR) have been well defined in their 
mode of inheritance and genetic heterogeneity(Snead & Yates 1999b), 
however the genetic risk of non-syndromic RRD in the general population is 
as yet, poorly characterised. A hereditary predisposition to rhegmatogenous 
retinal detachment was reported over 40 years ago and recently an 
autosomal dominant gene mutation with variable penetrance has been 
identified in a genetic linkage study. (FRANCOIS 1968), 
 Most remarkably however, Go et al have demonstrated that familial 
occurrence of RRD is a risk factor for its’ development, with a risk ratio of 
2.6 for cumulative lifetime risk of RRD in relatives of subjects with RRD 
compared to relatives of those without RRD.(Go et al. 2005b) Despite 
controlling known risk factors (myopia, age and sex), siblings of subjects 
with RRD had a 3-fold increased frequency of RRD compared with siblings of 
non-affected subjects. Go et al have also reported autosomal dominant RRD 
in 2 families with minimal systemic features of Stickler syndrome to be 
associated with an Arg453Ter mutation in the COL2A1 gene suggesting a 
wide phenotypic heterogeneity associated with this condition.(Go et al. 
2005a)These patients were significantly younger than the general population 
of patients who present with primary RRD. (Average age 36 in family A and 
14 in family B), and it would appear that these detachments are more 
difficult to treat and more likely to develop PVR.(Theelen T et al. 2004)  
 




   4.1.1.1    Retinal Dialysis and Giant Retinal Tears 
Retinal dialysis is a distinct type of retinal break which can account for 1.8-
10% of RRD.(Kinyoun J.L & Knobloch W.H 1984; Vaiser A. & Jost B.F. 1992) 
Some may be associated with ocular trauma but others may be idiopathic or 
familial. A study of 30 pedigrees of patients with retinal dialysis revealed a 
high concentration of cases in sibships examined (33%). The mode of 
inheritance could not be postulated for all cases, though the vast majority of 
cases had normal parents suggesting a possible recessive 
inheritance.(Verdaguer et al. 1975) The authors observed bilateral rate of 
54% percent; none of whom were significantly myopic, suggesting a genetic 
origin in some of the patients.  
 Some authors believe that virtually all retinal dialyses occur 
secondary to trauma.(Ross 1981; Ross 1991) Kinyoun et al failed to show a 
significant association with genetic causation, a series of over 30 retinal 
dialyses failed to show a familial tendancy.(Kinyoun J.L & Knobloch W.H 
1984) Hagler’s series of over 500 consecutive dialysis cases showed that 
less than 2% had a family history of dialysis or bilateral dialyses inferring 
that a genetic cause was unlikely.(Hagler 1980) 
However, the high rate of reported bilateral dialysis(Verdaguer et al. 1975; 
Hilton & Richards 1970) and numerous twin studies suggest a genetic 
predisposition in at least some cases.(Vaiser A. & Jost B.F. 1992) Recently, 
atrophic retinal holes have been reported in non traumatic phakic myopic 
monozygotic twins.(Chan et al. 2006) 
 Idiopathic giant retinal tears are uncommon and tears may be 
traumatic or idiopathic. However there is a high rate of bilateral 
involvement, a tendency to occur preferentially in males and in high 
97 
 
myopes.(Freeman 1978; Kanski 1975) Similarly, recent twin reports have 
raised the possibility of genetic influences in the pathogenesis of giant 
retinal tears.(Kumar et al. 2006; Chaudhry N.A. et al. 1999) 
 
4.1.2 Myopia and Rhegmatogenous Retinal Detachment 
Myopia is the most common eye disorder in the world.(Tang et al. 2008) It 
is an error of refraction primarily caused by increased axial length, but may 
also be caused by corneal or lenticular changes. (Angle & Wissmann 1980; 
Young et al. 1998) Axial length is the principal determinant of myopia and 
has been shown to have a heritability of 0.4-0.94.(Lyhne et al. 2001; Biino 
et al. 2005; Klein et al. 2009) The distribution of myopia has been found to 
be patterned in its appearance in different races and ethnic groups.(Angle & 
Wissmann 1980)  
Higher levels of myopia, usually defined as an axial eye length of >26 mm or 
a refractive error of  >-6.00 diopters is often called 'pathologic' myopia, 
because of the predisposition to develop further eye disorders such as retinal 
detachment, macular degeneration, cataract, or glaucoma. (Xu et al. 2007; 
Curtin BJ 1985; Curtin BJ & Karlin DB 1971) High myopia is the fourth most 
common cause of irreversible blindness because of associated complications. 
(Katz et al. 1997; Curtin BJ 1970) The prevalence of high myopia varies 
worldwide. High myopia (>-5D) has a prevalence if 4.5%, 4.6%  and 2.8% 
in over 40 year old adults in the United States, Western Europe and 
Australia respectively.(Kempen et al. 2004) In Mexico high myopia was seen 
in 1.4% of the population with a statistically significant higher prevalence in 
females. The prevalence of high myopia in Asians is higher than in 
Caucasians being 8.2% in Japan, 9.1% in Singaporean Chinese and 21% in 
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Taiwan students.(Sawada A et al. 2008) Highly myopic patients can 
represent up to 33% of the myopic population. (Curtin 1979) 
The aetiology of non-syndromic myopia is influenced by the broad clinical 
spectrum of this condition, genetic heterogeneity, and potential 
environmental modulating factors such as close work (which may account 
for 12% of phenotypic variation).(Nallasamy et al. 2007) The influence of 
genetic heredity on high myopia is a significant factor in its etiology.(Zhang 
et al. 2007; Naiglin et al. 2002),(Ashton 1985; Yap et al. 1993; Mutti et al. 
2002) Family aggregation studies demonstrate a myopia prevalence of 7.3% 
in children of emmetropic parents, increasing to 45% if both parents are 
myopic. Similarly, the risk of myopia in children with highly myopic parents 
is 4.6-15 fold higher than with non myopic parents and 1.5-3 fold higher for 
moderate myopia, suggesting a strong genetic basis for high myopia and a 
possible genetic basis for low or moderate myopia. Twin studies have also 
reported convincing evidence, with dizygotic heritability (the proportion of 
total phenotypic variance attributed to genetic variation) calculated at 0.5 
and monozygotic heritability of the condition are as high as 0.8 to 
1.(Hammond et al. 2001; Teikari et al. 1988b) The λs for myopia (the 
increase in risk to siblings of a person with the disease compared to 
population prevalence) has been estimated to be 4.9 to 19.8 for sibs for high 
myopia and 1.3 to 3 for sibs for low or common myopia, suggesting a 
definite genetic basis for high myopia and a strong genetic basis for low 
myopia.(Guggenheim et al. 2000; Farbrother et al. 2004) Previous studies 
have demonstrated an autosomal dominant, autosomal recessive(SORSBY & 
Benjamin 1973) and X-linked recessive mode of inheritance. 




4.1.2.1    High Myopia – Genes Identified 
Much of the current information on human myopia molecular genetics can be 
drawn from familial studies of high myopia and more recently, genome wide 
association studies. To date there are at least 16 identified loci associated 
with high myopia established through familial linkage analysis. These are 
summarised in table 4.1.  An X-linked recessive form of myopia to 
chromosome Xq28 (MYP1) has been shown to be associated with cone 
dysfunction.(Schwartz et al. 1990) More recently X linked recessive myopia 
has been mapped to Xq23-25(MYP13)(Zhang et al. 2006)in Chinese families, 
and further studies implicate hepatocyte growth factor and myocilin as 
putative candidate genes.(Yanovitch et al. 2009; Vatavuk et al. 2009) A 
recent genome wide association study associated and replicated a locus on 
chromosome 11q24.1 with high myopia in a Japanese population. (Nakanishi 
et al. 2009), and several European consortia have identified and replicated 
susceptibility loci on chromosome 15.(Verhoeven et al. 2012) Different 
genetic loci have been mapped and replicated to different extents in 
population groups, but none of the responsible genes have as yet been 

















Replication OMIM  Myopia 
MYP1307 Xq28 Bornholm, 
Denmark 
4.8 Yes 310460 -6.75to-11.25 
MYP2301 18p11.31 US Families 9.59 Yes 160700 -6 to -21 
MYP3281 12q21-q23 US Family 3.85 No 603221 -6.25 to -15 
MYP4292 7q36 French 
Family 
2.81 No 608367  -13.05 (avg) 
MYP5303 17q21-q22 C nadian 
Family 
3.17 No 608474 -5.5 to -50 
MYP6311 22q12 Ashkenazi 
Jews 
3.08 Yes 608908 ≥-1.0 
MYP7312 11p13 British Twins 6.1 No 609256 -12.12to 7.25 
MYP8312 3q26 British Twins 3.7 Yes 609257 -12.12to 7.25 
MYP9312 4q12 British Twins 3.3 No 609258 -12.12to 7.25 
MYP10312 8p23 British Twins 4.1 No 609259 -12.12to 7.25 
MYP11306 4q22-q27 Chinese 
Family 
3.1 No 609994 -5 to -20 
MYP12304 2q37 US Family 5.67 Yes 609995 -7.25 to -27 
MYP13308 Xq23-q25 Chinese 
Family 
2.75 No 300613 -6 to -20 
MYP14313 1p36 Ashkenazi 
Jews 
9.5 Yes 610320 QTL 
Refraction MYP15290 10q21.1 Hutterite 
family USA 
3.22 No 612717 -7.04 (avg) 
MYP16314 5p15.33 Chinese 
Families 
4.81 No 612554  NK 
Table 4.1 – The validated Online Mendelian Inheritance in Man (OMIM) 
genetic loci associated with myopia. (NK - No known) 
 
 
4.1.3 Heritability of Lattice Degeneration 
Lattice degeneration is a prevalent clinical feature associated with myopia  in 
a significant proportion of rhegmatogenous retinal detachments.(Straatsma 
BR et al. 1974; Folk J.C. et al. 1989) Family studies have proposed a 
hereditary factor implicated in the development of lattice degeneration.(Byer 
N.E 1979) Everett described a family of 88 people without myopia in whom 
22% showed lattice. This pedigree reported an autosomal dominant mode of 
inheritance with 80% penetrance.(Everett 1968) Other reports on large 
families have also implicated autosomal dominant transmission with 
incomplete penetrance.(Delaney W.V et al. 1963) Lewkonia et al have 
reported the hereditary pattern to be autosomal recessive pseudodominant 
which they consider explains the high prevalence seen in the general 
population.(Lewkonia I. et al. 1973) Murakami et al performed an in depth 
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examination of 100 consecutive patients with lattice degeneration without 
retinal detachment. The prevalence of lattice degeneration in first degree 
relatives was three times higher in this cohort than in the general 
population. Polygenic inheritance was proposed as no specific pattern of 
inheritance could be delineated.(Murakami F. & Ohba N. 1982) Most recently 
however, a GWAS from Japan has reported compelling evidence of an 
association between lattice degeneration and COL4A4, a component which 
has been localised to the vitreoretinal interface suggesting the role of 
basement membrane formation in the pathogenesis of lattice 
degeneration.(Meguro et al. 2012)   
 
4.2 Genetics of Common Hereditary Vitreo-retinopathy 
 4.2.1 Stickler Syndrome - Clinical Features 
Stickler syndrome is an autosomal dominant disorder of connective tissue 
with characteristic ocular, facial, auditory and articular 
manifestations.(STICKLER et al. 1965) It is a common connective tissue 
dysplasia and the commonest cause of inherited retinal 
detachment.(Richards et al. 1996; Scott J.D 1980) It is a genetically and 
phenotypically heterogenous disorder with the majority of families having 
mutations in the COL2A1 gene, coding for type II collagen, a major 
constituent of vitreous and cartilage. (Ahmad et al. 1995; Donoso et al. 
2003b; Fryer et al. 1990) There are no agreed diagnostic criteria for Stickler 
syndrome, but Snead and Yates’ widely accepted criteria are:(Snead & Yates 
1999a) 
Congenital vitreous anomaly with any three of the following: 
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- Myopia with onset before 6 years 
- Rhegmatogenous retinal detachment or paravascular pigmented 
lattice degeneration 
- Joint hypermobility with abnormal Beighton score with or without 
radiological evidence of degeneration 
- Audiometric confirmation of sensorineural hearing loss 
- Midline cleft palate 
Vision and Refractive Error 
The large majority of patients with Stickler syndrome are myopic 
(90%)(Donoso et al. 2003b). The myopia of Stickler syndrome is usually 
congenital of a high degree and is non progressive. (Snead & Yates 1999a) 
Anterior Segment 
Developmental abnormalities of the anterior chamber have been described 
and may predispose to glaucoma.(Nielsen 1981)  
Vitreous 
Vitreous abnormalities are described as pathognomonic of Stickler 
syndrome. Two clear phenotypes have been defined: (Snead et al. 1994; 
Snead & Yates 1999a; Snead et al. 1996a; Snead 1996b) 
 
Type 1 Anomaly (Membranous) - Vestigial gel remnant which occupies the 
anterior vitreous cavity and extends in a thin sheet over the pars plana 
anteriorly and may extend post equatorially. It is described as an optically 
empty vitreous in the retrolental space which is bordered by a distinct folded 
membrane. 
Type 2 Anomaly (Fibrillar) – Sparse and irregularly thickened bundles of 
variable diameter fibres scattered throughout the vitreous cavity. These may 





A characteristic perivascular pigmentary degeneration is seen in this 
condition. These lesions are similar to lattice degeneration, however they are 
broad, found post equatorially with an ill defined margin. Rhegmatogenous 
retinal detachment including giant retinal tears occurs in more than 60% of 
subjects over their lifetime.(Snead 1996a; Donoso et al. 2003b) 
Systemic manifestations: 
Facial manifestations 
Facial abnormality is present in up to 84% of cases.(Donoso et al. 2003a) 
The classically described features are a flattened mid face, depressed nasal 
bridge, reduced nasal protuberance, anteverted nares and micrognathia. 
These are usually most evident at a young age. One quarter of affected 
patients have cleft abnormalities, which vary in their severity from mild 
(bifid uvula) to severe (Pierre – Robin). (Temple 1989) 
Deafness 
This may be conductive secondary to chronic otitis media from cleft 
abnormalities or more commonly it may be sensorineural in origin. The 
pathogenesis of the sensorineural hearing loss is unknown, but is present in 
up to 40-70% (Snead & Yates 1999a; Donoso et al. 2003b) of subjects. It is 
usually a subtle loss to high tones, which may not be noticed by the patient. 
It is thought to be congenital in origin and does not progress throughout 
life.(Szymko-Bennett et al. 2001) It has also been observed that the hearing 
loss varies depending on the type of Stickler syndrome, being mildest with 
type 1.(Szymko-Bennett et al. 2001) 
Joint Hypermobility 
This is present in many young subjects with Stickler syndrome and reduces 
with growth. Most adult subjects develop a subsequent degenerative 





The first causative mutations in Stickler subjects were identified in the 
COL2A1 gene which was also found in the original Stickler pedigree. (Martin 
et al. 1999)  Further research has provided some genetic evidence to sub-
classify Stickler according to the phenotypic appearance. Up to 75% of 
patients with type 1 vitreous Stickler syndrome show linkage to COL2A1 on 
chromosome 12q13. (Snead & Yates 1999a)  
More recently, mutations in the gene encoding the alpha one chain of type 
XI collagen (COL11A1) on chromosome 1p21 have been found in families 
with type II fibrillar vitreous anomaly giving rise to what is sometimes 
referred to as type II Stickler syndrome.(Richards et al. 1996; Martin et al. 
1999; Fryer et al. 1990; Bonaventure et al. 1992) Linkage to COL2A1 in 
patients with type II vitreous anomaly has been excluded. (Snead et al. 
1994; Snead et al. 1996b) A predominantly systemic form of Stickler 
syndrome has also been reported with mutations in the COL11A2 gene 
which is not expressed in ocular tissue.(Brunner et al. 1994; Vikkula et al. 
1995) 
Collagen II and XI are in a family of fibrillar collagens which are found to 
predominate in the vitreous, cartilage and nucleus pulposus. (Snead & Yates 
1999a) Collagen II accounts for the majority of vitreous collagen and is 
responsible for its gel structure.(Forrester et al. 1996) Type XI collagen 
regulates collagen fibril diameter and mutations in the coding gene are 
thought to result in thickened, irregular, beaded vitreous strands.(Blaschke 
UK et al. 2000; Richards et al. 2006; Poulson et al. 2004) 
The COL2A1 mutations are usually stop mutations(Snead & Yates 1999a) 
and result in haploinsufficiency via nonsense mediated decay,(Richards et al. 
2006) although entire COL2A1 allele deletions have been reported.(Van Der 
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Hout et al. 2002)The phenotypic appearance of the vitreous has been 
correlated to a large part with the genetic mutation, with type 1 being linked 
to COL2A1 and type 2 showing linkage to COL11A1. However there have 
been cases of type I vitreous phenotype with a COL11A1 mutation(Parentin 
et al. 2001)A third locus is suspected, as in several Stickler pedigrees 
linkage to COL2A1 and COL11A1 has been excluded. (Wilkin et al. 1998; 
Snead & Yates 1999a; Snead 1996b)  
 
 4.2.3 Wagner Syndrome - Clinical Features 
Wagner first described a vitreo-retinal disorder with an autosomal dominant 
mode of inheritance in a Swiss pedigree.(Wagner H 1938) Patients were 
characterised as having mild myopia, vitreoretinal abnormalities and early 
onset cataract without extra-ocular manifestations. The disease may be 
evident in childhood and has a progressive clinical course. (Graemger RA et 
al. 1995) Additional findings reported include peripheral perivascular 
hyperpigmented regions of the retina, vascular sheathing, and visual field 
abnormalities. This is in contrast with Stickler syndrome where retinal 
function is normal, and visual loss is non-progressive. (Meredith SP et al. 
2007)  
Vision and Refractive Error 
Visual acuity progressively declines with age and by 50 years only 25% of 
patients have vision better than 20/100 (6/36). Studies indicate this to be 
related to the extent of chorioretinal degeneration illustrated by electro-
retinogram (ERG) worsening. (Zech et al. 1999; Graemger RA et al. 1995) 
Although documented refractive errors indicate a mild to moderate myopia 





Visually significant dot like cortical cataract and nuclear sclerosis is present 
in nearly all patients by the age of 33.(Zech et al. 1999) 
Vitreous 
The vitreous cavity is characteristically described as being optically empty 
apart from being traversed by membranes and strands or veils. These 
progressive alterations may occur early and are reported in the pre-
adolescent age group of affected individuals. Clinically, one of the prominent 
features has been described as the thickening and incomplete separation of 
the posterior hyaloid membrane, which occurs in a circular avascular pre-
retinal membrane sometimes referred to as a veil or rope.(Meredith SP et al. 
2007; Graemger RA et al. 1995; Brown MB et al. 1995)  
Retina 
Progressive pigmentary changes, punched out chorioretinal atrophy, loss of 
RPE and lattice degeneration are significant retinal features in Wagner 
syndrome. Whitish equatorial vitreous membranes, perivascular pigmentary 
clumping and and macular dragging have been observed.(Maumenee 1979; 
Michels RG et al. 1990)  In Wagners' original pedigree 54% of eyes affected 
exhibited an abnormal pattern of retinal vessels. (‘’dragged vessels’’).  
Pseudostrabismus and ectopic fovea have also been described. (Meredith SP 
et al. 2007; Miyamoto T et al. 2005) 
Retinal breaks have been reported in up to 75% of patients, 47% of those 
having an associated retinal detachment (combined tractional and 
rhegmatogenous). (Hirose et al. 1973) Follow up of the original Wagner 
pedigree suggests a much more infrequent incidence of RRD but tractional 
retinal detachment was seen in 35% of cases with an older average age of 
49 years.(Graemger RA et al. 1995) In contrast,  RRD occurs much earlier 
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with an average age as young as 16 years.(Zech et al. 1999) The prevailing 
sense is that the risk of RRD in Wagner syndrome is low compared with 
other vitreoretinopathies such as Stickler syndrome and erosive 
vitreoretinopathy.(Brown et al. 1994; STICKLER et al. 1965)  
Retinal Function 
Electrophysiological abnormalities such as elevated rod and cone thresholds 
on dark adaptation and subnormal b-wave amplitudes on the 
electroretinogram  which correlate with the severity of chorioretinal atrophy 
also feature as part of this syndrome.(Graemger RA et al. 1995) 
 
Genes Identified 
Brown et al first showed Wagner disease to be linked to chromosome 5q13-
14.(Brown MB et al. 1995) Further studies showed the localisation of the 
gene to a 2.5cM region on chromosome 5q14.3(Perveen R et al. 1999; Zech 
et al. 1999) which has more recently been confirmed in a Japanese family. 
(Miyamoto T et al. 2005)   
Analysis of a candidate gene CSPG2 found a single base pair change in one 
family, which was absent in 100 controls.(Perveen R et al. 1999) However, 
no mutation was found in 17 other families. Identification of the genetic 
defect in the original Wagner pedigree revealed a heterozygous substitution 
which cosegregated with the disease phenotype.(Kloeckener-Gruissem et al. 
2006) 
 
 4.2.5 Erosive Vitreoretinopathy - Clinical Features 
First described in 1993 this is hereditary vitreo-retinopathy is exhibited 
symptomatically by nycthalopia and visual field loss and clinically, by a 
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syneritic vitreous, RPE thinning and atrophy as well as RRD. In the original  
series, combined tractional and rhegmatogenous retinal detachment was 
found in 42% of the pedigree with the vast majority occurring under the age 
of ten years.(Brown et al. 1994) As with other vitreoretinopathies, 
considerable variation in expression exists within pedigrees. 
Vision and Refractive Error 
The visual prognosis is poor with 20% of eyes having an acuity of PL or 
worse from retinal detachment, as well as this a further 20% have a visual 
acuity of 20/200 or worse from RPE and/or photoreceptor damage. 
Refractive errors have been seen to vary between emmetropia and -
10diopters, but most remain in the myopic range. Visual field testing in 
these patients reveals progressive constriction of visual fields as well as 
peripheral or central scotoma corresponding to the erosive lesions. 
Anterior Segment 
Nuclear sclerotic cataract is common in affected eyes usually necessitating 
extraction by the age of 40. 
Vitreous 
Vitreous syneresis is seen in all affected patients with pronounced vitreous 
sheet, veils and ‘’ropes.’’ Vitreous traction is also common at the border of 
the erosive lesion and normal appearing RPE. 
Retina 
Progressive RPE changes allowing visualisation of the underlying choroid are 
manifest in all patients with this condition. Progressive thinning or erosion of 
the RPE leading to geographic atrophy with scalloped edges is often seen 
around the equatorial areas. In the original series 11 0f 15 patients had a 
rhegmatogenous retinal detachment, 5 of those suffering bilateral RRDs. 
Nearly all of the detachments occurred in the age group under 10. Dragged 
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disc vessels, an ectopic macula and a positive angle kappa (strabismus) 
have also been noted. (Brown et al. 1994) 
Retinal Function 
Striking ERG abnormalities feature in this condition, which resemble those 
seen in retinitis pigmentosa. Both rod and cone photoreceptor dysfunction is 
evident. The light adapted 30Hz flicker was abnormally prolonged in cases of 
rod and cone dysfunction. Oscillatory potentials were minimally developed. 
No systemic manifestations are associated. 
Genes Identified 
The critical region associated with erosive vitreoretinopathy was found to 
overlap that with Wagner disease to a 2cM region on chromosome 5q14.3, 
giving rise to the concept that both conditions are allelic.(Brown MB et al. 
1995)  
 4.2.7 Snowflake Vitreo-retinal Degeneration - Clinical 
Features 
This autosomal dominant hereditary vitreoretinopathy was first described by 
Hirose et al in 1974. It was characterised by early onset visually significant 
cataract, fibrillar degeneration of the vitreous, and crystal-like retinal 
deposits resembling snowflakes. No systemic features were evident.(Hirose 
et al. 1974) 
Vision and Refractive Error  
In the absence of other ocular disease, a good visual acuity was maintained 
in the snowflake pedigree.  The refractive error in these patients varied from 
high hyperopia to myopia, with the majority being in the myopic range. 21% 




Cataract was seen in all patients over 32 years. The type of cataract was not 
uniform. Anterior segment corneal guttata has been reported in the follow 
up study of the original pedigree.   
Vitreous  
The vitreous is characterised by fine swirling strands and liquefaction in 
affected individuals. This severe fibrillar degeneration was sometimes 
associated with localized thickening of the cortical vitreous over degenerated 
areas of the retina. These changes are seen in all snowflake subjects, and 
were reported as early as 12 years of age suggesting they may be 
congenital changes.(Lee M.M et al. 2003; Robertson et al. 1982) 
Retina 
Fundal appearance in the original series has been described as being a 
progressive degeneration passing through four stages:(Hirose et al. 1974) 
Stage 1 - ‘White with pressure’lesions around the peripheral fundus with 
minimal vitreous degeneration  
Stage 2 - Crystalline snowflake deposits which are found in the superficial 
layers of the retina and extend to the ora serrata, they may also extend 
radially along retinal vessels  
Stage 3 - Sheathing of retinal vessels and increased peripheral pigmentation  
Stage 4 - Increased retinal pigmentation and the disappearance of 
peripheral retinal vessels became apparent in patients aged over 58. The 
peripheral retina appears markedly atrophic and severe vitreous 
degeneration is evident.      
 
Radial perivascular degeneration seen frequently in Stickler subjects were 
noted in 33% of snowflake patients. Minute yellow-white crystals like 
deposits seen in the peripheral retina appear to be a unique finding in these 
subjects. Lattice degeneration was absent.  RRD was seen in 21% of 
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subjects at a mean age of 60. Tractional RD and retinal vessel abnormalities 
typical of Wagner disease were not seen. (Lee M.M et al. 2003) 
Retinal Function 
Elevated dark adaptation and reduced scotopic B wave with dim light are 
electrophysiological abnormalities evident in most snowflake 
subjects.(Hirose et al. 1974) 
 
Genes Identified 
A genome-wide scan of a pedigree with snowflake vitreoretinal degeneration 
showed linkage to a 20 Mb genetic locus on chromosome 2q36 flanked by 
D2S2158 and D2S2202.(Jiao X et al. 2004) Most recently, it has been 
demonstrated that within this region a heterozygous mutation in KCNJ13 
(coding a potassium rectifier channel) can cause snowflake vitreoretinal 
degeneration. This gene encodes Kir7.1 which has been localised to the RPE 
and inner-limiting membrane of human retina. (Hejtmancik et al. 2008) 
 4.2.9 Familial Exudative Vitreoretinopathy - Clinical Features 
Familial Exudative Vitreoretinopathy (FEVR) is an autosomal dominant 
nherited disorder of retinal vessel development that affects both 
eyes.(Benson 1995a) First reports (Criswick and Schepens) indicated that 
clinical features can be asymmetrical and highly variable even within the 
same family.(Criswick & Schepens 1969) The primary pathological process 
appears to be premature cessation of retinal angiogenesis leading to 
incomplete vascularisation of the peripheral retina, which may be evident on 
fundal fluorescein angiography (FFA) in asymptomatic individuals.(van 
Nouhuys 1991; Ober et al. 1980) The visual morbidity in these individuals 
develops from secondary complications such as peripheral 
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neovascularisation, falciform retinal folds, retinal traction, fibrovascular 
proliferation and exudative, tractional and rhegmatogenous retinal 
detachment.(Shukla et al. 2003) 
Vision and Refractive Error 
Visual acuity varies depending on age of onset and progression of secondary 
complications. Of note 50% of patients with FEVR will be 
assymptomatic.(Benson 1995a) It has been observed that patients with 
FEVR who have not had significant visual loss by the age of 20 tend to 
stabilise clinically and retain good visual acuity.(Gow & Oliver 1971; Ober et 
al. 1980; Feldman et al. 1983) In one series less than 10% of patients 
whose onset of symptoms occurred before their third birthday had a final 
visual acuity of 20/200.(Benson 1995a) There is no characteristic refractive 
error in FEVR with the majority being between +3 and -3 diopters.(van 
Nouhuys 1982) 
Anterior Segment 
Early onset posterior subcapsular cataract has been reported but it is not a 
characteristic feature.(Slusher & Hutton 1979; Boldrey et al. 1985) 
Vitreous 
Although originally postulated by Criswick and Schepens that the vitreous 
plays an important role in the development of the disease, it has 
subsequently been observed that vitreous may not play a primary role in the 
etiology, and up to 50% of subjects may have a normal appearing 
vitreous.(Miyakubo et al. 1982) Current clinical and pathological findings 
conclude that this is a disease of the small peripheral retinal vessels rather 
than a true vitreoretinopathy.(Laqua 1980; Criswick & Schepens 1969; Gow 




All affected individuals have an avascular peripheral retina, and in many 
cases this may be the only manifestation.(Benson 1995a) If this is the 
diagnostic criteria used, it is said that FEVR has 100% penetrance.(Benson 
1995b)  
Gow and Oliver established 3 clinical stages of FEVR:(Gow & Oliver 1971) 
Stage 1 - Demonstrated vitreoretinal interface changes, vitreous bands and 
peripheral retinal degeneration - ‘white-without pressure’ 
Stage 2 - Highlights a progression to neovascularisation, retinal exudation, 
elevated fibrovascular bands in the peripheral retina, localised retinal 
detachment, and dragging of the disc and macula. 
Stage 3 - End stage disease with total retinal detachment, cataract 
formation, iris atrophy and neovascular glaucoma. 
Significant vitreous adhesion and traction is a frequent cause of severe 
visual loss, being present in up to 41% of individuals.(Benson 1995a) The 
initial manifestation of this may be vitreomacular traction seen in up to 49% 
of affected eyes.(Miyakubo et al. 1982; Miyakubo et al. 1984) RRD is the 
most frequent form of retinal detachment present in 17 – 30% of eyes but is 
commoner in young subjects who also have a more rapid 
progression.(Miyakubo et al. 1982; Shukla et al. 2003; Tasman et al. 1981) 
Peripheral retinal neovascularisation is present in up to one fifth of eyes and 
is a poor prognostic sign.(Benson 1995a; Slusher & Hutton 1979) 
Retinal Function 
Electroretinogram, electro-oculogram, colour vision testing and visual fields 
are normal or mildly abnormal in affected individuals.(van Nouhuys 1982; 
Feldman et al. 1983; Ohkubo & Tanino 1987)No systemic manifestations 





FEVR like most hereditary vitreoretinopathies is genetically heterogeneous. 
Autosomal dominant,(Laqua 1980; Gow & Oliver 1971) X linked  (Plager et 
al. 1992; Shastry et al. 1997; Shastry et al. 1995) and autosomal 
recessive(de et al. 1998; Jiao et al. 2004) modes of inheritance have been 
described, with autosomal dominant being the most common.(Kondo et al. 
2001b; Kondo et al. 2001a) 
FEVR and Norrie disease share common molecular etiology and have highly 
overlapping ocular manifestations that are caused by alterations in the Wnt 
signalling network. Norrie disease is a severe X-linked recessive form of 
congenital blindness which is accompanied by mental retardation and 
deafness in one third of cases. (Berger et al. 1996) To date, mutations in at 
least four genes have been identified as responsible for autosomal dominant 
(FZD4, LRP5, and TSPAN12 genes) (Li et al. 1992) (Toomes et al. 2004) 
(Downey et al. 2001), autosomal recessive (LRP5)(Yang et al. 2012) or X-
linked (NDP gene) (Fullwood et al. 1993) forms of FEVR. Mutations in LRP5 
are also known to cause bone abnormalities.(Nikopoulos et al. 2010)  The 
encoded proteins of these four genes are involved in the Wnt signalling 
pathway, which regulates retinal vascular development. Retinal vascular 
angiogenesis is depende nt on TSPAN12, FZD4 and LRP5 to initiate the B-
catenin signalling cascade upon NDP binding, which is thought to play a 
critical role in ocular development and formation of the hyaloid vascular 
system during organogenesis.(Nikopoulos et al. 2010) FZD4, LRP5, and NDP 
are relatively small genes making sequence analysis of these genes cost 





CHAPTER 5 Investigating the genetics of 
complex disease 
5.1  The genetics of complex disease 
The nucleus of each human cell contains the same tightly compact 
deoxyribonucleic acid (DNA) molecules that make up our genome. DNA is a 
polymer molecule made up of four sub-units- adenine, cytosine, guanine and 
thymine (A,C,G,T). The sequence of these DNA base pairs carries our 
genetic information.  In 2001, the Human Genome Project published the first 
draft sequence of the human genome. This sequence was a consensus 
sequence showing what a typical human genome sequence looks like. It did 
not inform us of genetic differences between individuals. Following on from 
this, the International HapMap project is working to describe all single 
nucleotide positions where at least 5% of the population differs from the 
consensus genome and since 2008 the 1,000 Genomes project aims to 
discover >95 % of the variants with minor allele frequencies as low as 1% 
across the genome. By characterizing the genotypic variation in humans, 
genetic researchers seek to understand how genotypic variation relates to 
phenotypic variation. 
A complex or multi-factorial disease is a disease that does not exhibit classic 
Mendelian dominant or recessive inheritance attributable to a single gene 
locus, but is determined by a number of genetic and environmental factors. 
These diseases are common and usually occur later in life. (eg. 
Hypertension; diabetes) There have been many technologies and strategies 
used to detect genetic influences of complex disease all of which have 
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inherent limitations.(Schork 1997) The genetic influence in complex disease 
is multi-factorial and can involve: 
1 – Classical polygenic inheritance, in which a number of mutations at 
different loci must be present to result in disease. Polygenic traits may be 
classified as discrete traits which are measured by a specific outcome (such 
as death from myocardial infarction) or quantitative traits which are 
measured by a continuous variable (eg. Blood pressure).  
2 – Genetic heterogeneity, in which defects in a number of genetic loci 
confer disease susceptibility independent of each other. 
3 – Epistatis (gene interaction) in which the possession of a mutation will 
confer susceptibility to a degree dictated by the presence of other mutations. 
4 – Environmental vulnerability and gene-environment interactions in which 
gene products are influenced by environmental stimuli and some may only 
have a deleterious effect in the presence of certain environmental factors. 
5 – Incomplete penetrance and phenocopy – Some individuals who inherit a 
predisposing allele may not manifest the disease (incomplete penetrance) 
and others who do not inherit a predisposing allele may get the disease as a 
result of environmental or other influencing causes. 
6 – Aging, in which with age, genes either mutate more rapidly or produce 
sub-optimal end products resulting in weakened or damaged physiologic 
mechanisms.  
These features make the isolation of genes influencing complex disease 
difficult since the individual contribution may be obscured by the others or 
may exhibit dependency, where genetic effects may only occur in the 
presence of other factors. (Lander & Schork 1994; Schork 1997) 
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There are two basic strategies for identifying genes contributing to complex 
disease: Candidate gene analysis and whole-genome searches. 
5.2  Candidate gene analysis 
Candidate gene analysis involves testing the association between a 
particular genetic variant (allele) and a disease. If the particular genetic 
variant is more frequent in people with the disease than those without, it 
may either be a causative variant or may be related to a disease causing 
gene in a nearby locus. These analyses require prior information regarding 
the ‘candidate’ gene. This information usually derives from biological 
insights, similarity to other genes or deductive hypotheses. These studies 
are difficult in situations where little is known about candidate genes or if 
significant genetic heterogeneity occurs.(Schork 1997) 
 
5.3  Linkage Analysis 
Using evenly distributed genetic markers and knowledge of genetic linkage 
(where genes located close to each other on the same chromosome are 
inherited together more often than by chance), linkage analysis attempts to 
identify a genetic locus associated with a particular disease by identifying 
which alleles in the loci are segregating (being transmitted together) with 
the disease in families. If a set of marker alleles are segregating with the 
disease, they are said to be located near the disease gene. A likelihood of 
linkage ratio (LOD) is calculated to indicate statistical significance. Linkage 
analyses involve proposing a model to explain the inheritance pattern of 
phenotypes and genotypes observed in a pedigree. This method has worked 
well for monogenic Mendelian inheritance as there are few possible models 
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which may be easily tested. The applications to complex traits are more 
problematic as they may not fit a precise Mendelian inheritance model. Most 
linkage strategies are weak in detecting genes with small to moderate effect 
sizes and are rarely designed to assess multiple gene and environmental 
effects.(Lander & Schork 1994; Schork 1997; Mayeux 2005) 
 
5.4  Common Disease/Common Variant theory and 
association studies 
The principle of a genetic association study is to determine if there is a 
statistically significant difference in the frequency of one or more genetic 
markers between two groups. This is commonly tested between unrelated 
population-based cases and controls.(Orr & Chanock 2008) Association 
studies are based on an evolutionary theory, the common disease/common 
variant theory (CDCV), which hypothesizes that the genetic variation 
underlying susceptibility to common heritable diseases existed in the 
founding population of contemporary humans, such that the genetic variants 
predisposing to common disease arise on an ‘ancestral genetic backbone’ 
that is shared by a large proportion of those affected.(Reich & Lander 2001) 
Rare Mendelian inherited diseases which often result in strongly deleterious 
phenotypes would have been naturally selected out of the population. 
Common diseases often occur later in life and have little or no impact on 
reproductive fitness. Thus, common disease susceptibility alleles, rather than 
being selected out of the population, have persisted in moderate frequency 
because the human population has undergone a rapid and recent expansion. 
Alleles which may have been neutral or advantageous during human 
evolution may now confer susceptibility to disease because of a change in 
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the environment or living conditions that now results in disease 
manifestation.(Doris 2002; Altshuler et al. 2008)This theory hypothesizes 
that the genetic profile of common complex diseases is determined by 
genetic variants that are common in the population (allele frequency >0.05) 
and have individually a small effect on disease. Genome wide association 
studies are based upon this model and in design, they search for common 
variants of different allele frequencies between cases and controls. 
Human Variation 
Sequencing of the human genome has shown that the DNA sequence 
between 2 individuals from different populations is over 99% identical. 
However, the human genome includes over 3 billion base pairs, thus even 
with this high level of similarity between individuals, there are still more 
than 12 million sites of potential genetic variation between two individuals 
genome.(International HapMap Consortium 2005; Attia et al. 
2009)Differences in genetic structure between individuals that occurs with a 
frequency of <1% are known as mutations; occurring more commonly than 
1% are known as polymorphisms. These polymorphisms can take several 
forms. The presence (insertion) or absence (deletion) of an entire stretch of 
DNA, involving duplication of DNA is known as a copy number variation 
(CNV). Repeating patterns of DNA that vary in the number of repeats are 
known as Short Tandem Repeats (STR). Each repeating unit is usually 
between 200-300 base pairs in length and repeats several hundred times. 
Most commonly, a single nucleotide polymorphism (SNP) is a DNA sequence 
variation occurring when a single nucleotide (A, G, T, C) in the genome 
differs between individuals. Thus, SNPs describe locations in a chromosome 
where a single base varies between different people. These differences in 
individual bases are the most stable and common type of genetic variation 
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occurring in approximately 1 in 1000 base pairs. (2005; Doris 2002)They 
represent approximately 90% of common human genetic variation. Some 
SNPs are located in parts of the gene that code for a particular protein. In 
this case, they are known as non synonymous SNPs as they lead to a change 
in the amino acid sequence of the resulting protein, whereas synonymous 
SNPs do not result in an amino acid change. Other SNPs are not found in 
coding regions of DNA but may have an influencing effect on nearby genes. 
The most common nomenclature for SNPs refers to their reference SNP (rs) 
number eg. rs1837289. The presence of particular SNP allele in an individual 
is determined by testing (‘genotyping’) a DNA sample. The genotyping of 
random or selected SNPs in a group of unrelated cases and controls is 
known as a Genome Wide Association Study.   
5.5  Genome Wide Association  
Genome wide association studies (GWAS) are the method of choice for 
identifying common genetic variants predisposing to complex disease. They 
permit an unbiased and comprehensive analysis of the genome with the 
potential to identify novel susceptibility factors. These association studies 
are generally model free with no assumptions of the mode of inheritance and 
seek to determine whether or not a specific allele is associated with a 
disease.(Iles 2008a) 
The fundamental principle of GWAS is that common diseases must be in part 
caused by common mutations. The most common mutation in the human 
genome is a SNP; a single base pair change between people occurring 
approximately every 1000 bases.(Altshuler et al. 2008)   A GWAS depends 
on the identification of genetic variants in the form of SNPs and have been 
made possible by the International HapMap project and the rapid 
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development of massive parallel genotyping.  The International HapMap 
Project is a large international collaboration that began in 2002 and seeks to 
determine the common patterns of DNA sequence variation in the human 
genome. It has done this by characterizing sequence variants, their 
frequencies and the correlations between them in DNA samples from 
populations with ancestry from parts of Africa, Asia and Europe. Similar to 
the human genome project in scope, it was a huge and successful 
collaboration that made all data freely available in the public 
domain.(International HapMap Consortium 2005) This catalog of genetic 
variation has provided the necessary ‘blueprint’ of human genetic variation 
making GWAS possible. GWAS seek to identify if the differences in common 
genetic variants between cases with a particular disease phenotype, and 
controls without are true disease associated variants. Since the early part of 
the 21st century, rapid advances have been made in genotyping technology 
and several commercial companies (eg. Illumina and Affymetrix) now 
provide high density SNP genotyping of between 200,000 SNPs up to 1.2 
million SNPs. The methods of SNP selection differs between manufacturers, 
but Illumina and Affymetrix genotyping platforms (with greater than 
300,000 SNP markers) both provide an estimated >75% coverage of 
common HapMap SNPs with an allelic correlation of 80% in Caucasians of 
European ancestry.(Barrett & Cardon 2006)    
In GWAS, a large set of SNPs (>100,000) is genotyped across the human 
genome to determine the most common genetic variations that have a role 
in disease or to identify heritable quantitative traits that are risk factors for 
the disease.(Hirschhorn & Daly 2005) Commonly, GWAS use a case-control 
study design with a large number of participants, comparing the frequency 
of SNPs in a defined group of individuals with the disease and a similarly 
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matched group without the disease. If certain genetic variations are found to 
be significantly more frequent in people with the disease compared to people 
without, these variants may either be causative or more commonly may be 
associated with the causative mutation.(Satagopan & Elston 2003; Iles 
2008a) By careful population selection and stringently phenotyping cases 
and controls, this approach has been highly successful identifying new 
genetic variants predisposing to medical disease.(Tenesa et al. 2008; Klein 
et al. 2005; Vitart et al. 2008)  
 
5.6 DNA pooling 
Although GWAS are a powerful and useful approach to detect new genetic 
variants contributing to disease, their cost can be prohibitively high. DNA 
pooling is a method designed to improve genotyping efficiency whilst trying 
to minimise loss of phenotypic and genotypic information. Using a DNA 
pooling strategy, pooled DNA from a group of cases and pooled DNA from a 
group of controls are formed. The allele frequency of each marker is then 
estimated by genotyping case and control pools instead of individual 
subjects, markedly reducing the number of genotyping assays 
performed.(Zhao & Wang 2009) DNA pooled GWAS are a viable alternative 
for screening disorders with common variations of large effect and have 
been demonstrated as a reliable and valid initial screening tool. DNA pooling 
has been successfully used to identify susceptibility loci in genome-wide 
association studies of neuroticism, schizophrenia and supra-nuclear 
palsy.(Shifman et al. 2008; Kirov et al. 2008; Melquist et al. 2007) 
However, apart from the challenges of analysis, DNA pooling does also have 
inherent limitations such as the introduction of experimental error in 
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formation of DNA pools (eg. accuracy of pool construction, integrity of 
pooled genomic data, unequal allele amplification) and within pool 
genotyping measurement variance which may necessitate several replicate 
measurements to reduce standard error.(Macgregor 2007; Barratt et al. 
2002) 
5.7 Next generation sequencing 
While GWAS focus on identifying common SNPs which have a role in disease 
pathogenesis, advances in the understanding of the genome and in next-
generation sequencing (NGS) technologies have permitted the study of rarer 
risk alleles that may influence complex disease.(Metzker 2010) NGS aims to 
sequence all base pairs in the genome providing a resolution that has not 
previously been possible. NGS technology is a rapidly evolving field that is 
constantly changing.(Cirulli & Goldstein 2010) New NGS technologies read 
DNA templates randomly along the entire genome and synthesise DNA in 
short reads of overlapping segments approximately 50-500 basepairs. To 
ensure the correct identification of genetic variants, short-read coverage 
must be sufficient to ensure the complete and accurate sequence assembly, 
and currently, at least 30 fold coverage is recommended in whole-genome 
scans for rare genetic variants.(Zhang et al. 2011) In the near future, NGS 
is predicted to become the best method of disease gene identification in 
large population based case-control studies, however the challenges in 
bioinformatics, data analysis and cost remain significant obstacles.(Faita et 
al. 2012) To overcome some of these challenges, geneticists have adopted 
different approaches such as targeted exome sequencing, sequencing of 
families or of phenotypic extremes.(Shi et al. 2011; Bras & Singleton 2011) 
In the last few years, reports of novel mutations in unknown disease and a 
move towards NGS as a diagnostic tool have been emerging, making this a 
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very exciting and promising tool in the future of clinical genetics.(Desai & 
Jere 2012; Shanks et al. 2012; Davies et al. 2012) 
 
5.8 Genetic association studies 
Genetic association studies may be designed to examine direct 
polymorphism association or indirect association.(Cordell & Clayton 2005) 
  5.8.1  Direct association 
Direct association studies are designed so that polymorphisms studied are 
themselves putative causal variants. This is the most powerful type of 
association study and the easiest to interpret, however it requires a prior 
hypothesis about functional variants which may have a biological relation to 
the disease process. In practice, a set of SNPs are decided upon in regions 
of likely candidate genes and are used to test association in well 
characterised groups of cases and controls.(Cordell & Clayton 2005; Doris 
2002; Campbell & Rudan 2007) 
 5.8.2 Indirect association 
Because the odds of selecting the true causative SNP for direct association 
are impossibly low, indirect association studies are the predominant method 
of GWAS interpretation. In an indirect association approach there is no prior 
hypothesis, and polymorphisms may be in linkage disequilibrium with the 
true polymorphism conferring genetic susceptibility. These studies are 
weaker and more complex to interpret than direct association studies and 
they depend on the accurate knowledge of linkage disequilibrium patterns 
between associated markers within specific populations. (Cordell & Clayton 
2005; Doris 2002; Campbell & Rudan 2007) 
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 5.8.3 Linkage disequilibrium 
When two alleles are statistically independent of each other they are said to 
be in linkage equilibrium. This is more likely to occur if the two alleles are far 
apart on the same chromosome. However when loci are sufficiently close 
together or are transmitted together, there is a statistical correlation 
between the alleles at each locus. This correlation is known as linkage 
disequilibrium (LD).(Conrad D.F. & Pritchard J.K. 2007; Orr & Chanock 
2008) This allelic association may be interrupted in several ways such as 
gene conversion and by recombination events resulting in crossing 
over.(Myers et al. 2005) LD reflects human population history because its 
magnitude is determined by the level of recombination, migration, 
admixture, selection and random drift over successive generations.(Altshuler 
et al. 2008) If LD is well preserved, a single marker within a region of LD 
may be sufficient to give information on the adjacent polymorphisms. If LD 
is low or mixed, denser SNP markers are needed for more extensive 
coverage of the genome.(Doris 2002) When LD is plotted across the 
genome, it creates blocks of common genetic variation separated by so-
called hotspots, where recombination rates are much higher than is usual. 
These blocks of common genetic variation are known as haplotypes. The 
characterisation of population specific haplotypes was carried out by the 
International HapMap Project, and the size and variation of haplotype blocks 
is critical in the analysis of GWAS. Haplotype blocks vary between population 
groups and have been shown to be smaller in Africans than in other 
populations.(Orr & Chanock 2008; Reich & Lander 2001; International 




5.8.4 Quantifying LD in the Genome 
A large number of statistical measures have been proposed as ways to 
quantify the level of LD between alleles. The three most common measures 
are: D, D’ and r2. D is the most basic measure of LD and represents the 
difference between the observed frequency of a haplotype from the expected 
frequency. A haplotype describes a sequence of alleles coming from the 
same chromosome. D takes a value of zero when there is no LD. D’ is a 
standardised form of D (D/Dmax) and has a value between -1 and 1. A 
value of 1 represents complete LD. A maximum D’ of 1 is reached when less 
than a total of four possible two locus haplotypes is observed in a 
population. r2 represents the correlation co-efficient between two alleles at 
different loci. r2 = 1 (perfect LD) if there are only two locus haplotypes 
present. As it is prohibitively expensive at present to perform whole genome 
sequencing, the knowledge of LD patterns in the genome allow the use of 
‘tagSNPs’, where chosen SNPs within an LD block provide information about 
nearby SNPs without needing to genotype them. TagSNPs are usually 
selected so that they tag common nearby SNPs with an r2>0.8. (Conrad D.F. 
& Pritchard J.K. 2007; Orr & Chanock 2008; Pritchard & Przeworski 2001)  
5.9 Design of Genome Wide Association Studies 
 5.9.1 Case selection 
Case ascertainment in GWAS is an important consideration in planning a 
successful study. Methods of case ascertainment can sometimes improve 
study power to find a disease causing allele by selecting cases from the 
extremes of clinical phenotypes or those cases with early onset disease or 
from large well characterized families. In addition, it is important that case 
definition is consistent particularly if multiple recruitment sites are involved 
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and that cases derive from the same or a similar population. (McCarthy et 
al. 2008b)  
 5.9.2 Control selection 
 Increasingly, common control databases are being used in GWAS. 
This method was successfully used in the Wellcome Trust Case Control 
Consortium (WTCCC) where controls were derived from a U.K. birth cohort 
and sampling of blood donors. Differences in survival and ascertainment 
between the two groups did not result in any spurious or significant 
associations indicating that perhaps their effect on genotype distributions 
were overestimated.(2007b) Nevertheless, disease prevalence and age of 
onset are important considerations in a control group. Certain common 
diseases may have a high prevalence in unselected controls which will 
reduce effective study power. Late-onset disease may cause misclassification 
bias, as susceptible individuals who have not yet reached the ‘at risk’ age 
period may be wrongly classified in a control group.   
 5.9.3  Two – stage design 
Most current GWASs typically adopt a 2-stage design. When first 
established, conducting a well powered GWAS was prohibitively expensive 
for many scientific laboratories.  Satagopan et al(Satagopan & Elston 2003) 
demonstrated the effective use of a 2 stage study as a design methodology 
that significantly reduced the quantity of genotyping needed and maintained 
study power. This method involves genotyping all cases and controls with a 
dense genome wide array in the first stage and selecting the most 
statistically significant associations from the analysis to genotype in a 
second (often larger) group of cases and controls. Significant polymorphism 
associations after this stage are then replicated in larger sample sizes or in 
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different case-control population groups as the best way to confirm a true 
association.(Igl et al. 2009) 
5.10 Genome wide association studies– Error and bias 
Although the design and analysis of GWAS are becoming more standardised, 
careful consideration should be given to the potential sources of error in 
GWAS.  
The first step of GWAS is the whole genome amplification of the DNA 
and then hybridisation of DNA samples to the arrays.(Fan et al. 2006) 
Illumina hybridisation contains specific probes bound to beads (BeadChip). 
Their genotyping technology is based on the subsequent detection of 
fluorescently labeled molecules hybridized to these beads which are 
immobilized on a micro chip array. Genotypes are then called specific to 
different arrays by an automated algorithm. Defining a ‘cut-off’ genotype call 
rate is an important consideration. An excessively stringent cut-off call rate 
can lead to a loss of many SNPs ( with a low call rate) such that true signals 
may be lost, and secondly, a potential rise in type 1 error ( incorrectly 
rejecting the null hypothesis) , where differences in the pattern of missing 
genotype calls between cases and controls may result in a false association, 
a concept known a informative missingness.(McCarthy et al. 2008b) Too low 
a threshold reduces these problems at the expense of reduced accuracy and 
a higher chance of poorly called SNPs (due to technical error) being 
misrepresented in the association signals.  Overall, a prudent approach 
appears to be more relaxed thresholds of genotype calling, followed by a 
careful assessment of other quality control measures and the inspection of 
signal genotype clusters. (McCarthy et al. 2008b; McCarthy & Hirschhorn 
2008; Sebastiani et al. 2009)Other sources of laboratory error include 
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inefficient sample tracking, sample swaps and sample duplication. A 
standard way to identify some of these errors is to examine the agreement 
between phenotype gender classification and genotype by examining the 
heterozygosity of SNPs on the X chromosome and genotypically inferring 
gender. Samples with mis-matching gender assignments are usually 
removed from the analysis.  
 5.10.1 Population Stratification  
An important potential source of confounding and significant cause of 
spurious associations in GWAS is due to population structure. This problem 
arises when cases (or controls) disproportionately represent a genetic 
subgroup, such that particular allele frequencies are more common within 
this group when compared to the general population. This may be due to a 
true association, but could equally be caused by different case and control 
ethnicities or relatedness or even hidden population substructure. 
(Freedman et al. 2004; Cordell & Clayton 2005)  Several methods have been 
proposed to control for this potential source of confounding, however 
carefully selected cases and controls from a similar region of origin with the 
same ancestral ethnicity remains one of the best ways to reduce this source 
of error. (Hoggart et al. 2003) (Bacanu et al. 2000)A commonly used 
genomic method to identify and reduce population stratification is by 
examining genome wide identity by state (IBS).  Individuals that are 
identical by state contain an independent copy of a particular allele. 
Individuals that share identity by descent (IBD) contain identical copies of 
the same ancestral allele.(Sebastiani et al. 2009) (see Figure 5.1)  On the 
basis of the genomewide average proportion of alleles shared identical by 
state between any two individuals there are several GWAS analysis tools 
(eg. PLINK(Purcell et al. 2007)) that cluster individuals into subsets and 
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perform multidimensional scaling (MDS) which provides indices of population 
genetic variation (principal components). By plotting these principal 
components, outlying individuals representing population substructure can 
be identified. Similarly, by scoring the genetic similarity between every pair 
of subjects using estimates of the frequencies of alleles that are the same, a 
probability estimate for relatedness among study subjects can be calculated. 
(pi-hat) Individuals showing hidden relatedness are usually excluded in a 
case-control population design study. 
 5.10.2 Hardy-Weinberg Equilibrium 
An allele is one form of a DNA sequence in a gene at a particular site on a 
chromosome. As all humans have 2 pairs of chromosomes, an individual is 
said to have a heterozygous genotype at a locus if they have two different 
alleles and homozygous if they have two identical alleles.  In 1908 Hardy 
and Weinberg described the mathematical relationship between genotypes 
and alleles representing a genetic trait. This relationship is known as the 
Hardy-Weinberg Equilibrium(HWE) and describes the relationship between 
the genotype frequencies from the allele frequencies. The law states that for 
two alleles A and a with frequency p and q. Then the distribution of these 
alleles is described by p2+2pq+q2=1 as long as there  are no forces such as 
selection or migration that affect the frequencies and there is random 
mating in the population.(Hardy 1908) In GWAS it is important to check that 
observed allele frequencies in a population based study are in expected HWE 
proportions. This is observed by plotting a quantile-quantile(QQ) plot of the 
observed and expected allele frequencies. If there is deviation from the line 
(of null hypothesis) throughout, this may represent population stratification, 
relatedness or genotyping error. Deviation at the end of the range may 
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indicate large-effect susceptibility loci.(McCarthy et al. 2008b; Attia et al. 
2009; Sebastiani et al. 2009) 
 
Figure 5.1-   Identity by state (IBS) and identity by descent (IBD) - Both 
sib pairs share allele A1. The first sib pair have two independent copies of A1 
(IBS but not IBD); the second sib pair share copies of the same paternal A1 
allele (IBD). 
 5.10.3 Association testing 
The most common analysis of SNP genotypes and case-control status is a 
per SNP χ2 test of independence in a 2X3 contingency table. (cases and 
controls vs the two homozygote genotypes and the one heterozygote 
genotype) This statistical approach estimates a P-value at a particular 
threshold (usually α =5%), above which the null hypothesis of no association 
is rejected.(Balding 2006) Other investigators have suggested using the 
Cochrane-Armitage trend test with 1 degree of freedom, which improves 
power to detect an association in an additive model. (ie. Where two copies of 
a variant confers a higher risk than one copy)(Cardon & Bell 2001) In 
situations where genotype frequencies are small (<5), a Fisher exact test is 
appropriate. The limitation of all these tests is that they cannot include 
information about phenotype covariates. In this case, logistic regression is 
used to model the log odds for association to calculate a genetic effect odds 
ratio.(Balding 2006; Sebastiani et al. 2009) The regression equation is 
robust as it includes covariates (such as age and gender) and can also be 
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extended to incorporate gene-environment and gene-gene interactions.  The 
other principal statistical approach involves Bayesian statistics. Bayesian 
statistics are based upon assuming a prior probability on the hypothesis of 
association or no association and then to predict the posterior probability of 
an unknown given the data. At present in GWAS this approach is not widely 
performed and is computationally intensive.(Lunn et al. 2006)  
 5.10.4 Multiple testing 
The adjustment for multiple testing in GWAS is an important component of 
analysis. The significance level for association is usually at an α of 5%. Thus 
all the performed one SNP association tests together should not have a 
probability of a false positive greater than α. To correct for this a Bonferroni 
correction is applied depending on the number of independent tests 
performed: To achieve an  α= 5% if conducting 100,000 independent tests 
the actual threshold for genome wide significance of association is P<5X10-7. 
Another method of estimating the type-1 error rate is to use permutation. 
This procedure is commonly used and involves randomising the phenotype 
labels but keeping the same genotype data. By running several analyses, a 
false-positive rate can be calculated.(Balding 2006)  
 5.10.5 Imputation 
Imputation describes the process of predicting or ‘imputing’ genotypes that 
are not directly assayed in individuals. In GWAS this refers to using a 
reference set of densely genotyped haplotypes (HapMap release reference) 
to impute into a study of individuals that have had a subset of these SNPs 
genotyped. In unrelated individuals, haplotypes over short distances will be 
related to each other by identity-by-descent (IBD).Haplotypes describe a 
sequence of genotype alleles on one chromosome copy, haplotype phasing is 
133 
 
a process that describes the two corresponding haplotypes for each 
individual given a set of genotypes. (Figure 5.2) Individuals that are 
homozygous at one or both loci have defined haplotypes, it is only when an 
individual is heterozygous at both loci that the phase is ambiguous.  The 
haplotypes of each individual over short distances are phased and modeled 
as a mosaic of those in the haplotype reference panel (HapMap). After DNA 
strand alignment, the reference haplotype is the used to infer the missing 
genotypes and calculate a probability distribution. The main advantage of 
imputation, is that it can extend genomic coverage, allowing more tests for 
association and thus improving study power to detect association. However, 
the drawback is that imputed genotypes have not been directly assayed and 
provide only a likelihood score.(Marchini & Howie 2010; Kong et al. 2008) 
 
AA AT TT 
GG AG AG AG TG TG TG 
GC AG AC 
AG TC or  
AC TG TG TC 
CC AC AC AC TC TC TC 
Figure 5.2 – Example – A given locus has alleles A and T with three 
possible genotypes AA, AT, and TT, the second locus has G and C, also 
giving three possible genotypes GG, GC, and CC. For a given individual, 
there are nine possible configurations for the genotypes at these two loci 











CHAPTER 6 Clinical epidemiology of RRD in 
Scotland: Methodology  
 
6.1  Study Population 
Scotland is a well defined geographic region with a stable population and a 
highly developed infrastructure and healthcare system which provides an 
rare opportunity to study disease incidence with great accuracy.  
This study was conducted in all six vitreo-retinal surgical sites in Scotland 
responsible for managing and administering surgical vitreo-retinal 
ophthalmic care for the population of Scotland. Data was collected between 
the 1st November 2007 and the 31st October 2009. The study participants 
are derived from the entire resident population of Scotland.  The last formal 
Scottish census was conducted in April 2001 and was administered over one 
day. Data was gathered on all usual residents (excluding visitors) in 
Scotland. It was a highly accurate census with an overall response rate of 
96% and an estimated coverage of 100%. Annual mid-year estimates (by 
age and gender) are calculated by the General Register Office of Scotland 
using a demographic cohort component method. Mid-year population 
estimates for 2008 were used in the analysis. The total population in 2008 
was 5,168,500 (Males – 2,500,205; Females – 2,668,295) (http://www.gro-
scotland.gov.uk/statistics/publications-and-data/population-estimates/mid-
2008-population-estimates-scotland/index.html ) 
Fourteen health boards are established in Scotland to administer the 
Scottish health service. These health boards are divided geographically (See 
Figure 6.1) and all diagnosed RRD cases in Scotland are referred to one of 
six vitreo-retinal surgical sites for assessment and surgery. Figure 6.2 and 
6.3 highlight the age, gender and health board distribution of the Scottish 




6.2 Participating centres  
The six vireo-retinal surgical sites (Ayr Hospital, Ayr, Gartnavel General 
Hospital, Glasgow, Princess Alexandra Eye Pavilion, Edinburgh, Ninewells 
Hospital, Dundee, Aberdeen Royal Infirmary, Aberdeen and Raigmore 
Hospital, Inverness) are geographically distributed across 14 different health 
boards and they are responsible for and manage the operative workload of 
all cases requiring retinal surgery throughout Scotland. Each identified case 
in Scotland is referred to one of these centres for assessment and further 
management. There are 16 vitreo-retinal consultant specialists in Scotland 
who helped to co-ordinate this study.  
 
6.3 Ethical aspects 
Multi-centre research ethics committee (Scotland) (06/MRE00/19) and NHS 
Trust management committee approval (MRAD07/OP01/DI) were obtained 
from all participating sites. Individual informed consent was received on the 
basis that each participant understood and had time to consider the merits 
of study participation; participation was voluntary and did not affect 
subsequent care of the patient; the DNA sample and clinical data about the 
individual would be stored by the research team at Edinburgh University for 
use in future research and may be shared with other medical research 
groups (with appropriate ethical approvals first being obtained where 
necessary). All data was recorded and stored in compliance with ethical and 





6.4 Case Definition 
All incident cases of primary rhegmatogenous retinal detachment (RRD) 
presenting to all participating centres were invited for study inclusion. The 
diagnosis of RRD was based on a case definition of “a full thickness break in 
the neurosensory retina with a surrounding area of sub-retinal fluid 
extending greater than 2 disc diameters” (Zou et al. 2002; Schepens 1951; 
Li 2003; Polkinghorne & Craig 2004b). No distinction was made in this study 
between clinical and subclinical (asymptomatic) retinal detachment, all 
diagnosed cases were invited.(Schepens 1951) As the original definition 
shows observer dependant bias, I extended RRD classification in surgical 
terms as any break in the neurosensory retina with surrounding sub-retinal 
fluid requiring intervention more than cryotherapy and/or laser treatment to 
reattach or stabilise the retina. Thus in practice any patient who had a RRD 
of significant size which was treated with barrier laser alone as well as those 
who underwent an operative procedure including vitrectomy and internal 
tamponade, pneumoretinopexy or external buckle were included. Patients 
were also included if they presented with a RRD but for medical, social or 
occupational reasons the decision to perform surgery was not taken. Cases 
of a retinal tear and associated vitreous hemorrhage where a vitrectomy and 
internal tamponade procedure was performed were excluded. Blunt 
traumatic cases of RRD were included, penetrating trauma was excluded. All 
other types of retinal detachment (exudative, tractional and combined) were 
excluded. Re-detachments regardless of duration of attachment post-
operatively were excluded.   
Three conditions must be satisfied to cause RRD: vitreous liquefaction, 
tractional forces producing a full thickness retinal break and an open retinal 
break allowing fluid to gain access to the sub-retinal space.(Ghazi & Green 
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2002) By convention, the subtype of RRD is described according to the type 
of retinal break causing the detachment and may be classified as follows: 
Horse-shoe shaped tear (HST) – This refers to tear in the neurosensory 
retina due to a persistent site of vitreo-retinal traction which occurs during a 
posterior vitreous detachment.  
Giant Retinal Tear (GRT) - This is defined as circumferential retinal break of 
90 degrees or more. The tear is usually along the posterior margin of the 
vitreous base, may have a rolled edge and rarely may occur at the anterior 
margin through the ciliary epithelium.(Michels RG et al. 1990) 
Dialysis – Defined as circumferential tears along the ora serrata with 
persistent vitreous attachment to the posterior retina (ie. Incomplete 
posterior vitreous detachment).(Hagler 1980) 
Round Hole – This refers to an avulsed or operculated area of peripheral 
retina induced by a complete or localised vitreous separation. It may also 
refer to atrophic retinal holes associated with areas of pigmentation or 
peripheral retinal degeneration which may be present with or without an 
associated PVD. 
Retinoschisis – This describes a degenerative process causing a splitting of 
the retinal layers. If retinal breaks occurs in both the outer and inner leaves 
of a retinoschisis causing a progressive extension of sub-retinal fluid 
requiring intervention this is classified as a retinoschisis detachment 
(Straatsma & Foss 1973). 
 
6.5  Case identification and recruitment  
Cases eligible for recruitment were confirmed through clinical examination 
by a retinal consultant. After informed consent, a detailed history and clinical 
examination was performed on all cases personally or by a senior 
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ophthalmologist (consultant or vitreo-retinal fellow). Where there was 
ambiguity over clinical characterisation, the most senior opinion was used.  
Blood sampling was performed on all consenting participants.  The principal 
method of data collection involved daily to weekly personal visits to each 
participating centre. I attended pre and post operative ward rounds on a 
weekly or twice weekly basis in the busiest centres, namely Edinburgh, 
Glasgow and Dundee. The other centres (Ayr, Aberdeen, Inverness) were 
visited every 2-3 weeks. In these peripheral centres, I liaised with an 
appointed local investigator or vitreo-retinal consultant on a weekly basis to 
ensure complete case capture. I also liaised on a weekly basis with the 
relevant secretarial department of each consultant vitreo-retinal surgeon in 
each centre to ensure that any discharge or post-operative letters dictated 
with ‘retinal detachment’ of any type as the principal diagnosis were kept for 
my examination. The majority of cases were identified and recruited on the 
day of surgery or on the first post-operative day. Further cases were 
identified through informal referrals, accident and emergency/ out-of-hours 
attendance and waiting list office registration.  
 
 6.5.1 Data Quality 
A number of procedures were established to ensure optimal data quality. 
Firstly, at the outset, I visited each centre and established didactic tutorials 
with the retinal department staff and nominated local investigators. All 
nominated investigators were trained by demonstration and explanatory 
protocols on accurate completion of the questionnaires.  I visited each site 
regularly to guarantee data completeness. If possible, all incident cases 
were identified and approached for inclusion while in hospital. Where cases 
were recruited pre-operatively, the clinical notes were examined post-
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operatively and the extent of pathology discovered intra-operatively was 
recorded. Attempts were made to complete all data fields by directly 
contacting the optician or patient by telephone. In particular, to obtain the 
refractive error measurements of individuals who underwent cataract 
surgery prior to RRD presentation, I sent a self-addressed questionnaire to 
each individual requesting their earliest glasses prescription. If this was 
earlier than the date of cataract surgery in the detached eye, the refractive 
error was noted. If not, a ‘missing’ entry was recorded.   
 
 6.5.2 Data Validation 
Several validation techniques were established to ensure complete case 
capture. Firstly, I examined surgical logbooks in each centre (where each 
operation is recorded in detail) on each visit to determine all cases that 
underwent vitreo-retinal surgery of any type. This list was then cross 
referenced with locally collected data during this time period to identify any 
potentially missed cases. Subsequently, I reviewed all out-patient letters, 
discharge letters and clinical case notes to determine how many cases met 
the inclusion criteria but were not recruited during the short time period 
between my visits.(e.g. 3 days or one week) I followed up any ambiguous or 
incomplete information by contacting the patient or surgeon directly. Cases 
that were missed during their in hospital stay but that met the inclusion 
criteria were invited for inclusion at the first post-operative follow up 
appointment. Each nominated local investigator was also asked to record 
information on any willing study participant who did not undergo surgery for 
medical or other reasons. The number of identified cases that were lost to 
follow up or that refused consent was recorded.  
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The data collection method established ensured, as close as possible, 
complete case capture of all symptomatic RRD cases presenting for 
treatment and all RRD cases that underwent surgical repair in Scotland. This 
methodology was not robust enough to accurately establish the incidence of 
asymptomatic RRD or cases which may not be referred for treatment. 
Similarly, patients presenting privately may have been missed. However 
with the availability and access to healthcare in Scotland and the well 
established pattern of referral in the NHS and highly developed transport 
infrastructure, I expect that in Scotland, this number is very small.    
 
6.6 Data fields  
Data fields gathered by the author comprised (see Appendix B for 
proforma): 
  
1.   Demographic details 
Date of Birth 




Route of referral 
  
2. Ocular/Medical parameters 
Presenting complaint - nature and duration of symptoms  
History of ocular trauma and type of trauma 
Past medical history 
Refractive status (prior to any ocular surgery surgery) – derived from 
optician letter, contact with the optician or through focimetry of participants’ 
glasses. 
Biometry – Average axial length measurement 
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Previous ophthalmic history- type of ocular condition, date of any previous 
intra-ocular surgery or prophylactic laser treatment, presence of complicated 
cataract surgery with vitreous loss, presence of YAG capsulotomy, features 
of Stickler syndrome. 
Known parental consanguinity 
Family history of eye disease 
Family history of retinal detachment; A positive family history was 
considered to be any first degree relative affected by a retinal detachment 
which required treatment. (i.e. subclinical cases which did not warrant 
treatment were not considered 
Type and date of RRD repair surgical procedure was noted 
 
3.  Biomicroscopic and clinical examination  
Snellen chart corrected distance visual acuity 
Applanation tonometer intra-ocular pressure measurement 
Fundal examination – macula status; type, number and location of 
 retinal breaks; presence and grade of proliferative vitreoretinopathy; 
clock hours of detachment, location and extent of detachment 
Vitreous examination – partially detached; detached; optically empty; 
haemorrhage; membranous deposits Peripheral retina examination – 
Presence, type and location of any peripheral retinal degeneration. 
Fellow eye examination – documentation of any observed vitreo-retinal 
pathology.  
 
6.7 Examination protocol 
Visual acuity  
Visual acuity for distance was performed at presentation by a trained nurse 
practitioner using a Snellen chart at 6 meters. Best corrected visual acuity 
was measured separately for each eye and is recorded as the smallest line 
which the patient can accurately read with corrected refractive error. If the 
largest letter was not visualised (6/60), the examiner tests finger counting 
at one meter. The examiner then tests ‘hand motion’ detection at one meter 
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and finally light perception is tested by with a pen-torch light and a visual 
acuity of perception of light, or no perception of light is then recorded.  
Slit lamp biomicroscopy 
A slit lamp biomicroscopy examination was performed on all participants by 
a vitreoretinal specialist. After appropriate positioning of the patient, the 
anterior segment of each eye was examined and the structures of the 
anterior segment were inspected for any lesions or abnormalities which were 
then documented. 
Applanation tonometry  
Intra-ocular pressure was measured by a standard method using a 
Goldmann Applanation Tonometer.  
Dilated fundal examination 
All participants had both eyes dilated (tropicamide 1% and phenylephrine 
2.5%) and a systematic examination of both fundi was performed by a 
consultant ophthalmologist or senior clinician. Examination was performed 
initially at the slit-lamp using a condensing lens and subsequently in the 
supine position using an indirect ophthalmoscope with scleral indentation. 
Each quadrant was examined systematically and all noted pathology was 
recorded on a standardised fundal drawing. 
 
6.8 Ocular features defined 
A myopic refractive error was defined as a spherical equivalent refractive 
error (SER) of ≥-1 dioptre (D), a hypermetropic refractive error as a 
spherical equivalent refractive error of ≥+1D and emmetropia as a spherical 
equivalent refractive error of less than -1 and less than +1D. Low myopia 
was defined as a SER of >-1D to <-6D.  High myopia was defined as a 
spherical equivalent refractive error of >-6D. Low hypermetropia was 
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defined as a spherical equivalent refractive error of >+1D to <+6D and high 
hypermetropia was defined as a SER of >+6D. 
Trauma was defined as any direct or indirect trauma to the eye resulting in 
loss or disturbance of vision warranting ophthalmological review. 
Posterior vitreous detachment is due to progressive liquefaction of the aging 
vitreous which induces its separation from the inner-limiting membrane of 
the retina. This process may be partial or complete. The presence of a Weiss 
ring designated a complete PVD, its absence designated an incomplete 
PVD.(Sebag 1987) 
Peripheral retinal degeneration delineates peripheral retinal lesions which 
cause anomalies in vitreo-retinal adhesion which may predispose to RRD. 
These lesions include pavingstone degeneration, retinal cysts, retinal tufts 
and white without pressure. 
Lattice degeneration is characterised clinically as circumferentially 
distributed, sharply demarcated, elliptical areas of peripheral retinal thinning 
with variable pigmentation. There are often localised areas of overlying 
vitreous liquefaction, a criss-crossing network of hyalinised vessels and 
exaggerated vitreoretinal attachments along the edge of the lesion (Byer N.E 
1979). 
Proliferative vitreoretinopathy (PVR) – This is characterised as an anomalous 
scarring process due to growth and contraction of cellular membranes in the 
vitreous and on the retinal surface. An updated classification of the 1983 
Retina Society Terminology Committee classification was used as a clinical 




6.9 Scottish Index of Multiple Deprivation 
The Scottish Index of Multiple Deprivation (SIMD) is the Scottish 
Government's official tool for identifying small area concentrations of 
multiple deprivation across Scotland, which enables effective targeting of 
policies and funding. 
(http://www.scotland.gov.uk/Publications/2009/10/28104046/0) The SIMD 
approaches deprivation as a range of problems that arise due to lack of 
resources or opportunities and provides a multi-dimensional indicator of 
deprivation. It uses a total of 6,505 datazones, which are population based 
geographic areas with approximately 750 people living in each one. The 
datazone for each patient could be identified by their postcode. The SIMD 
ranks these areas from 1, the most deprived, to 6,505, the least deprived, 
providing a ranking for every datazone in Scotland. The datazones are 
ranked according to an overall deprivation score, which is a weighted sum of 
seven domain scores (current income, employment, health, education, 
geographic access, crime and housing) derived from 37 different indicators. 
The SIMD index provides a relative ranking and not an absolute measure of 
deprivation. (ie. The datazone ranked 50 is not twice as deprived as the one 
ranked 100). The domain weightings used in SIMD 2009, expressed as a 
percentage of the final score are: current income (28%), employment 
(28%), health (14%), education (14%), geographic access (9%), crime 
(5%) and housing (2%). Using the SIMD 2009 database I matched the 
postcode of each case to the ranked datazone to analyse the socio-economic 





6.10 Statistical methods 
Annual RRD incidence rates and 95% confidence intervals were calculated 
for gender and age-group based on the Poisson distribution using the 2008 
population mid-year estimates. Age-standardised incidences were calculated 
by a direct method using the European Standard Population reference.  
Differences in incidence between comparison groups were calculated based 
on Poisson distribution and exact p-values are reported. Proportionality 
differences, including trends, were calculated using chi-squared statistics. 
Meta-estimates were calculated based on a random effects model and 










Figure 6.1 – Health board distribution in Scotland. (Courtesy of the National 






Figure 6.2 – The age and gender distribution of all Scottish residents in 
Scotland based on the 2008 mid-year population estimate. (Courtesy of the 




Figure 6.3 - The age and population structure of all Scottish residents in 
each health board region in the 2008 mid-year population estimate. 
(Courtesy of the National Regsitry Office, Scotland)  










CHAPTER 7 – Genome-wide association study of 
primary RRD: Methodology  
 
 
7.1  Overall Design 
 
The genome wide association study (GWAS) was designed in 2-stages to 
increase genotyping efficiency.(Satagopan & Elston 2003) In the first 
(discovery) stage,  912 prospectively recruited Scottish RRD cases were 
genotyped using the Illumina CNV370v3 Quad genotyping array and we 
compared the genotypic counts with 1,986 ethnicity matched Scottish 
controls that were previously genotyped using the Illumina Hap 300 and Hap 
240S in an unrelated study.(Tenesa et al. 2008)  
In stage 2 we genotyped the most significant 4,541 SNPs in 217 cases 
recruited in London, 470 cases recruited in Cambridge, 121 cases recruited 
in Scotland,  and 264 cases recruited in Nijmegen, Holland. The phenotype 
and genotypic data of the 1958 Birth Cohort were used as a control group 
for the English cases (N=2,594). Nijmegen collaborators provided 326 age 
and gender matched local controls for analysis.  
  
7.2  GWAS Power and sample size 
In assessing study power, there should be sufficient power to detect genetic 
effects likely to be of biological and public health importance. Thus, it is 
important to be able to detect a genotypic risk ratio of ~1.5 with minor allele 
frequency (MAF) of >10%. Genotypic risk ratios for GWAS in common 
complex diseases have ranged fairly widely but most are in the range 1.1 – 
1.7.(Iles 2008a) Using a case-control power calculator for a two stage 
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association study http://www.sph.umich.edu/csg/abecasis/CaTS/ and 
assuming perfect LD between marker and risk alleles I explored power 
calculations for a number of genotypic relative risk variants with an 
estimated disease prevalence of 0.003.(Iles 2008b) Figure 7.1 illustrates 
power for varying genotypic risk ratio and MAFs to detect a disease locus 
with multiplicative effect by a two-stage strategy with a significance level of 
p<1x10-7. I estimate that a total of 2,000 RRD cases and 2,000 matched 
population-based controls in a two stage approach would give acceptable 
power to detect a genotypic risk ratio of approximately 1.5 at a MAF of 10-
15% or greater. 
 
 
Figure 7.1 – Power estimates by genotypic relative risk (GRR) and allele 
frequency for a 2 stage genome wide association study with a total sample 





7.3  Peripheral blood storage and DNA extraction 
The peripheral blood sample from each consenting participant was stored in 
a freezer provided at each of the six recruitment sites in Scotland. I 
delivered samples on dry ice every 3 weeks to the Wellcome Trust Clinical 
Research Facility (WTCRF), Edinburgh. At the WTCRF, blood tubes were 
stored at -40°C until ready for extraction. 100μl of blood from each sample 
were spotted onto an FTA card (Whatman) and cards archived at room 
temperature in a safe. DNA extraction used the Nucleon Kit (Tepnel Life 
Science) with the BACC3 protocol. The precipitated DNA was hooked out and 
placed directly into a labeled 2.0ml microtube (Scientific Specialities Inc) 
containing 1.0 ml TE buffer pH 7.5 (10mM Tris-Cl pH 7.5, 1mM EDTA pH 
8.0). Microtubes were rotated for 2 weeks until DNA was fully re-suspended. 
8 out of 92 samples were electrophoresed on a 1% agarose gel to test for 
integrity of the DNA and were also tested via the Nanodrop method for 
protein contamination. DNA concentration (ng/μl) was measured using 
picogreen. DNA master stocks were split into 500μl in a deep well plate and 
500μl in a microtube. DNA in the deep-well plate was then normalised to 
50ng/μl and used to make working stock plates.  
 
 
7.4  Stage 1 
Figure 7.3 summarises the case- control comparison for stage 1 genotyping. 
Overall, we compared genotypes of 912 cases of primary rhegmatogenous 
retinal detachment with 1,986 Scottish individuals derived from the 





 7.4.1 Case selection 
DNA was extracted on 1,139 cases of primary RRD recruited throughout 
Scotland between 31st October 2007 and 1st November 2009. For genotyping 
of stage 1 cases, all cases of known relatedness and of non-white British 
ethnicity were excluded. In addition, I developed further exclusion criteria in 
addition to ones previously outlined(Mitry et al. 2009b) based upon 
phenotypic variables in order to enrich our database for cases more likely to 
have a genetic or heritable component.  Cases meeting the following criteria 
were excluded from the genetic analysis: 
-Aphakia 
-Complicated cataract surgery 
-Direct ocular trauma 
-Ocular/ systemic features of hereditary vitreoretinopathy or syndromic RRD 
-Previous posterior segment intra-ocular surgery 
-Previous uncomplicated cataract surgery presenting with RRD within 2 
years from the time of initial cataract removal 
 
In total, 912 cases of primary non-traumatic rhegmatogenous retinal 
detachment  were selected for genotyping. These samples were genotyped 
between November 2009 and January 2010 at the Wellcome Trust Clincial 
Research Facility in Edinburgh using the Illumina 370 Quadv3 Beadstation 
array. 
 
 7.4.2 Control selection 
 Unrelated controls for the stage 1 genotyping analysis of this project 
comprised the cases and controls from an unrelated study,  the phase 1 
Scottish Colorectal Cancer Study (SOCCS).(Tenesa et al. 2008) The 




Controls for the SOCCS study were randomly identified through the 
Community Health Index (CHI), which is a NHS population-based register. 
CHI is a national register of all individuals who are registered with a general 
practitioner (GP) in Scotland. The controls were drawn following a matching 
protocol applied to the CHI and they were recruited through clinics set up in 
over 40 locations across Scotland. Controls were selected at random and 
invitations passed on to these individuals via their GPs. Figure 7.2 below 
summarises the control recruitment algorithm protocol for the phase 1 
SOCCS study.  
Cases for the phase 1 SOCCS study were recruited from all tertiary 
treatment centres in Scotland between 1999 and 2006. All cases had a 
confirmed histological diagnosis of adenocarcinoma of the large bowel 
epithelium and were diagnosed with colorectal cancer at age <55yrs. 
Detailed demographic, clinical as well as environmental exposure 
information was collected on recruited cases and controls. The clinical data 
(self reported past medical and surgical history) of all SOCCS cases and 
controls was reviewed and individuals reporting either a history of retinal 
detachment or intra-ocular surgery for retinal detachment repair or of 
undetermined type were excluded from further analysis. Based on these 
criteria, one SOCCS control sample was excluded and seven SOCCS case 
samples were excluded. 
 In total genotypic data was used for 1,002 SOCCS controls and 983 
SOCCS cases. The quality control thresholds for the exclusion of SOCCS 
individuals have been described in a previous publication.(Tenesa et al. 
2008) In total, seven people were excluded due to non-Caucasian ethnicity, 
fourteen individuals with gender discrepancies, 5 individuals with hidden 
relatedness and fifteen individuals with genotype failure.  This cohort was 
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genotyped using the Illumina HumanHap 300 and the Illumina HumanHap 
240S in 2007. 
    
 
Figure 7.2 – Recruitment algorithm for SOCCS control participants 
  
  
7.4.3 Suitability of cases and controls 
The justification of control selection for stage one was based on several 
considerations. Firstly, the SOCCS participants were genotyped with the 
Illumina 300 and 240S genotyping platforms, which together provide over 
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95% coverage of SNP markers on the Illumina 370Quad array which we 
have used to genotype our cases. Approximately 50% of the SOCCS 
database however comprised selected individuals with a diagnosis of 
colorectal cancer. Although these individuals have been recruited according 
to a pathological diagnosis and specific age criteria, and may represent a 
possible source of population stratification, they have been recruited 
‘Scotland-wide’ from the same Scottish referral centres as our cases. In 
addition there is no known clinical or etiological association between 
colorectal cancer and rhegmatogenous retinal detachment. Thus I concluded 
that it was reasonable to include these cases into the control group in our 
analysis to improve the study power for association. Colorectal cancer status 
was noted and included as a variable in the analysis model to determine if 
this inclusion did have an impact on any potential SNP association. Figure 
7.4 highlights the age difference between the RRD cases and our SOCCS 
control group demonstrating the younger SOCCS group. Similarly there was 
a gender disparity between our cases and controls (RRD(N) cases: 
Male(513):Female(355) = 1.44:1 and SOCCS cases and controls(N): 
Male(1,003):Female(965)= 1.04:1 ; Х2 difference – 15.92;p<0.0001) 
However, based on the postcode region of residence between the RRD cases 
and SOCCS control group, there was no difference noted in the geographical 



















Figure 7.4 – Age distribution of RRD cases and all SOCCS a controls (RRD 






Figure 7.5 – The geographic distribution by the first two postcode letters of 
all RRD cases (left) and SOCCS controls (right) used in stage 1. There was 





7.5   Illumina 370 Quad Genotyping Array 
The RRD cases were genotyped using the Illumina CNV370v3 Quad 
genotyping array. There were several reasons behind this selection. Illumina 
was the commercial company chosen primarily to match the SNP markers 
used in the previously genotyped controls and because of previous 
experience with the high levels of genoptyping quality achieved. The 
CNV370v3 Quad array represents a compromise between financial 
limitations and genomic coverage, containing approximately 95% of SNP 
markers on the Illumina 300S and 240 HumanHap genotyping platform 
(which was used to genotype the SOCCS controls) allowing appropriate 
case-control comparison with a high degree of genome coverage. 
 
7.6 Stage 2 
To develop case collection in additional populations suitable for replication, I 
established a working collaboration with several other centres in the U.K. 
and Europe based upon the case eligibility criteria and the ethical principles 




 7.6.1 Case selection – London 
I extended ethical and research and development approval to enable 
collection of cases of primary RRD from Moorfields Eye Hospital (MEH) in 
London. (MREC:06/MRE00/19 – Amendment date 5th May 2009) MEH has 
the highest throughput of cases in the U.K. and represents an important 
source of potential cases, which can be readily collected as all surgery for 
RRD cases is performed on-site. I commenced collection in January 2010 
using the same inclusion criteria and proforma as in the Scottish RD Study 
making cases derived from both studies highly comparable. Blood samples 
were similarly stored in a locally provided freezer and were transported on 
dry ice each month to the Wellcome Trust Clinical Research Facility (WTCRF) 
in Edinburgh where DNA extraction was performed and DNA stored using the 
same protocol as for the Scottish cases.   
  
 7.6.2 Case selection – Cambridge 
 The retinal research unit in Addenbrookes Hospital in Cambridge 
(http://www.vitreoretinalservice.org/research.htmlitreo-retinal) is led by Mr 
Martin Snead and Mr Allan Richards, both of whom have a well established 
interested in the familial genetics of retinal detachment. I approached Mr. 
Snead about the project and together, we applied for ethical approval 
(Cambridgeshire REC 02/172- Amendment date 20th April 2009), and 
extended case collection using the same ethnicity and diagnostic criteria, to 
recruit unrelated population based cases from an established large clinical 
database. These cases were recruited from May 2009 onwards. DNA was 
stored and extracted in the molecular genetic laboratory at Addenbrookes 
Hospital and samples were transported to the WTCRF in Edinburgh where 






7.6.3 Case selection - Nijmegen, Holland  
Professors Carel Hoyng and Anneke den Hollander from the 
Department of Human Genetics at the Radboud University Medical Centre in 
Nijmegen, Holland 
(http://www.ncmls.nl/NCMLS/MenuStructures/PI/theme3/AnnekeDenHolland
er.asp ) have published extensively on the genetics of inherited retinal 
dystrophy. I approached this group outlining the principal aims of our 
project and we applied for ethical approval to extend case collection and 
recruit cases in Nijmegen. Case collection had been initiated in 2003 with 
the analysis of several pedigrees with inherited RRD.(Go et al. 2003) We 
extended case collection to recruit unrelated cases. All cases derived from 
Holland matched the clinical eligibility criteria outlined for the Scottish study 
and were of Dutch ethnicity. DNA samples were stored, extracted and 
quantified in Holland using the nanodrop method and samples were 
delivered to the WTCRF Edinburgh for genotyping.   
 
7.6.4 Control selection – The 1958 Birth Cohort 
The British 1958 cohort (also known as the National Child Development 
Study - http://www.cls.ioe.ac.uk/studies.asp?section=000100020003 ) 
includes all births in England, Wales and Scotland, during one week in 1958. 
From an original sample of over 17,000 births, survivors were followed up at 
ages 7, 11, 16, 23, 33 and 42 years. Immigrants of the same dates of birth 
were identified at ages 7, 11 and 16, and followed into adulthood, but adult 
immigrants (after age 16) have not been included. Data was collected up to 
age 42 by interviews with parents and cohort members, and at school 
medical examinations, includes information on growth, health and health 
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related behaviour, family background, socio-economic circumstances, 
behavioural, emotional and cognitive development, educational 
achievement, employment, psychosocial work characteristics, partnership 
and pregnancy histories. I applied to the clinical oversight committee of the 
1958 Birth Cohort, and successfully obtained access to the genotypic data on 
4,000 British individuals that were genotyped in 2006 using the Illumina 
550K genotyping platform. This control group provided a large group of 
unselected individuals from the same ethnic background as our cases from 
London and Cambridge, providing a suitable comparison group to minimise 
the potential effect of population stratification. 
 
 7.6.5  Control selection – Utrecht, Holland 
Dr. Roel Ophoff is an associate professor in the Department of Medical 
Genetics and the Rudolf Magnus Institute of Neuroscience in Utrecht, 
Holland. I approached him seeking collaboration with the aim of providing a 
suitable population control group to match the Dutch cases of RRD. As one 
of his recent projects, he genotyped 750 individuals recruited from 
outpatient and community centres throughout Nijmegen. These individuals 
were screened for the absence of psychiatric disease and were genotyped 
using the Illumina 550k platform in 2007. Participants did not undergo 
specific ocular examination however all participants were of Dutch origin and 
lived in the local region providing an appropriate control comparison groups 
for the Dutch cases of RRD. 
 
 
 7.6.6 Illumina iSelect Platform 
Polymorphic variants found to be statistically significant from stage 1 case / 
control analysis were genotyped in the samples compiled from the developed 
collaborations.(Table 7.1) The Illumina iSelect platform  was used for stage 
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2 genotyping.  The most statistically significant  4,541 SNPs (~1%) from the 
first stage case control comparison as well as 1,440 SNPs chosen to tag 17 
genes (versican/CSPG2, OPTC, LAMC1, LAMB1, LAMA1, KCNJ13, HAS1, 
HAPLN1, FZD4, FN1, FBN1,  COL9A1, COL6A1, COL4A4, COL2A1, COL11A1, 
COL11A2)  that are thought to have a putative biological role in RRD or have 
been proven to be implicated in syndromic RRD development were selected 




  CONTROLS 
(N) 
 Scotland 121 1958 Birth Cohort 2,594 
Cambridge 470   
London 217   
Nijmegen 
(Netherlands) 
264 Dutch controls 326 
Total 1,072  2,920 
Table 7.1 demonstrates the number of cases and controls that were 
available for analysis in stage 2. The 1958 UK birth cohort were used 
as a control group for the combined samples from Cambridge, 







GWAS  4541 4076 
Candidate genes 1440 1092 
Table 7.2 -  Summary table highlighting the selected and genotyped 
SNPs in stage 2.  An additional 921 SNPs were not used as they were 
not genotyped in the new control groups (1958 Birth Cohort , Dutch 












CHAPTER 8 – The epidemiology of 
rhegmatogenous retinal detachment in Scotland- 
A two-year prospectively recruited population 
based study  
 
8.1 Sample Size 
Over the 2 year study period, a total of 1,202 cases of primary RRD were 
recruited. Through regular examination of all vitreo-retinal operating 
logbooks and identification of individual case notes, I am confident that this 
represents approximately 96% of all operated cases of primary RRD in 
Scotland during the study period. An additional 42 cases met the inclusion 
criteria but were missed while in hospital or refused to participate. Including 
these 42 cases, the annual incidence of RRD was 12.05 per 100,000(95%CI 
11.35 - 12.70). Clinical data on these cases was not available and is not 
included in further analysis.    
 
8.2 Age and Gender Distribution 
Table 8.1 shows the baseline characteristics of all cases. The incidence rates 
are shown in table 8.2. 61.1% of cases were male; 38.9% female. Virtually 
all cases were of white British ethnicity. The median age at presentation of 
all cases was 60.2 years (IQR= 49.7 to 67.6 years). The incidence rates 
varied significantly with age and between genders (Table 8.2); the peak 
incidence for both sexes was in the 60-69 year age group, with an overall 
incidence of 33.10 per 100,000(95%CI 29.85-36.65). When examined at 5 
year age intervals, a secondary peak in incidence was identified in males 
aged 15-24 years(4.53 per 100,000; 95%CI 2.53-7.28) and slightly later in 
females aged 30-39 years at presentation(6.23 per 100,000; 95%CI 3.83-
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9.48).(see Figure 8.2) In females this is attributed to a greater 
predominance of high myopia (>-6 dioptres(D)) in the 30-39 year age group 
compared to the total case population (33.33% vs 16.63%)(p=0.023). No 
significant refractive error (>-6D) difference was noted in males aged 15-24 
years compared to the case population (14.8% vs 16.6%)(p=0.85), however 
38.7% of males in this age group had traumatic RRD compared to 11.8% 
overall. (p<0.0001)  
 A significantly higher incidence of all types of RRD was seen in males. 
This gender difference was also noted in the age standardised incidence 
(M:F= 1.76:1). Excluding all cases with previous cataract surgery and 
reported ocular trauma; the male predominance in incidence persisted (M:F-
1.4:1). The incidence for males in this group was 9.35 per 100,000 (95%CI 




8.3 Pseudophakic RRD  
For descriptive purposes I have divided RRD cases into those that have had 
previous cataract surgery (pseudophakic or aphakic) and those that have 
not (phakic). Approximately one in five presenting cases (21.6% -
260/1,202) had previous cataract surgery with intra-ocular lens insertion; if 
those who have had cataract extraction without an intra-ocular lens inserted 
are included, this rises to 23.4%. The median time from cataract surgery to 
presentation with RRD was 3.28 years (IQR- 1.06-7.23 years). Of the 
pseudophakic cases 46/260 or 17.7% had complicated surgery at the time 
of cataract removal with vitreous loss with a shorter median time to 
presentation of 1.38 years (IQR- 0.37-7.23 years). Sixty eight percent 
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(178/260) of pseudophakic RRD occurred in men; the female pseudophakic 
RRD group had a higher proportion of complicated cataract surgery (23.1%-
19/82 vs 15.1%-27/178).  
 
8.4 Refractive error  
Spherical equivalent refractive error(SER) measurements were calculated as 
dioptres (D). To avoid any potential inaccuracies between measured SER in 
phakic and pseudophakic/aphakic cases (which in some cases may have 
been recorded after cataract surgery), only the SER of the 920 phakic 
patients are included for further analysis.(Table 8.1) However, table 8.3 is a 
comparison between the refractive error classifications of phakic and 
combined pseudophakic/aphakic cases demonstrating similar proportions 
noted. The majority of cases (53.2%) were myopic with an SER of ≥-1D and 
18.1% of all cases were highly myopic with an SER of >-6D. Figure 8.1 
demonstrates the age distribution of all cases as a function of SER. Under 
the age of 50, 82.14% (161/196) of phakic cases  exhibit myopia >-1D. 
With increasing age this trend diminishes, with an increasing proportion of 
emmetropic and hypermetropic individuals affected. (Figure 8.1) There was 
no difference in the gender distribution of RRD associated with 
myopia(p=0.217)(Figure 8.3).  
 
8.5 Laterality 
The right eye was affected significantly more frequently than the left eye 
(54.9% vs 43.4%)(p<0.0001) in both men and women. 1.5% (18/1202) of 
cases described unilateral symptoms, but clinical examination revealed RRD 
to be present in both eyes. 70/1202 or 5.8% had a previous RRD in the 
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fellow eye outside the study period, and 8/1202 or 0.67% suffered a 
consecutive fellow eye RRD during the study period.  
 
8.6 Indices of Deprivation 
Postcode data was available for matching to SIMD rank for 1,178 cases. 
Figure 8.4 shows the age standardised annual incidence of primary RRD per 
quintile of ranked deprivation for both genders. The age standardised 
incidence of RRD rose from 9.15 to 13.5 per 100,000 between the most 
deprived and the least deprived quintile, with a strong association across 
quintiles of increasing affluence (2 for trend = 22.48 p=2.11x10-6). This 
was greater for men (2 for trend = 18.74 p=1.49x10-5) than women (2 for 
trend = 4.08 p=0.043). A similar trend was observed across the component 
domains making up the SIMD score, with a higher incidence in the most 
affluent quintiles. A significant difference was found between the domains of 
income, employment, health, education and housing. (p<0.0001) The 
strongest association was found in the domain of education (2 
trend=40.22;p=2.27x10-10). Geographic access to essential services 
demonstrated the opposite trend (2 trend = 8.29; p=0.004). (See Figure 
8.6) 
Attachment of the macula at presentation, the most important prognostic 
factor for final visual outcome, showed a marked variation across quintiles of 
deprivation. (Table 8.4) 65.13% of cases in the most deprived quintile 
presented with a detached or bisected macula at diagnosis compared to 
50.86% in the most affluent quintile. (2 for trend = 6.83, p-value = 
0.0089) 
 The extent of detachment may be an indicator of chronicity of RRD and this 
also demonstrated significant variation across quintiles of deprivation.(Table 
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8.5) One quadrant of detachment was more frequent in least deprived 
quintile compared to the most deprived (29% vs 18%, 2 for trend = 9.69, 
p-value = 0.0018). Total RRD (four quadrants of detachment) was much 
more frequent in the most deprived quintile compared to the most affluent. 
(13% vs 4%, 2 for trend = 14.17, p-value = 0.0001)  
 A higher proportion of cases from the most deprived quintile had previous 
cataract surgery compared to the least deprived (28.39% vs 18.79%; 2 = 
8.74, p-value = 0.003). There were no significant differences between 
quintiles of deprivation in the proportions of significant ocular trauma. (Table 
8.6 and 8.7) 
Refractive error and SIMD ranking was available for 90.4% (832/920) of 
phakic cases. Figure 8.5 illustrates the proportion of low myopia (≥-1 to ≤-
6D) and high myopia (>-6D) across quintiles of deprivation for these cases. 
A significant trend was noted for low myopia (≥-1 to ≤-6D) (2 for trend = 
7.85, p-value = 0.005), with 32.4% of cases in the most affluent quartile 
having low myopia compared with 22.4% in the most deprived. No such trend 
was observed for high myopia (>-6D). (16.4% in the most affluent quartile 
versus 11.7% in the most deprived; 2 for trend = 1.34, p-value = 0.2462) 
Examining all cases with spherical equivalent refractive error >-1D a 
significant trend was noted (2 for trend= 11.19, p-value = 0.00081), with 









I have undertaken one of the largest prospectively recruited epidemiology 
studies of primary RRD and found the annual incidence in a population of 5.1 
million to be 12.05 per 100,000 of population. In the U.K., this equates to 
approximately 7,300 incident cases of primary RRD annually.  
There have been several studies over the last 40 years whose principal aim 
was to  estimate the incidence of primary RRD, however a wide range of 
results have been reported.(Wong et al. 1999; Tornquist et al. 1987a; 
Algvere et al. 1999; Haimann et al. 1982a; Limeira-Soares et al. 2007; 
Rowe et al. 1999; Laatikainen et al. 1985; Ivanisevic et al. 2000; Sasaki et 
al. 1995; Polkinghorne & Craig 2004b; Mowatt et al. 2003; Zou et al. 2002; 
Wilkes et al. 1982) Only one study from Beijing, China,(Li 2003) examined a 
population at risk comparable to ours in size and estimated a lower annual 
incidence of 7.98 per 100,000 (95%CI-7.3-8.67). This difference may be 
attributable in part to the age distribution of the study population. In Beijing, 
14% of the population were over 60 years, in Scotland 22.6% were above 
60 years. Examining previous reports with a sample size of over 500 cases, 
a minimum recruitment period of 1 year and pre-defined case inclusion 
criteria the estimated annual incidence varied nearly two-fold, between 7.98 
per 100,000 to 14 per 100,000.(Li 2003; Tornquist et al. 1987a; Wong et al. 
1999; Algvere et al. 1999) Analysing previous reports from European 
countries only, I note a similar variation in annual incidence between 6.9 per 
100,000 to 14 per 100,000 of population.(Laatikainen et al. 1985; Algvere et 
al. 1999) There are several possible reasons for the noted variation: the 
methodology used in previous studies has differed considerably18 ;there 
were no clearly defined inclusion criteria across studies making accurate 
comparison problematic. RRD incidence varies with age, gender, affluence 
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and prevalence of both myopia and pseudophakia, thus characteristics of the 
underlying study population will influence the reported incidence. Finally, 
changing treatment modalities for RRD and a move toward more daycase 
surgery and out-patient procedures(Sodhi et al. 2008) may influence case 
recording, making comparison of rates between countries and different time 
periods difficult.  
There is a large difference in the annual incidence of RRD between 
men and women. (M:F=1.68:1) This increased incidence was significant and 
persisted in the age standardised incidence ratios (M:F=1.76:1) and was not 
affected by excluding trauma and previous cataract surgery (M:F= 1.40:1). 
Within the pseudophakic and aphakic group, the overrepresentation of males 
was even more marked (M:F=2.3:1), despite a higher rate of cataract 
surgery in women in the U.K.(Keenan et al. 2007b) Most previous studies 
show a higher incidence in males,(Mowatt et al. 2003; Ivanisevic et al. 
2000; Rosman et al. 2001; Polkinghorne & Craig 2004b; Limeira-Soares et 
al. 2007)(M:F=1.3:1 to 2.3:1); a minority find that females predominate in 
the phakic non-traumatic group.(M:F= 1:1.16 to 1:1.4)(Tornquist et al. 
1987a; Sasaki et al. 1995) A meta-estimate of previous studies reporting 
the gender distribution in RRD incidence indicate a male proportionality of 
between 52-59%(p<0.0001)(Figure 8.7). There may be several reasons 
behind this gender imbalance in RRD incidence. 
Long term cohort studies in Taiwan have demonstrated that the risk 
of RRD after cataract surgery is higher in males. The increased risk of RRD 
in patients with myopia and a history of RRD was seen to be significant in 
males only, up to 4 years after cataract surgery.(Sheu et al. 2007; Sheu et 
al. 2009) 
 In this study males with RRD had a significantly longer axial length 
in their fellow eye than females (mean;standard deviation); males [N=330, 
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25.05mm(1.65)], females [N = 24.39mm (1.64), T=4.51; p<0.001] The 
Beaver Dam Eye Study(Lee et al. 2009) also reported a greater axial length 
in white males compared to females [males 23.92mm (1.10); females 
23.51mm (1.17); p<0.001)], as do other large population-based studies. An 
increase in axial length is significantly associated with an increased risk of 
RRD(Tuft et al. 2006).  
Gender differences in the anatomy of the vitreoretinal base may also 
contribute to differences in the incidence of RRD. In a study of donor eyes, 
Wang et al(Wang et al. 2003) reported a posterior migration of the posterior 
border of the vitreous base in males. This may predispose males to retinal 
breaks after posterior vitreous detachment, either from greater dynamic 
vitreoretinal traction, and/or an increase in vitreoretinal irregularities of the 
posterior border. Hence, both the longer axial length in males and 
differences in basal vitreoretinal adhesion may contribute to the higher 
incidence of RRD. Furthermore, perhaps due to lifestyle differences, males 
tend to under-report ‘lesser’ trauma that may contribute to RRD risk. 
The age distribution of our cases indicates a peak in both genders in the 60-
69 year age group. This is widely supported in previous studies. (Wong et al. 
1999; Tornquist et al. 1987a; Algvere et al. 1999; Haimann et al. 1982a; 
Limeira-Soares et al. 2007; Rowe et al. 1999; Laatikainen et al. 1985; 
Ivanisevic et al. 2000; Sasaki et al. 1995; Polkinghorne & Craig 2004b; 
Mowatt et al. 2003; Zou et al. 2002; Wilkes et al. 1982)  
The right eye was involved significantly more frequently than the left 
eye (1.26:1), the majority of previous studies support this finding- (ratios 
ranging between 1.09:1 to 1.36:1)(Tornquist et al. 1987a; Haimann et al. 
1982a; Laatikainen et al. 1985; Li 2003; Rowe et al. 1999)Despite excluding 
all cases with previous cataract surgery and reported trauma, I found a right 
eye to left eye ratio of 1.18:1. (p=0.001) A meta-estimate of previous 
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studies reporting this indicates a right eye proportionality of 53.5-
56.7%(p<0.0001)(Figure 8.7). The explanation for the greater incidence in 
the right eye remains unknown. However, right eyes are more frequently 
dominant, and dominant eyes are frequently more myopic(Cheng et al. 
2004). Nonetheless,  in this series of RRD cases, there was no difference in 
the axial length of right and left fellow eyes [right eyes, N = 243, 
24.87mm(1.64);  left eyes, N = 285 24.75mm(1.71); T=0.82; p=0.42]. 
Similarly, in other population studies, there was no difference in right and 
left axial lengths(Lee et al. 2009) 
Socioeconomic status can affect the incidence of many diseases and 
the association between deprivation and visual impairment is well 
known.(Tielsch et al. 1991) Unexpectedly, I found a disparity in the 
incidence of RRD between socio-economic groups, with an association 
between affluence and RRD. This trend was a significant finding in both 
genders but was much more marked in men. The trend was significant in 
five of seven socio-economic demographic domains that determine the 
overall deprivation score and the strongest association was found in the 
domain of educational achievement (2 trend = 40.21; p-value = 2.3 x 10-
10). In addition to the association with affluence, the characteristics of RRD 
at presentation showed dramatic variation between quintiles of deprivation. 
RRD cases from the most deprived quintile more frequently presented with a 
total RRD (13% vs 4%) and more frequently presented when the macula 
was detached (65% vs 51%) when compared to the least deprived quintile. 
These findings indicate that cases from more deprived areas tend to present 
later and with more extensive detachments. This has important 
consequences for final visual prognosis.  
I explored several possible explanations for the association between 
RRD and affluence. The incidence of RRD increases with age to a peak in the 
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sixth decade.  Age specific mortality rates may differ between the most 
deprived and least deprived quintiles so that fewer people from deprived 
areas live long enough to be at greatest risk of retinal detachment. Similarly, 
elderly individuals may have accrued more wealth over many years and a 
larger proportion of elderly individuals may live in affluent areas. However 
there was a significant increase in the age specific incidence of RRD across 
quintiles of deprivation in the age groups comprising the highest natural 
incidence of RRD (age groups 50-59 and 60-69), suggesting that the 
influence of age was not the primary factor behind the association with 
affluence . (see Table 8.8) 
Trauma may influence the incidence of RRD however the proportion of 
traumatic cases was equal across quintiles. Previous cataract surgery, a 
known risk factor for RRD did not significantly influence the association with 
affluence as more pseudophakic RRD cases were present in the more 
deprived quintiles. 
This study has only recorded patients on presentation to hospital, and it is 
possible that patients from areas of greater deprivation have poorer access 
to healthcare services and have been excluded from the study. However, 
based on the SIMD classification of our cases, those from the most deprived 
areas ranked higher than those from the least deprived areas in the 
geographic access to services domain. This suggests that access to essential 
services was not a limiting factor in presentation to hospital.   
Myopia is a significant risk factor for RRD and has been associated 
with higher educational achievement and IQ, and thus, perhaps, higher 
income and socio-economic status. (The Eye Disease Case-Control Study 
Group 1993; Williams et al. 2008; Saw et al. 2004) It is interesting to note 
that of the SIMD rank determinants, the strongest association was found 
between RRD and educational achievement. Detachments in the most 
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affluent quintiles were more likely to be associated with myopia than those 
in the most deprived quintiles. This increased proportion of myopic RRD 
cases in more affluent areas is an important factor that partly explains the 
rise in RRD incidence between the most and least deprived quintiles. 
Although myopia is an important factor in the observed association between 
RRD and affluence,  I cannot exclude other as yet unidentified risk factors 
associated with socio-economic status which may underlie this observation.   
 In summary, I have prospectively estimated the overall 
incidence of primary RRD in Scotland to be 12.05 per 100,000 population. 
Males are affected more than females in all age groups and all types of RRD. 
Over 50% of all phakic cases are myopic. One in five cases with RRD have 
had previous cataract surgery. RRD incidence and the proportion of myopic 
RRD  are significantly associated with affluence, however RRD cases from 

















Baseline Characteristics  































Spherical Equivalent Refractive Error (Dioptre)* 
≥+6 D  7(0.8%) 
>+1D  to <+6D 79(8.6%) 
 ≥-1D to ≤+1D 269(29.2%) 
>-1 D to <-6 D 323(35.1%) 
≥-6 D 166(18.1%) 
Not Known 76(8.2%) 
*Spherical equivalent refractive error (SER) of all 920 phakic cases of RRD. 





 Annual Incidence   
 
Incidence/100,000 
(95%CI)   
Overall Annual Incidence 11.65 (11-12.30) 
12.05(11.35- 
12.70)*  
    
Sex Male Female 
P-
value**  
Overall Incidence 14.70(13.60 - 15.80) 8.75(8-9.60) <0.0001 
    
Age Group     
0-9 0.35(0.10-1.30) - - 
10-19 2.65(1.50-4.25) 1.65(0.80-3) 0.3 
20-29 3.30(2.10-4.90) 2.50(1.45-4) 0.49 
30-39 7.30(5.35-9.70) 6.20(4.45-8.30) 0.48 
40-49 11.90(9.55-14.60) 6.55(4.90-8.55) <0.0001 
50-59 28.90(24.95-33.33) 14.60(11.90-17.75) <0.0001 
60-69 45.85(40.30-50) 21.40(17.80-25.50) <0.0001 
70-79 27.10(21.85-33.20) 19.85(15.90-24.50) 0.04 
80+ 16.70(10.8-24.65) 10.70(7.25 - 15.20) 0.13 
    
Age standardised 
Incidence 13.09(11.23-14.95) 7.41(6.43- 8.39) <0.0001 
    
Traumatic RRD 2(1.60-2.40) 0.5(0.35-0.75) <0.0001 
Non traumatic RRD 12.70(11.75 - 13.75) 8.25(7.50-9.05) <0.0001 
* Overall incidence of all eligible cases 
**P-value for male and female incidence comparison 
Table 8.2 – Annual incidence of primary RRD based on all diagnosed cases 




(N=260) and Aphakia (N=22) 
Median age at presentation 
(IQR) 58.71(48.02-65.77) 63.86(55.44-72.53) 
Spherical Equivalent Refractive Error (Dioptre)* 
≥+6D  7(0.76%) 7(2.5%) 
>+1 to <+6D 79(8.58%) 23(8.2%) 
≥+1 to ≤-1D 269(29.23%) 65(23%) 
>-1 to <-6D 323(35.10%) 92(32.6%) 
≥-6D 166(18.04%) 31(11%) 
Not Known 76(8.2%) 64(22.7%) 
Table 8.3 – Comparison of refractive error between phakic and combined 
pseudophakic/aphakic individuals. The proportions of myopia were similar 
between both groups, however the combined pseudophakic/aphakic group 













































Age Distribution of Refractive Error
 
Figure 8.1 – Scatterplot and trendline of age and spherical equivalent 







Figure 8.2 – Annual RRD incidence by gender and 5 year age group in 
Scotland 
 
Figure 8.3 – The gender distribution of refractive error among all phakic 





Figure 8.4 – Age standardised incidence and 95% confidence interval of 
primary RRD by quintiles of deprivation in males (blue) and females (red). 
(2 for trend males = 18.74 p=1.49x10-5; 2 for trend females = 4.08 





Figure 8.5 – Bar plot demonstrating the distribution of low and high myopia 
across quintiles of deprivation for 90.4% (832/920) of all phakic cases. (Low 
myopia (≥-1D to ≤-6D): 2 for trend = 7.85, p-value = 0.005; High myopia 
(>-6D) 2 for trend = 1.34, p-value = 0.2462; All spherical equivalent 
refractive errors >-1D: 2 for trend= 11.1987, p-value = 0.00081) (1=Most 










Figure 8.6abcdefg – Histograms showing the Scottish Index of Multiple Deprivation scores, by quintiles, for 1,178 incident cases of primary RRD 
in Scotland. Figure 8.6a-g represents the frequency of cases in each of seven domains comprising the overall SIMD score ordered by domain 
weight. Significant trend associations with affluence were found in five of seven domains. In the geographic access to services domain, the opposite 
association, between deprivation and better geographic access was noted. The association between RRD frequency and affluence was strongest in 
the education and income domain. Income (a): 2 for trend = 25.0079, p-value = 5.71 x 10-7  Employment (b): 2 for trend = 18.6629, p-value 
= 1.56 x 10-5 Education (c): 2 for trend = 40.2163, p-value = 2.273 x 10-10 Health (d): 2 for trend = 21.6235, p-value = 3.318 x 10-6 Access to 
Services (e): 2 for trend = 8.29, p-value = 0.003986 Crime (f): 2 for trend = 3.4793, p-value = 0.06214 Housing (g): 2 for trend = 15.1077, 













1 65 34.86 123 65.13 188 
2 83 41.50 115 58.49 198 
3 100 43.66 129 56.33 229 
4 110 39.82 166 60.17 276 
5 141 49.13 146 50.86 287 
Table 8.4 – The proportion of macula affected RRD in quintiles of deprivation. A higher proportion of macula affected cases were noted in the most 
deprived quintile, with a significant decreasing trend across higher ranked quintiles. (2 for trend = 6.8364, p-value = 0.008932) (1=Most deprived 



































1 34 18.08 69 36.89 46 24.55 25 13.16 14 7.29 188 
2 32 16.04 95 48.07 34 17.20 23 11.34 14 7.32 198 
3 48 20.87 100 43.51 48 20.82 18 7.826 16 6.94 230 
4 54 19.61 132 47.81 55 19.96 18 6.504 17 6.10 276 
5 83 29.00 119 41.36 48 16.71 14 4.87 23 8.03 287 
Table 8.5 – The extent of RRD in quadrants of detachment ordered by quintiles of deprivation. A higher proportion of one quadrant detachments 
was noted in the least deprived quintiles. By contrast, a higher proportion of total detachment was noted in the most deprived quintiles with a 
significant decreasing trend with higher socio-economic ranking. (1=Most deprived quintile; 5=Least deprived quintile)  
One quadrant  2 for trend = 9.6918, p-value = 0.001851 
Two Quadrants 2 for trend = 0.4757, p-value = 0.4904 
Three Quadrants 2 for trend = 2.3238, p-value = 0.1274 
Four Quadrants 2 for trend = 14.171, p-value = 0.0001669 














1 26 13.83 188 
2 17 8.59 198 
3 24 10.48 229 
4 26 9.42 276 
5 29 10.1 287 
Table 8.6- The distribution of traumatic RRD across quintiles of deprivation. (1=Most deprived quintile; 5=Least deprived quintile)  2 for trend = 
0.8607, p-value = 0.3536 
Table 8.7- The distribution of phakic and pseudophakic or aphakic cases across quintiles of deprivation. No significant difference was found in 
proportions of pseudophakia or aphakia across quintiles of deprivation.   





1 135 71.60 53 28.39 0 188 
2 145 73.37 53 26.62 0 198 
3 171 74.65 58 25.34 0 229 
4 220 79.65 55 19.96 1 276 
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Figure 8.7 – Forest plot demonstrating the meta-estimate and 95% confidence interval for the reported proportion of males affected and the 
reported proportion of right eye affected in previous population based epidemiology studies. Males were affected more frequently 52%(95%CI= 52-
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Table 8.8 – The age specific incidence and associated 95% confidence interval of RRD by quintile of socioeconomic deprivation. (1=Most deprived 
quintile; 5=Least deprived quintile) A significant increase was found in RRD incidence in age groups 50-59, 60-69 and 80+ years across quintiles.  
Age group 0-9 2 for trend = 0.001, p-value = 0.9696 
Age group 10-19 2 for trend = 0.260, p-value = 0.61 
Age group 20-29 2 for trend = 0.144, p-value = 0.7041 
Age group 30-39 2 for trend = 1.604, p-value = 0.2053 
Age group 40-49 2 for trend = 0.045, p-value = 0.8311 
Age group 50-59 2 for trend = 10.64, p-value = 0.001103 
Age group 60-69 2 for trend = 10.99, p-value = 0.0009124 
Age group 70-79 2 for trend = 0.331, p-value = 0.5651 
Age group 80+ 2 for trend = 4.793, p-value = 0.02850
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CHAPTER 9 - Clinical characteristics in the 
Scottish rhegmatogenous retinal detachment 
study I – Predisposing pathology 
9.1 Introduction 
Rhegmatogenous retinal detachment (RRD) is a common sight-threatening 
condition initiated by a full thickness break in peripheral retina. Predisposing 
associations of RRD, such as high myopia, previous cataract surgery, direct 
ocular trauma and peripheral retinal degenerations are well established(The 
Eye Disease Case-Control Study Group 1993; Tielsch et al. 1996), however, 
the incidence of these features and their relative contribution to RRD 
occurrence in populations is not well documented. Similarly, the occurrence 
of hereditary vitreo-retinal degenerations in RRD populations is uncertain. As 
part of the Scottish Retinal Detachment Study, I analysed the predisposing 
characteristics of 1,202 incident cases of primary RRD presenting to all 
vitreoretinal services in Scotland between 2007 and 2009 and present the 
epidemiological features by vitreous status and type of retinal break, and 
examine the prevalence of predisposing factors such as myopia, trauma, 
peripheral retinal degeneration and cataract surgery. Associated features in 
the fellow eyes of RRD cases are described, as are the epidemiological 
characteristics of familial and syndromic RRD.  
9.2 Results 
A total of 1,202 incident cases of primary RRD were recruited in Scotland 
over the 2 year study period. An additional 42 cases were identified but did 
not participate in the study and are not included in this analysis. In 1,130 
cases there was detailed data on the clinical features of RRD. All cases were 
classified by the presence or absence of a posterior vitreous detachment and 
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by the type of retinal break causing the detachment. In total, PVD was 
present in 87.6% (990/1130) of cases, with single or multiple HST RRD 
accounting for 98.5% (975/990) of this group and giant retinal tear RRD 
accounting for 1.5% (15/990). PVD was absent in 12.4% (140/1130) of 
cases and these comprised round hole RRD in 40% (56/140), retinal dialysis 
in 47.8%(67/140) and retinoschisis RRD in 12.1%(17/140). The annual 
incidence of HST RRD was 9.45 (95%CI= 4.02-8.85) per 100,000, of GRT 
RRD was 0.15 (95%CI = 0.1-0.25) per 100,000, of RH RRD was 0.55 
(95%CI = 0.4-0.7) per 100,000, of retinal dialysis was 0.65 (95%CI = 0.5-
0.8) per 100,000, and of retinoschisis RRD was 0.15 (95%CI = 0.1-0.25). 
Continuous data was analysed using a two-sample T-test and differences in 
categorical data was analysed using the Z-test of proportionality.  
 
9.2.1 Age and gender Distribution 
Table 9.1 highlights the age and gender distribution of the subtypes of RRD. 
Males predominated in both PVD associated RRD (61.7%- 95%CI=58.6-
64.7%;M:F ratio= 1.6:1; Z=10.73;p<0.0001) and in RRD without 
PVD(60%- 95%CI=51.4-68.1%; M:F ratio= 1.5:1; Z=3.42;p=0.001). Cases 
of RRD without a PVD were significantly younger than cases associated with 
a PVD.  The mean(SD) age of the group without PVD was 43.3(18.9) years 
versus 59.6(13.3) in the PVD present group. (T=9.89; p<0.001) 
9.2.2 Affected Eye 
The right eye was affected more frequently than the left eye (55.2%- 
95%CI=52-58.3%;RE:LE ratio 1.23:1; Z=4.7;p<0.0001) in RRD associated 
with PVD. There was no difference was seen in the laterality of RRD in the 
absence of PVD. (Right eye affected in 49.3%- 95%CI=40.7-57.8%;p=0.9) 
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In all subtypes of RRD a small proportion of cases presented with 
simultaneous bilateral RRD.(see Table 9.1)  
9.2.3 Refractive Error 
There were marked differences in refractive error depending on the type of 
RRD.(Table 9.1)  Overall, GRT RRD and RH RRD had the largest proportion 
of high myopia  (26-27%). Approximately 60% of all retinal dialysis cases 
were emmetropic. A significant difference was noted between RRD 
associated with a PVD and round hole RRD without PVD. (PVD RRD group: 
mean(SD) spherical equivalent refraction (D) = -2.63D(3.65); RH RRD 
group: mean(SD) spherical equivalent refraction(D) = -4.09D(4.55); 
T=2.21;p=0.032) Overall in the series, high myopia (>-6D) comprised 
16.8% (190/1130) of cases.  Excluding the eighteen aphakic cases, there 
was no significant difference in the (fellow eye) axial length and spherical 
equivalent refractive error between phakic and pseudophakic RRD cases. 
(Mean(SD) axial length (known in 49.8%; 440/883) of phakic RRD was 
24.81mm(1.71mm); mean(SD) axial length (known in 29.4%; 67/228) of 
pseudophakic RRD was 24.69mm(1.53mm);p=0.56) (Mean(SD) spherical 
equivalent refraction (SER) (known in 91.6%;809/883) of phakic RRD was -
2.59D(+3.66D); mean(SD) SER (known in 75.9%; 173/228) of 
pseudophakic RRD was  -2.46D(+3.42);p=0.6) 
 
9.2.4 Phakic Status 
Overall, 20.2% (228/1130) of cases were pseudophakic at presentation. The 
vast majority (94.7%-216/228) had phacoemulsification and intra-ocular 
lens insertion, the remainder having had intra-capsular or extra-capsular 
cataract extraction.  In the younger group without PVD, previous cataract 
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surgery was relatively uncommon (6.4%, 95%CI=3-11.8%) compared to 
the group of RRD associated with PVD (23.7%, 95%CI=21.1-26.5%). A 
higher proportion of pseudophakia (53.3%-8/15) was present in cases of 
GRT RRD and one (12.5%) of these cases was complicated by vitreous 
loss.The median time from cataract surgery to presentation with RRD was 
3.28 years (IQR= 1.06-7.23 years).  Approximately 17% (38/228) of 
pseudophakic cases had  YAG laser capsulotomy, the median time from YAG 
capsulotomy to presentation with RRD was 2 years (IQR= 0.8-6.1 years). 
Nineteen percent (44/228) of pseudophakic cases had complicated surgery 
with posterior capsule rupture noted at the time of cataract surgery.   
Aphakia was uncommon (<2%) in all incident cases.  
9.2.5 Trauma 
Overall, trauma was implicated in 10.3% (116/1130; 95%CI= 8.5-12.2%) 
of all types of RRD (range 7-13%;Table 9.1). Trauma was documented in 
55.2% of cases of retinal dialysis RRD explaining the large proportion of 
young (<40 years) males affected in this group. Head trauma (classified as 
‘other trauma’) was associated with 57.5% (42/73) of PVD associated RRDs 
and 41.9%(18/43) of non-PVD RRDs in the trauma group.   The median time 
from reported trauma to RRD presentation was 3.48 months with a wide 
inter-quartile range of between 0.36 to 88.6 months. Lattice degeneration 
was present in 10.3% (12/116) of traumatic RRD cases.  
9.2.6 Predisposing retinal degenerations 
Table 9.1 demonstrates the prevalence of predisposing vitreoretinal 
degenerations in the study group. Overall, lattice degeneration was present 
in 18.7%(211/1130) of detached eyes, and in 11%(164/1130) of fellow 
eyes. The fellow eyes of affected eyes with lattice degeneration exhibited 
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lattice degeneration in 61.6%(130/211). The fellow eyes of PVD associated 
RRD exhibited lattice degeneration in 13.6% (135/990) which was less than 
in the fellow eyes of PVD absent RRD (20.7%-29/140; Z=1.97;p=0.049). 
The highest proportion of fellow eye lattice degeneration was seen in the 
fellow eyes of RH RRD, where 39.2% (22/56) demonstrated the 
degeneration. 
Lattice degeneration was associated with RH RRD in 35.7%(20/56) of cases 
compared with 18.9%(188/990) of RRD associated with PVD. 
(Z=2.56;p=0.01) Similarly, other peripheral retinal degenerations (eg. 
pavingstone/cobblestone degeneration, peripheral chorio-retinal scarring) 
were more frequently associated with RH RRD(21.4%-12/56) than RRD 
associated with PVD(10.4%-103/990) (Z=1.98;p=0.048). In affected eyes 
with peripheral retinal degeneration other than lattice degeneration, 59% or 
79/122 of fellow eyes also demonstrated peripheral retinal degeneration. 
Lattice degeneration was significantly associated with high myopia; 22.7% 
(48/211) of eyes with lattice degeneration had a refractive error ≥-6D 
compared to only 15% (138/919)of eyes without lattice.(Z=2.48; p=0.013) 
On average eyes with lattice degeneration were 1.4 dioptres more myopic 
than eyes without.(Eyes without lattice degeneration: Mean(SD) spherical 
equivalent refraction (D) =-2.23D(3.68); eyes with lattice degeneration: 
mean(SD) spherical equivalent refractive error= -3.63D(3.62); T=4.77; 
p<0.0001) This was also reflected in the distribution of fellow eye axial 
length, where on average, eyes with lattice degeneration had an axial length 
0.65mm longer than eyes without lattice degeneration. (Eyes without lattice 
degeneration: Mean(SD) axial length (mm) =24.65mm(1.70); eyes with 
lattice degeneration: mean(SD) axial length(mm) = 25.30mm(1.54); 




9.2.7 Familial RRD 
Excluding cases of hereditary vitreo-retinopathy, 6.8% (82/1202) of cases 
reported a first degree relative who also had a rhegmatogenous retinal 
detachment. The characteristics of this group were: 95%(78/82) were PVD 
associated RRD, 76 of 82 had a HST RRD,  2 of 82 had a GRT RRD. In 5% 
(4/82) a PVD was absent; these comprised 3 cases of RH RRD and 1 retinal 
dialysis. In total, 19.5%(16/82) had lattice degeneration and 17%(14/82) 
had other peripheral retinal degeneration. Of the sixteen affected eyes with 
lattice degeneration, 68.7%(11/16) had lattice degeneration in the fellow 
eye. Similarly, 71.4%(10/14) of affected eyes with other peripheral retinal 
degeneration demonstrated bilateral disease. The familial group was of 
similar age and gender distribution to the general RRD population but were 
on average 1 dioptre more myopic and had an elongated axial length when 
compared to the general RRD population. (Positive family history group: 
mean(SD) spherical equivalent refractive error (D) =-3.51(3.61); No family 
history group: mean(SD) spherical equivalent refractive error (D)= -
2.42(3.71); T=2.5;p=0.014) (Figure 9.2)  
9.2.7.1 Syndromic RRD 
8 cases (0.7%) in the series had ocular and systemic features of syndromic 
RRD. One case was previously diagnosed with Stickler syndrome. Two 
further cases exhibited features suggestive of Stickler syndrome: high 
myopia, an optically empty vitreous, a strong family history of RRD and both 
cases had GRT RRD. Three cases had systemic developmental features that 
may be associated with RRD: One case had suspected Pierre-Robin 
syndrome, one had cleft palate and sensorineural deafness and the third 
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case had laryngomalacia, developmental delay and hypotonia. One patient 
was known to have Marfan syndrome and presented with RRD in the context 
of subluxated lenses. One case known to have Kneist dysplasia presented 
with a multiple break RRD. 
9.3 Discussion 
The epidemiological data I present is derived from the Scottish 
population which is 95.47% White British in ethnicity 
(http://www.scotland.gov.uk/Publications/2004/02/18876/32939 ); however 
the incidence and clinical features of RRD may vary in other populations. The 
data from this study is, however, the most extensive and detailed ever 
compiled on the epidemiology of RRD – it provides important clinical 
information for vitreoretinal surgeons and useful data for healthcare 
resource planning. For analysis RRDs were divided into those secondary to 
posterior vitreous separation and tractional (commonly “u”) retinal tear 
development and those without PVD where atrophic (eg round) holes or 
retinal dialyses were causative. This represents an important clinical 
distinction as the management of RRD is markedly different depending on 
posterior vitreous status. The differentiation may also be important in 
genetic predisposition and pathogenesis of RRD although it is notable that 
both PVD and non-PVD related RRD are associated with myopia and 
peripheral retinal degenerations. 
In this series, both PVD present and PVD absent RRD were more common in 
men (M:F 1.5:1-1.61:1). There were, however, notable differences in other 
associated characteristics between PVD and non-PVD RRDs. RRD associated 
with PVD demonstrated a higher proportion of right eyes affected (55.2%- 
95%CI=52-58.3%) and a peak incidence in the 6th decade of life. RRD 
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without PVD showed no difference in laterality and a peak incidence in the 
3rd decade of life. A higher incidence in men, (M:F=1.3:1 to 2.3:1) (Mowatt 
et al. 2003; Ivanisevic et al. 2000; Rosman et al. 2001; Polkinghorne & 
Craig 2004b; Limeira-Soares et al. 2007) and a predominance of affected 
right eyes (Right eye:left eye= 1.09:1 to 1.36:1)(Tornquist et al. 1987a; 
Haimann et al. 1982a; Laatikainen et al. 1985; Li 2003; Rowe et al. 
1999)have been previously reported in population based studies. 
Of the 1,130 cases of primary RRD with detailed clinical information, a PVD 
associated retinal tear was causative in 87.6% of cases (“u” tears in 86.3%), 
with non-PVD RRD comprising 12.6% of cases. Non-PVD retinal dialysis was 
responsible in 5.6% of cases and 55% of these were associated with 
significant ocular trauma. Complete case ascertainment of GRT can be 
difficult,(Ang et al. 2010) however in our series, GRT and retinoschisis RRD 
accounted for 1.3% and 1.2% of all cases. The proportion of PVD related 
RRD in our study is higher than in previously reported clinical series, where 
HST was the most common causative break in between 50-61% of cases, 
and atrophic round hole RRD was causative in 12-21% (Laatikainen & 
Tolppanen 1985b; Sasaki et al. 1995; Ashrafzadeh et al. 1973; Tornquist et 
al. 1987b)  Previous studies have generally classified retinal breaks 
according to their morphology, so breaks that appear circular may have 
been treated as atrophic round holes when in fact they were caused by 
vitreous traction.  Alternatively, the higher proportion of PVD related RRD in 
our series may be due to an older population in Scotland, with a higher 
number of pseudophakic eyes than in other reports, or it may represent a 
genuine difference in this population.  
High myopia (>-6D) comprised 16.8% of our series in total and was most 
common in RH and GRT RRD. The proportion of high myopia is similar to 
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previous European series, where high myopia was present in between 12.7-
21.8% of cases(Laatikainen et al. 1985; Tornquist et al. 1987a), but it is 
lower than in other Asian populations (32.4% in Beijing, China).(Li 2003) On 
average RH RRD cases were 1.5 dioptres more myopic than PVD associated 
RRD cases. It is possible that the Scottish population has a lower incidence 
of myopia (potentially due to a lesser genetic susceptibility) resulting in 
fewer myopia-related round-hole RRDs which may result in a higher 
proportion of PVD related RRDs in our series. 
In this population, approximately 1 in 5 presenting cases was pseudophakic, 
which is comparable to other recent series.(Polkinghorne & Craig 2004b) 
Pseudophakic RRD was much more common in PVD associated RRD (23.7%- 
95%CI=21.1-26.5%) than RRD without PVD (6.4%- 95%CI=3-11.8%). Of 
all pseudophakic cases, 36% had a posterior capsule defect (either due to 
YAG capsulotomy or complicated cataract surgery), thus approximately two 
thirds of pseudophakic cases had an intact posterior capsule. The median 
time to presentation was 3 years post cataract surgery, suggesting that a 
causal relationship may not apply to all pseudophakic RRDs. No significant 
difference was noted between the proportions of myopia between phakic and 
pseudophakic cases. A higher proportion of pseudophakia (53.3%-8/15) was 
present in cases of GRT RRD. Occurrence of aphakic RRD was rare (<2%) 
compared with older series,(Ashrafzadeh et al. 1973; Everett & Katzin 1968) 
reflecting modern cataract surgery techniques. 
Trauma is an important association of RRD. In Scotland, one in ten cases of 
primary RRD report ocular or head trauma with a possible temporal 
relationship to RRD, which is at the upper end of the range reported 
previously in population based studies (1.6-12.2%).(Sasaki et al. 1995; Zou 
et al. 2002; Li 2003; Haimann et al. 1982a) The variation in time interval 
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between injury and presentation (median 3.48 months; IQR=0.36 – 88.56 
months) can make it difficult to attribute direct causation of trauma to RRD 
however the relatively short (3.5 months) median duration between trauma 
and RRD and the difference in RRD aetiology (a higher proportion of GRTs 
and retinal dialyses) is evidence  that many of these RRDs have a genuine 
traumatic causation and that non-penetrating trauma may be an 
underestimated cause of RRD.   
Lattice degeneration is a common vitreo-retinal anomaly with a reported 
population prevalence of 6 to 9.5%.(Byer 1965; Straatsma BR et al. 1974) 
Lattice degeneration was present in 18.7% of all RRDs and in 61% of fellow 
eyes of these cases,  which is within the range of 7-29% reported in 
previous observational studies from Europe.(Laatikainen & Tolppanen 
1985b; Tornquist et al. 1987a) In our series, RRD cases with lattice 
degeneration were significantly more myopic and demonstrated an 
elongated axial length compared with RRD not associated with the lesion. 
This suggests that the underlying genetic predisposition to myopia and to 
lattice degeneration may be linked. Genetic associations of myopia, lattice 
degeneration and RRD remain, however, uncertain. In Japan, lattice 
degeneration has been noted in between 60-65% of RRD cases, with 
refractive error in these cases showing a myopic deviation away from the 
mean of >2 dioptres.(Sasaki et al. 1995),(Shimizu H 1989) In the Scottish 
population, all peripheral retinal degenerations including lattice degeneration 
were more frequently associated with RH RRD compared with PVD 
associated RRD (21-35% vs 10-19%; p<0.05). It was notable also that the 




 A positive first degree relative family history in patients with RRD not 
associated with other ocular or non-ocular findings has been reported 
between 1 – 8.2% in large population studies.(Wilkes et al. 1982; Zou et al. 
2002; CUENDET et al. 1975) Similarly, our series supports the familial 
tendency of RRD at the upper end of this range, with approximately 7% of 
non-syndromic cases reporting an affected first degree relative. This sub-
group demonstrated a more myopic refractive error and elongated axial 
length when compared to the general RRD population.(Figure 9.2) RRD 
associated with systemic features or hereditary vitreoretinopathy is rare, 
accounting for 0.7%(8/1130) of our cases, three of these eight cases had 
features consistent with Stickler syndrome. 
In summary, in the Scottish population the proportion of PVD related RRD 
appears to be higher than previously reported series. RRD cases without a 
PVD are younger, more myopic and have a higher prevalence of peripheral 
vitreoretinal degeneration. Lattice degeneration was present in 
approximately 1 in 5 cases, was frequently bilateral, and associated with 
higher degrees of myopia. Twenty percent of cases were pseudophakic at 
presentation, and two thirds of these had had non-complicated cataract 
surgery. Ocular trauma and familial RRD may be underestimated 
predispositions occurring in 10% and 7% of cases respectively in this series. 
Eyes with RRD and associated lattice degeneration or family history of RRD 
































     Male 598(61.3%) 13(86.7%) 26(46.4%) 44(65.7%) 14(82.3%) 
Female 377(38.7%) 2(13.3%) 30(53.6%) 23(35.3%) 3(17.6%) 
      Age Group 
     0-9 0 1(6.7%) 0 1(1.5%) 0 
10-19 8(0.8%) 1(6.7%) 3(5.3%) 12(17.9%) 0 
20-29 21(2.1%) 0 7(12.5%) 12(17.9%) 0 
30-39 48(4.9%) 2(13.3%) 14(25%) 18(26.9%) 0 
40-49 107(11%) 1(6.7%) 10(17.8%) 15(22.4%) 0 
50-59 263(27%) 3(20%) 8(14.3%) 4(6%) 3(17.6%) 
60-69 332(34%) 3(20%) 7(12.5%) 3(4.5%) 5(29.4%) 
70-79 149(15.3%) 3(20%) 6(10.7%) 1(1.5%) 8(47%) 
80+ 47(4.8%) 1(6.7%) 1(1.8%) 1(1.5%) 1(5.9%) 




     ≥-6D 164(16.8%) 4(26.7%) 15(26.8%) 3(4.5%) 0 
<-6 to >-1D 349(35.8%) 2(13.3%) 23(41.1%) 11(16.4%) 2(11.8%) 
≥-1to ≤+1D 263(27%) 2(13.3%) 7(12.7%) 40(59.7%) 2(11.8%) 
>+1to <+6D 78(8%) 3(20%) 3(5.4%) 4(6%) 3(17.6%) 
≥+6D 8(0.8%) 0 1(1.8%) 1(1.5%) 4(23.5%) 
Not Known 113(11.6%) 4(26.7%) 7(12.5%) 8(11.9%) 4(23.5%) 
      Affected Eye 
     Right 539(55.3%) 8(53.3%) 25(44.6%) 38(56.7%) 6(35.3%) 
Left 427(43.8%) 6(40%) 30(53.6%) 24(35.8%) 11(64.7%) 
Both 9(0.9%) 1(6.7%) 1(1.8%) 5(7.5%) 0 
      Phakic status 
     Phakia 748(76.5%) 7(46.7%) 51(91.1%) 65(97%) 15(88.2%) 
Pseudophakia 213(21.8%) 8(53.3%) 4(7.1%) 1(1.5%) 2(11.8%) 
Aphakia 14(1.4%) 0 1(1.8%) 1(1.5%) 0 
      Trauma 71(7.2%) 2(13.3%) 4(7.1%) 37(55.2%) 2(11.8%) 
Blunt 29 2 2 23 0 
Other 42 0 2 14 2 




     Lattice 
Degeneration 
188(19.2%) 0 20(35.7%) 3(4.5%) 
 
0 






98(10%) 5(33.3%) 0 5(7.5%) 
 
0 
T ble 9.1 – Baseline clinical characteristics of 1,130 cases of RRD by type of causative 





















Figure 9.1 – Density plot of the spherical equivalent refractive error(SER) 
and axial length(AL) of detached eyes with lattice degeneration and those 
without.(SER was known in 90.5%(191/211) of eyes with lattice 
degeneration and in 87.8%(807/919) of eyes without)(AL was known in 
48.8%(103/211) of eyes with lattice degeneration and in and 
43.5%(409/919) of eyes without) Eyes with lattice degeneration were on 
average 1.3 dioptres more myopic. (Eyes without lattice degeneration: 
Mean(SD) spherical equivalent refraction (D) =-2.23D(3.68); eyes with 
lattice degeneration: mean(SD) spherical equivalent refractive error= -
3.63D(3.62); T=4.77; p<0.0001) Eyes with lattice degeneration had an 
average axial length 0.65mm longer than those without.  (Eyes without 
lattice degeneration: Mean(SD) axial length (mm) =24.65mm(1.70); eyes 
with lattice degeneration: mean(SD) axial length(mm) = 25.30mm(1.54); 
T=3.77; p<0.0001)  
 
Figure 9.2 – Comparative distribution of spherical equivalent refractive 
error and axial length of RRD cases with an affected first degree relative and 
of RRD cases without a family history of the condition.(SER was known in 
90.2%(74/82) eyes with a family history of RRD and in 88.2%(924/1048) of 
eyes without)(AL was known in 39%(32/82) eyes with a family history of 
RRD and in and 45.8%(480/1048) of eyes without) Excluding cases with 
known hereditary vitreo-retinopathy, cases with a positive family history of 
RRD were on average 1 dioptre more myopic. (Positive family history group: 
mean(SD) spherical equivalent refractive error (D) =-3.51(3.61); No family 
history group: mean(SD) spherical equivalent refractive error (D)= -
2.42(3.71); T=2.5;p=0.014) Similarly, cases with a positive family history 
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had an average axial length 0.85mm longer than those without. (Positive 
family history group: mean(SD) axial length (mm) =25.58mm(1.43); No 




















































Chapter 10 - Clinical characteristics in the 
Scottish rhgematogenous retinal detachment 
Study II – Clinical presentation 
10.1 Introduction 
Few of the previous epidemiological studies of RRD have described in detail 
the clinical characteristics of RRD from a large prospectively recruited 
population. In this section, I aim to describe the clinical features at 
presentation and the associated ophthalmic pathology in the Scottish RRD 
Study cases and thus utilize this large population-based RRD cohort to 
provide clinically important data to aid vitreoretinal surgeons in the 
assessment and management of RRD. 
10.2  Results 
A total of 1,244 incident cases of primary RRD were identified in Scotland 
over the 2 year study period of which 1,202 were recruited to the study and 
1,130 had detailed information on clinical features. All cases were classified 
by the presence or absence of a posterior vitreous detachment and by the 
type of retinal break(s) causing the detachment. In total, PVD was present 
in 87.6% (990/1130) of cases; of these cases, single or multiple horse-shoe 
tear (HST) was causative of RRD in 98.5% (975/990) and giant retinal tear 
RRD was seen in 1.5% (15/990). PVD was absent in 12.4% (140/1130) of 
cases and these comprised round hole RRD in 40% (56/140), retinal dialysis 
in 47.8%(67/140) and retinoschisis RRD in 12.1%(17/140).  
Continuous data was analysed using a two-sample T-test and differences in 




10.2.1    Duration of Symptoms and Route of referral 
On presentation, 73.6% (832/1130) of patients reported a peripheral visual 
field defect, 57.4% (649/1130) floaters and 25.1% (284/1130) photopsia. 
PVD associated RRD more frequently presented with floaters compared to 
PVD absent RRD (58%(594/990) vs 39.3%(55/140);Z=4.7;p<0.001), 
however a similar proportion in both groups presented with phostopsia 
(25.5% (253/990) vs 22.1%(31/140);Z=0.95;p=0.13) and with a peripheral 
visual field defect (73.8%(731/990) vs 72.1%(101/140);Z=0.42;p=0.6). 
Seventy eight percent (879/1130) presented with two or more symptoms, 
with only 22.2%(251/1130) of cases presenting with a single visual 
symptom. Less than two percent (15/1130) of cases were asymptomatic, 
being referred to hospital by an optician/optometrist or primary healthcare 
worker. The median duration of photopsia was 7 days (IQR=3-21 days), 
floaters was 10 days (IQR=4-28 days) and of peripheral visual field 
symptoms was 7 days (IQR= 3-16 days). There was no significant difference 
in the duration of symptoms between myopes >-1dioptres(D) and non-
myopes. The routes of referral differed between myopes (>-1D) and non-
myopes. Forty one percent (288/690) of myopes (>-1D) were referred 
through their optician/optometrist compared to 36.1%(159/440) of non-
myopes (Z=1.9;p=0.058).  Fifteen percent of non-myopes (67/440) were 
referred through their general practitioner compared to only 10.2%(70/690) 
of myopes (Z=2.46;p=0.01). A similar proportion of myopes and non-
myopes presented to the emergency services, 20.6% (142/690) and 17.5% 
(77/440) respectively (Z=1.3;p=0.19). Overall, ninety cases (8%) self 




10.2.2  Intra-ocular pressure (IOP) 
We found a significantly lower IOP at presentation in the detached eye 
compared to the fellow eye in PVD associated RRD, (Mean(SD) IOP in PVD 
associated RRD =14.7(4.22)mmHg; Mean(SD) IOP in fellow eyes of PVD 
associated RRD = 15.5(3.48)mmHg; T= 4.02 ;p<0.001). No IOP difference 
was seen in PVD absent RRD. (Mean(SD) IOP in PVD absent RRD 
=15.5(5.55)mmHg; Mean(SD) IOP in fellow eyes of PVD absent RRD = 
14.7(2.74)mmHg; T= 1.49 ;p=0.14) 
  10.2.3    Distribution of retinal breaks 
The frequency of causative retinal breaks varied with break type. PVD 
associated HST RRD was caused by single breaks in 57.3% (500/975) and 
multiple breaks in 48.7% (475/975). In RH RRD there was a significantly 
higher proportion of multiple breaks with 67.8% (38/56) of cases having 
more than one causative break. (Z=2.97;p=0.003) The frequency, type and 
distribution of retinal breaks in detached eyes are shown in table 10.1. 
Overall, in PVD associated RRD (including GRT), breaks were significantly 
more frequent in the supero-temporal retina (56.1%- 95%CI=53.8-58.3%), 
with the second most common location being the superior nasal retina 
(25.7%- 95%CI=23.7-27.7%). In PVD absent RRD, the site of the causative 
break in round hole RRD was most commonly infero-temporal (45.9%) or 
supero-temporal (41.9%). In single break PVD associated RRD cases 
(excluding GRT RRD) (N=500), 62.2%(311) of cases had a supero-temporal 
break, 15.6%(78) had a supero-nasal, 16%(80) had an infero-temporal 
break, and the least common site was infero-nasal in 31 cases(6.2%). A 
higher distribution of supero-temporal and infero-temporal retinal breaks 
were found in multiple break PVD associated RRD cases (excluding GRT 
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RRD) (N=475), where 72.6%(345) of cases had a supero-temporal break, 
36.2%(172) had an infero-temporal break, 19.8%(94) had a supero-nasal 
break and 40 cases(8.4%) had an infero-nasal break. In single break PVD 
absent RRD (excluding retinoschisis RRD) (N=78),64.1%(50) of cases had 
an infero-temporal break, 25.6%(20) had a supero-temporal break, six 
cases had a supero-nasal break and two cases an infero-nasal break. In 
multiple break PVD absent RRD (excluding retinoschisis RRD) (N=45), 
62.2%(28) had an infero-temporal break, 48.8%(22) of cases had a supero-
temporal break, three cases had an infero-nasal break and two cases a 
supero-nasal break.  In retinal dialysis and retinoschisis RRD breaks were 
predominantly infero-temporal accounting for over 72.3% and 62.5% of 
breaks respectively. Ten percent (7/67) of retinal dialyses had more than 
one retinal break. 
Full-thickness retinal breaks were found in 95/1,130 (8.4%) of fellow eyes 
on presentation. Of cases with PVD, 8.5% (85/990) had fellow eye breaks, 
(71.7% (61/85) horse-shoe tears and 28.3%(24/85) round holes) In cases 
without PVD, fellow eye breaks were present in 7.1%(10/140). Of these, in 
RH RRD (N=7) all fellow eye breaks were round holes, in dialysis cases 
(N=3), 1 fellow eye break was a HST, and two fellow eyes also had retinal 
dialysis.  
10.2.4    Previous Retinal prophylaxis 
Table 10.1 documents the number of patients who had previous retinal 
prophylaxis and subsequently had a RRD in the treated eye. Overall, 5.8% 
(66/1130) of cases had previous treatment aimed at preventing RRD, most 
commonly laser or cryotherapy to retinal breaks only. Previously treated 
peripheral retinal degeneration was uncommon. Notably, 3.8% (43/1130) of 
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fellow eyes had been treated for a retinal break or degeneration and 
subsequently presented with a RRD in the contra-lateral eye (study eye).  
10.2.5    Simultaneous and consecutive bilateral RD 
Overall 7.3% (88/1202) of cases had RRD in both eyes- of these, eighteen 
cases (1.5%) presented with simultaneous bilateral RRD. All cases 
underwent sequential RRD repair. Of this group of 18 simultaneous bilateral 
cases; 3 were bilateral HST associated RRD, 4 were bilateral RH RRD, 5 
cases had RH RRD in one eye and HST RRD in the fellow eye,  5 cases were 
bilateral retinal dialysis and one case was a bilateral GRT RRD. Three of five 
retinal dialysis cases reported significant ocular trauma within 9 months 
prior to presentation. The proportion of lattice degeneration in simultaneous 
bilateral RRD (27.8%) was not significantly different from that of the general 
RRD population. All cases presented with unilateral symptoms and symptom 
duration did not differ with that of the general RRD population. There was no 
significant difference in levels of myopia between the eighteen simultaneous 
bilateral cases and the general RRD population however bilateral cases were 
significantly younger (mean age =45 years; SD - 18 years; p=0.008).  
Seventy cases (5.8%) had had a previous RRD in the contra-lateral eye 
during or outside the study period. The proportion of lattice degeneration 
(22.8%-16/70) and myopia >-6 dioptres (24.2%-17/70) in this consecutive 
bilateral RRD group was similar to the general RRD population, however a 
greater proportion of these cases (41.4%-29/70) were pseudophakic in the 






10.2.6  Macula Status 
The proportion of cases with an attached, bisected or detached macula at 
presentation is detailed in table 10.2. Across all types of RRD, less than 50% 
of cases had a fully attached macula at presentation.  
10.2.7   Quadrants of Detachment and Proliferative 
vitreoretinopathy 
PVD associated RRD cases presented with up to 2 quadrants of detachment 
in 66%(95%CI=63-69%), compared to 77.8%%(95%CI- 70-84.4%) in PVD 
absent RRD;(Z=3.35;p=0.001).(Table 10.2) Total RRD was present in 7.7% 
(87/1130) of cases. Using a standard classification of proliferative vitreo-
retinopathy(PVR) in RRD,(Pastor 1998) pre-operative PVR complicated 
11.7%(116/990) of PVD associated RRD and 8.5%(12/140) of PVD absent 
RRD. This was predominantly grade A or B, however grade C PVR was much 
more common in PVD associated RRD (22.4%-26/116) compared to PVD 
absent RRD (0.8%-1/12).  
10.2.8    Fellow Eye Best Corrected Visual Acuity 
The best corrected visual acuity (BCVA) by type of retinal break in the fellow 
eye of all RRD cases is shown in table 10.3. Overall, the fellow eyes of most 
cases had good visual acuity; 79.2% (895/1130) had a BCVA of 6/9 or 
better, however, 13.1% (148/1130) of affected fellow eyes had a BCVA of 
6/18 or worse. In PVD associated RRD the most common causes of BCVA of 
6/18 or worse in the fellow eye were: 40%(52/130) cataract, 
21.5%(28/130) RRD, 18.4%(24/130) age-related macular degeneration, 
9.2%(12/130) amblyopia, 5.3%(7/130) injury and 3%(4/130) primary open 
angle glaucoma. In PVD absent RRD the most common causes of BCVA of 
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6/18 or worse in the fellow eye were: 44.4%(8/18) cataract, 22.2%(4/18) 
injury,16.7%(3/18) RRD and 5.5%(1/18) amblyopia.  
10.2.9    Type of Primary Surgery 
Table 10.4 highlights the type of primary surgery in 1,130 RRD cases. 
Significant differences were seen in the type of primary operation performed 
depending on the type of retinal break. In the presence of a PVD, pars plana 
vitrectomy(PPV) was the primary procedure in 77.3%(95%CI= 74.5-79.8%) 
of cases compared to 24.3%(95%CI= 17.4-32.2%) of PVD absent cases. 
(Z=13.7; p<0.0001) In the absence of a PVD, an external cryo-buckling 
procedure (with or without subretinal fluid drainage) was performed in 70% 
(95%CI= 61.7-77.4%) of cases. Pneumoretinopexy was an uncommon 
primary procedure in Scotland and was used in approximately 1% of RRD 
cases.  
10.3 Discussion 
The clinical presentation of RRD varies primarily in relation to the type, 
distribution and number of retinal breaks. This has important implications for 
the clinical management and in particular the selection of surgical procedure 
for RRD cases. The data presented here from the Scottish RD study 
highlights key clinical characteristics in the largest prospectively recruited 
series of RRD where detailed clinical information is available. 
The  nature of symptoms of RRD can vary markedly and their 
duration does not reliably indicate the presence, extent or duration of 
detachment.(Polkinghorne & Craig 2004a; Tanner et al. 2000) Notably, in 
this study, over 75% of cases presented with more than one visual symptom 
and RRD was asymptomatic in less than two percent of cases. The most 
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common presenting symptom was a shadow or peripheral visual field defect, 
present in 73.6% (832/1130) with a median duration of 7 days(IQR=3-16), 
emphasising that new and relatively acute subjective loss of peripheral 
vision is an important predictive symptom of RRD.(Hollands et al. 2009) 
There is also a difference in hospital referral patterns between myopes and 
non-myopes. Myopes (of more than one dioptre) preferentially visited and 
were referred for treatment by their optician/optometrist, compared to non-
myopes who more frequently attended primary care physicians.   
The distribution of retinal breaks is an important consideration in the pre-
operative assessment and subsequent treatment of RRD. In this series, of 
PVD associated RRD, 56.1% (95%CI=53.8-58.3%) of breaks were identified 
in the supero-temporal retina. In non-PVD RRD, 54.6%(95%CI- 47.9-
61.1%) of breaks were infero-temporal followed by supero-temporal in 
34.9%(95%CI- 28.7-41.5%), however in retinal dialysis and retinoschisis 
RRD, a higher number of breaks were seen in the infero-temporal quadrant; 
72.3%(95%CI=59.8-82.7%) and 62.5%(95%CI=35.4-84.8%) respectively. 
This finding supports previous observations that between 46.4-57.2% of 
retinal breaks in older (PVD present) patients and in RH RRD were noted in 
the supero-temporal retinal quadrant,(Laatikainen & Tolppanen 1985b; 
Everett & Katzin 1968; Tornquist et al. 1987b) and that retinal dialysis was 
most frequently in the infero-temporal quadrant in between 44.7%(17/38) 
to 54%(7/13).(Laatikainen & Tolppanen 1985b; Tasman 1972; Zion & 
Burton 1980)  
In the present series, 48.7% of PVD associated RRD and a significantly 
higher proportion (67.8%) of RH RRD were caused by 2 or more retinal 
breaks. There are few recent studies on the distribution of retinal breaks in a 
large RRD population that distinguish between PVD and non-PVD RRD, 
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however this finding is similar or higher than older reports from clinical 
series, where 57% of phakic RRD cases (2,351/4,126) (Ashrafzadeh et al. 
1973), 36%(75/590) 11 of RH RRD and 42%(144/342)(Laatikainen & 
Tolppanen 1985b) overall were reported to be caused by two or more 
breaks.(Tornquist et al. 1987b) In this series, multiple breaks had a similar 
retinal quadrant distribution to single break RRD in both PVD present and 
absent cases.  Fellow eye retinal breaks were found in 8.4% of cases, which 
supports previous estimates of 5-20% and highlights the risk of RRD in the 
fellow eyes of affected individuals.(Laatikainen 1985; Gupta & Benson 2005) 
There was no difference in the proportion of fellow eye breaks between PVD 
present and absent RRD.  
Reports of the bilateral incidence of RRD have shown considerable variation 
(between 9-33%) depending on inclusion criteria and duration of follow 
up.(Folk & Burton 1982; Gupta & Benson 2005; Krohn & Seland 2000; 
Michels RG et al. 1990) Approximately 2% of the Scottish cases presented 
with simultaneous bilateral RRD and a further 5.3% of patients had a 
previous RRD in the contra-lateral eye. Retinal dialyses in younger patients 
accounted for approximately 30% of simultaneous bilateral cases, with 
trauma being implicated in 55% of dialysis cases. Notably, a significantly 
higher proportion (41%) of bilateral RRD cases were pseudophakic on 
presentation compared to the general RRD population (21.6%), which may 
reflect a higher risk to the pseudophakic fellow eye in cases of RRD.(Gupta & 
Benson 2005; Ashrafzadeh et al. 1973; Sharma et al. 2003)   
Involvement of the macula at presentation remains the most significant 
prognostic indicator of post-operative functional visual outcome after RRD 
repair.(Pastor et al. 2008) Overall less than 50% of all RRD types in 
Scotland present with the macula fully attached. Referral patterns and 
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access to vitreoretinal surgical services will clearly influence rates of macular 
involvement and the figures for this study are broadly similar to those 
reported in other recent Western studies with macula off detachment rates 
of 40-60%(Laatikainen & Tolppanen 1985a; Pastor et al. 2008; Sullivan PM 
et al. 1997; Rowe et al. 1999), compared to a higher rate of 86% in 
developing countries.(Jalali et al. 2005) Thus despite recent advances in 
RRD treatment, the proportion of cases presenting with a macula-on 
detachment has not improved dramatically in the last 30 years. 
(Ashrafzadeh et al. 1973),(Sullivan PM et al. 1997; Minihan M. et al. 2001)  
Previous epidemiology series indicate that between 71-75% of RRD cases 
present with ≤2 quadrants of detachment.(Laatikainen & Tolppanen 1985b) 
In our series, a significantly higher proportion of PVD absent RRD (78%) 
presented with ≤2 quadrants of detachment compared to RRD associated 
with PVD(66%), suggesting that although PVD related RRD may be more 
symptomatic its progression is also more rapid. Total retinal detachment was 
present in approximately 8% of cases at presentation. PVR was present in 
11.3%(95%CI= 9.5-13.3%) of all cases and there was no difference in 
proportions between PVD and non-PVD RRD, however this was mostly early 
(grade A or B) PVR. More established, grade C, PVR was seen almost 
exclusively in tractional tear RRDs being present in 2.7% (26/ 975) of cases 
at presentation. 
Laser photocoagulation and cryotherapy are commonly used to treat 
tractional retinal tears.(Wilkinson 2000) Up to 10% of previously treated 
tears nevertheless go on to develop RRD.(Mastropasqua et al. 1999b) In this 
series, 5.8% of RRD cases had had retinal prophylaxis to a previously 
identified retinal break or an area of peripheral retinal degeneration and 
subsequently detached in the treated eye. In over two thirds of cases, this 
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treatment was to a retinal break. Similarly, 3.8% of fellow eyes received 
prophylactic treatment and subsequently detached in the contra-lateral eye 
(study eye). As I did not record the total number of cases of treated retinal 
tears in our population it is not possible to comment on the effectiveness of 
this treatment. 
Thirteen percent (148/1130) of affected fellow eyes had a best corrected 
visual acuity (BCVA) of 6/18 or worse. The most common reason for this 
was cataract in 40.5%(60/148), however RRD in the fellow eye accounted 
for 20.9% (31/148) of the reduced visual acuity, highlighting the importance 
of rhegmatogenous pathology in the other eye. 
Pars plana vitrectomy (PPV) was the most common primary surgical 
procedure performed for all PVD associated cases of RRD (77.3%; 95%CI= 
74.5-79.8%). By contrast in PVD absent RRD, external cryo-buckling 
surgery was performed in 70% (95%CI= 61.7-77.4%) of cases, with PPV 
being a primary procedure in only  24.3% (95%CI= 17.4-32.2%). 
Pneumatic retinopexy has previously been recorded to be an uncommon 
primary procedure for RRD repair in the U.K.(Mastropasqua et al. 1999a) 
and the data from this sudy demonstrate that this remains the case in 
Scotland. 
The Scottish RRD Study has generated extensive and detailed information on 
a large cohort of retinal detachment patients. The presenting clinical 
characteristics of the cases in this study provide valuable information for 
clinicians treating retinal detachments - for example the likelihood of single 
or multiple retinal breaks and their position. The presenting symptomatology 
and the incidence of vitreoretinal pathology in the fellow eye are also of 





























Proportion of single and 
multiple breaks in cases 
     









2 breaks present 222(22.8%) 1(6.7%) 14(25%) 6(8.9%) 
11 
(64.7%) 
3 breaks present 121(12.5%) 0 
8 
(14.3%) 1(1.5%) 0 
More than 3 breaks present 122(12.6%) 0 
16 
(28.6%) 0 0 
Not Known 10(1%) 0 0 0 0 
Number  and location of 
retinal breaks 



























Previous retinal prophlaxis 
in detached eyes of RRD 
cases 
     




     Laser to periperal 
degeneration 2 0 0 0 0 
Laser to retinal breaks 27 1 3 0 1 
Cryo to peripheral 
degeneration 0 0 0 0 0 
Cryo to retinal breaks 12 0 1 0 0 
Both laser and cryo to either 
retinal breaks or 
degeneration 16 0 0 2 1 
Table 10.1 – Highlights the distribution of retinal breaks, the proportion of 
multiple break RRD in the series and the frequency of cases receiving 
previous retinal prophylaxis in the detached eye. RH - Round hole; 


























      Macula 
     On 416(42.7%) 7(46.7%) 25(44.6%) 26(38.8%) 6(35.3%) 
Bisected 77(7.9%) 0 8(14.3%) 9(13.4%) 4(23.5%) 
Off 482(49.4%) 8(53.3%) 23(41.1%) 32(47.8%) 7(41.2%) 
      Quadrants of 
Detachment 
    1 212(21.7%) 5(33.3%) 12(21.4%) 16(23.9%) 2(11.8%) 
2 432(44.3%) 5(33.3%) 30(53.6%) 37(55.2%) 12(70.6%) 
3 189(19.4%) 2(13.3%) 8(14.3%) 10(14.9%) 2(11.8%) 
4 78(8%) 3(20%) 1(1.8%) 4(6%) 1(5.9%) 
Not 
Known 64(6.6%) 0 5(8.9%) 0 0 
      PVR 
     YES 114(11.7%) 2(13.3%) 5(8.9%) 4(6%) 3(17.7%) 
Grade 
A 46 1 4 2 2 
Grade 
B 42 1 1 2 0 
Grade 
C 26 0 0 0 1 
Table 10.2 – The extent of detachment and the proportion of pre-operative 





























































































































0 0 1 
(5.9) 
Table 10.3 – The distribution of fellow eye best corrected visual acuity by 
retinal break in all RRD cases.  
 



























      Type of Primary Surgery 
    Vitrectomy and 














Both Vitrectomy and 
External Buckle 33(3.4%) 2(13.3%) 1(1.8%) 2(3%) 
2 
(11.8%) 
Pneumoretinopexy 7(0.7%) 0 2(3.6%) 1(1.5%) 0 
Not operated 5(0.4%) 0 0 0 0 
Not Known 6(0.6%) 0 0 0 0 




CHAPTER 11 - Population based estimate of the 




Many epidemiological and genetic studies to date have demonstrated 
important genetic influences on syndromes associated with RRD and on 
myopia development.(Young 2009) To date, there are over 15 reported 
chromosomal regions showing linkage with myopia, the reported range of 
estimated heritability is between 62-90%(Lee et al. 2001; Hammond et al. 
2001; Lyhne et al. 2001) and the sibling recurrence risk ratio for myopia (>-
2D) has recently been reported as 2.98 (95%CI=1.56-5.79).(Wojciechowski 
et al. 2005b) Nonetheless, there have been few studies into the heritability 
of  non-syndromic RRD. Population studies indicate that between 1- 8.2% of 
incident cases of RRD also have an affected first degree relative and 
recently, the cumulative lifetime risk of RRD has been shown to be 2.6 fold 
higher in relatives of cases compared to controls.(Wilkes et al. 1982; Go et 
al. 2005b; Zou et al. 2002) The sibling recurrence risk and its relation to 
population prevalence (λs) is commonly used in genetic epidemiology to 
determine the power to detect genetic influences. In this section, I calculate 
a population based estimate of the sibling recurrence risk ratio for RRD. I 
also examine the effect of gender, proband age at diagnosis, refractive 







Of all 1,202 recruited cases,  full postal addresses were available for 922 
cases. All of these cases were white Caucasian in ethnicity and resident in 
Scotland. After informed consent, each case was contacted by a postal 
questionnaire. The questionnaire requested information on a diagnosis of 
retinal detachment in a relative, the height and weight of the proband, birth 
order of the index case and the affected relative(s), and the size of the 
family. (Appendix C)  A cover letter was included encouraging return of the 
questionnaire even if the family history was negative.  
 11.2.1 Statistical Methods  
A widely used measure of familial aggregation is the sibling recurrence-risk 
ratio (λs), which is defined as the ratio of risk of disease manifestation, 
given that one’s sibling is affected, compared with the disease prevalence in 
the general population. The λs expresses the increased risk of developing 
the disease in an individual who has a sibling with the disease, and is a 
quantifiable measure of the genetic contribution to the disease. (Guo 1998; 
Khoury et al. 1988) Similarly, the parent-offspring recurrence risk ratio is 
defined as the proportion of affected parent-offspring pairs among all 
parent-offspring pairs in a population compared with the normal population 
prevalence and describes the increased risk of developing the disease in an 
offspring who has a parent with the disease.  The normal population 
prevalence of RRD in Scotland is unfortunately not known and recent high 
quality data on the prevalence of RRD is lacking. However estimates from 
the U.S. indicate a normal prevalence in white Caucasians of 0.7%.(Brinton 
D.A & Wilkinson C.P 2009) I defined the prevalence of RRD as the proportion 
of individuals in the Scottish population that have had a RRD. Based on the 
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age standardised incidence of RRD in Scotland(Mitry et al. 2010) of 13.09 
per 100,000 in men and 7.41 per 100,000 in women and an average life 
expectancy of 73 years for men and 78 years for women, 
(http://www.isdscotland.org/isd/files/HLE%20_exec_summary.pdf), I 
estimated the population prevalence of RRD to be 0.96% (13.09*73/1000) 
for men and 0.58% for women. The average of these values is 0.77%, thus 
I estimate that the normal prevalence of RRD in Scotland is expected to be 
approximately 0.8%. 
To calculate the λs parameter, I used a population approach(Olson & Cordell 
2000) and the standard formula: 
λs = Ks/K 
where Ks is the sibling recurrence risk, denoted as the proportion of affected 
siblings among all siblings of affecteds in a population and K is the normal 
population prevalence of the condition.  
Using generalized estimating equations (GEE) in a logistic regression model 
with sibling affected status as the binary outcome, I estimated the odds ratio 
(OR) of a sibling being affected with RRD given an affected proband and 
examined the effect of proband characteristics on sibling risk. A repeated 
measures logistic regression model using GEEs allows the incorporation of 
covariates and can accommodate for different family sizes.(Farbrother et al. 
2004) In our model, I used a repeated measures analysis to cluster data by 
individual family size such that responses from different families are 
assumed to be independent and responses within families are assumed to be 
correlated. Regression covariates examined included proband age at 
diagnosis, gender, spherical equivalent refractive error (SER), lens status, 
birth order and height. Axial length (AL) measurements were available in 
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40% of participants but were excluded from the regression analysis due to a 
high missing rate and fewer data points for regression analysis, however 
increasing AL was strongly correlated with a more myopic SER (r2=0.78).   
I used stepwise logistic regression to identify the best fitting model with the 
lowest Akaike Information Criterion (AIC). The AIC is a goodness-of-fit 
measure of statistical models based upon a likelihood function and is 
commonly used to select between competing statistical models.(Lindsey & 
Jones 1998) The main covariates included in the final model were proband 
age at diagnosis, proband gender and SER. Proband birth order, height and 
body mass index (BMI) and lens status were not significantly associated in 
our regression models and were excluded from the final analysis. There were 
no significant age-gender interaction terms. Table 11.1 highlights the model 
coefficients and associated standard errors. The statistical analyses were 




In total I received 602 (65.3%) returned questionnaires from index cases 
that were included in the analysis.  The demographic characteristics between 
respondents and non-respondents were similar: age (respondents- 
mean(SD) age= 60.4(13) years; non-respondents- mean(SD) age= 
58.9(16.7) years); gender (respondents= 57% male; non-respondents= 
60.3% male) and spherical equivalent refractive error (SER) (respondents 
mean(SD) SER= -2.56(3.73)D; non-respondents mean (SD)= -
2.49(3.72)D). SER was known for 90% of index cases; 51.8% were myopic 
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(>-1), 28.1% were emmetropic and 9.6% were hypermetropic(>+1). Of all 
index cases, 78.2% were phakic, 20.1% were pseudophakic and 1.6% were 
aphakic at presentation.   
Of the 602 families (parents, siblings, offspring), 7.8%(47) had one 
affected member and 0.5%(3) had two affected members. Including all 
relatives (grandparents to cousins) 12.1% (73) of probands had a relative 
affected with RRD and 8 families had two or more affected individuals. In 
total, 83.2% (501/602) of probands had one or more siblings. Sibship size 
ranged from 2 to 12 in 501 families, with a mean of 2.5 siblings per family. 
Table 11.2 and 11.3 highlight the distribution of affected family members 
and the frequency of affected members by family size. 
Logistic regression model coefficients are shown in table 11.1 and are based 
on all families with at least 2 siblings (N=501). The adjusted OR of a sibling 
being affected given another affected sibling is 1.91(95%CI: 1.18-3.05) Of 
covariates examined, the degree of myopia of the proband demonstrated a 
significant effect on the sibling risk of RRD. An increase of 1 dioptre (D) of 
myopia in the proband, resulted in a 9.8% increased risk to a sibling to 
develop RRD. Table 11.4 highlights the increasing odds of RRD in a sibling 
by the increasing level of myopia in the proband. 
Assuming a population prevalence of 0.8%, the sibling recurrence ratio (λs) 
for RRD is 2.1 (95% CI=1.3-3.2) and the parent-offspring recurrence risk 
ratio is 2.9 (95%CI – 1.9-4.2). Table 11.5 highlights the sibling recurrence 














Intercept -6.2328 1.1575 29 <0.001 
SER -0.0931 0.0437 4.55 0.028 
Age 0.0285 0.0161 3.13 0.077 
Female 0.4667 0.4835 0.93 0.334 
Akaike Information Criterion (AIC): 85.53 
Table 11.1 – The association of RRD affected index case covariates on the 
sibling risk of RRD among a population of Scottish families. (SER- Spherical 













  Father 13 602 
Mother 15 602 
Paternal 
  Grandfather 0 
 Aunt 3 850 
Uncle 3 808 
Cousin 1 2633 
Maternal 
  Grandfather 4 
 Aunt 3 777 
Uncle 4 704 
Cousin 5 2623 
Siblings 
  Brother 12 666 
Half-brother 0 
 Sister 8 590 
Half-sister 1 
 Offspring 
  Son 1 535 
Daughter 3 515 
Table 11.2 – Highlights the relative distribution of the family members of 






Family Size Number of individuals with RRD (excluding index case)  
 
0 1 2 3 Total 
2 22 3 
 
- 25 
3 46 5 
 
- 51 
4 86 6 1 - 93 
5 106 10 
 
- 116 
6 92 9 1 - 102 
7 60 6 
 
- 66 
8 41 0 1 - 42 
9 31 1 
 
- 32 
10 15 1 
 
- 16 
11 13 0 
 
- 13 
12 11 3 
 
- 14 
13 6 0 
 
- 6 
14 0 2 
 
- 2 
15 2 0 
 
- 2 
NA 21 1 
 
- 22 
Total 552 47 3 - 602 
Table 11.3 – Number of families by size (parents, siblings and offspring)  
and number of cases of RRD (excluding index case) among 3,510 relatives 






Odds Ratio (OR) and 
confidence interval of a 








Table 11.4 – The OR of a sibling developing RRD as a function of the level 
of myopic equivalent refraction in the affected index case. Adjusting for age 
and gender, each additional dioptre of myopia in the index case increases 








Sibling recurrence risk ratio - 
λs (95%confidence interval) 
All RRD cases 2.1(1.3-3.2) 
Male index  1.8(1.0-3.5) 
Female index 2.9(1.4-5.1) 
Index age ≤60 years 2.29(1-4.3) 
Index age >60 years 2.36(1.1-4.1) 
Non-myopic RRD  1.9(1.1-3.2) 
Myopic RRD (>-1D) 2.8(1.5-4.6) 
Phakic RRD only 2.5(1.5-3.9) 
Pseudophakic or Aphakic RRD only 2.0(0.4-5.9) 
Table 11.5 – The sibling recurrence risk ratio by gender, myopia and lens 
status of index cases with RRD derived from a Scottish population of 501 
sibships. 
11.4 Discussion 
This data provides evidence that genetics and heritability play an important 
role in the predisposition to RRD. In 501 Scottish sibships, the risk of having 
an affected sibling with RRD is increased nearly 2-fold given that one sibling 
has had the condition. I examined the effect of proband age, gender, height, 
weight, birth order, lens status and spherical equivalent refraction on the 
sibling risk. Of these, an increase in spherical equivalent refractive error of 1 
dioptre towards myopia in the proband conferred a significant increased risk 
of RRD to a sibling of 9.8% adjusting for proband age and gender.  
This work should however be understood in the context of its limitations. An 
incomplete questionnaire response rate (65%) may lead to participation bias 
if persons with an affected sibling are more or less likely to participate. 
However all cases were encouraged to return the questionnaire regardless of 
family history and comparison of the demographic characteristics between 
responders and non-responders did not show significant differences. The 
diagnosis of RRD in family members was ascertained through a self-reported 
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questionnaire, which may similarly introduce bias, however RRD is most 
commonly an acute condition causing visual loss requiring surgical 
intervention, and thus its’ nature is likely to be remembered with a degree of 
accuracy.  Also, the conclusions on the genetic influences of RRD reached by 
this study depend on inherent assumptions in the design and statistical 
models used. This demonstration of the familial aggregation of RRD has 
been derived through contacting all incident cases, thus I cannot comment 
on the risk of RRD in relatives of unaffected controls.  We have sought to 
model the OR of RRD in a sibling accounting for relevant changes in proband 
characteristics known from previous epidemiological studies to affect RRD 
incidence.  There may be other shared environmental factors that contribute 
to the familial aggregation observed and finally, the model I have used has 
no way of accounting for potential gene-environment interactions.  
I estimate the sibling recurrence risk ratio (λs) and the parent offspring 
recurrence risk ratio of RRD to be 2.1 (95% CI=1.3-3.2) and 2.9 (95%CI – 
1.9-4.2) respectively. Hence the estimated prevalence of RRD in siblings of 
affected cases is twice that of the normal population prevalence (1.68% vs 
0.8%).  The λs parameter is directly related to the power of genetic studies, 
however its estimate is subject to bias and is dependent upon the 
prevalence of affection in the overall population. λs  diminishes linearly as 
the overall population prevalence approaches unity,(Olson & Cordell 2000; 
Risch 1990) and over or under estimation of population prevalence can thus 
dramatically affect the estimated λs value. To my knowledge, there have 
been no previous estimates of the sibling recurrence risk of RRD, however 
this finding is similar to previous reports of moderate myopia >-2D (2.52 – 
95%CI: 1.51-5.87)(Wojciechowski et al. 2005a) but less than the reported 
values for high myopia (reported range: 4.9 - 20).(Farbrother et al. 2004; 
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Guggenheim et al. 2000) The λs for phakic RRD is higher than for 
pseudophakic or aphakic RRD (table 11.5) suggesting that non-genetic 
factors may have a greater influence on RRD after cataract surgery. The 
sibling recurrence risk for complex ocular traits with a proven genetic 
component such as age-related macular degeneration has been 
demonstrated to be modest (λs or Ks=2.96).(Luo et al. 2008)  In general 
however, the higher the λs value (>5), the more likely a significant genetic 
contribution to the pathogenesis of disease exists although the the 
relationship between an underlying disease-susceptibility allele and λs  is 
complex.(Rybicki & Elston 2000; Vyse & Todd 1996)    
Familial aggregation studies of RRD are uncommon because of the low 
frequency of the condition, however Go et al(Go et al. 2005b) have 
demonstrated a 3-fold increased frequency of RRD in siblings of affected 
subjects compared to siblings with unaffected subjects. Accounting for 
myopia, age and gender did not fully explain the familial aggregation 
observed. I have similarly noted the odds of having an affected sibling with 
RRD is significantly increased (OR= 1.91: 95%CI-1.18-3.05) given that one 
sibling has had the condition. Go et al(Go et al. 2005b) report a higher 
frequency of RRD in relatives of myopic probands and controls compared to 
non-myopic probands and controls (1.13% vs 0.33%) and interestingly they 
found a higher frequency of RRD in relatives of myopic probands compared 
to myopic controls (1.8% vs 0.6%), suggesting that genetic factors other 
than those controlling myopia may influence RRD pathogenesis but that 
myopia genes may influence other putative genetic determinants of RRD. 
The regression analysis similarly demonstrates that increasing degrees of 
myopia in the proband increases the sibling risk of RRD (by approximately 
10% for each spherical equivalent dioptre), but this doesn’t completely 
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account for the familial aggregation observed. The λs for non-myopic RRD is 
1.9 (95%CI – 1.1-3.2), which, although lower than the estimate for myopic 
RRD (2.8 [95% - 1.5 – 4.6]) nonetheless highlights the presence of a 
genetic component to RRD not associated with myopia. 
Myopia and in particular high myopia are one of the most relevant risk 
factors for RRD development. Several studies have highlighted the 
importance and the complexity of genetic influences on the etiology of these 
traits and to date numerous chromosomal regions have been identified 
through genetic linkage(Naiglin et al. 2002; Paluru et al. 2003; Young et al. 
1998) and more recently genome wide association studies.(Nakanishi et al. 
2009) Marked variability in heritability has been demonstrated between 
different population ethnicities and the relevance of environmental 
influences has been confirmed.(Klein et al. 2009; Wojciechowski et al. 
2005c; Saw et al. 1999) In a similar way, the genetic influence of RRD is 
likely to be complex and multi-factorial and may demonstrate similar ethnic 
variation, as has been noted in population based incidence studies.(Mowatt 
et al. 2003; Rosman et al. 2001) 
Genetic studies of RRD not associated with known syndromes (such as 
Stickler syndrome or Wagner syndrome) are in their infancy and few reports 
confirming  linkage to chromosomal regions exist for non-syndromic 
RRD.(Go et al. 2003) Known regions involved in collagen development have 
been implicated in causing RRD in association with other vitreous 
abnormalities and may provide potential candidate genes.(Richards et al. 
2002) Similarly, genes coding for components involved in vitreo-retinal 
adhesion such  as laminin and fibronectin may prove to be important in the 
pathogenesis of this condition. Despite its limitations, this work which is 
derived from a large well characterised and stable Caucasian population 
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highlights that familial occurrence of RRD is a risk factor for its development, 
proband refractive error significantly influences sibling risk independent of 
age at diagnosis and gender and that genetic factors are likely to be 





















CHAPTER 12 – Genotype Case-Control 
Association Testing 
 
Quality control procedures and statistical analysis was led and performed 
primarily by Dr. Veronique Vitart and Dr. Mirna Kirin at the Medical Research 
Council Human Genetics Unit in Edinburgh. I observed and where possible 
assisted in the analysis, however I did not directly undertake data 
manipulation or de novo analysis of the genome wide data.  
12.1 Quality control measures 
 
Genotype calling was performed by the Wellcome Trust Clinical Research 
Facility, Edinburgh using a standard Illumina call algorithm on the genome 
analysis software BeadStudio and a GenCall cut off of 0.15 and the 
recommended parameters for the Infinium assay. Genotype call rate for 
cases and controls was high (>98%). 
Quality control analysis was performed in R (v2.10.1), using the GenABEL 
package. The same thresholds were used for cases and controls. The 
following per SNP thresholds were used:  
Excluded markers out of HWE proportions (P<1 x 10-10) – 1,106 SNPs in 
control population 
Per SNP call rate (<97%) – 8,088 SNPs removed in cases and controls 
SNP minor allele frequency(MAF) <0.02 – 9,659 SNPs removed in cases and 
controls 
 
The following samples were excluded: 
Low call rate (<97%) – 20 case samples 
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High autosomal heterozygosity (False discovery rate (FDR)<1%) – 5 case 
samples 
Whole genome identity-by-state (IBS) sharing (IBS≥0.95) (Figure 11.1) – 
13 case samples 
Gender discrepancy between phenotypic record and genotype – 4 case 
samples 
  
There was no overall inflation of the test statistic (λ = 1.0197) in either 
cases (Case λ(se) = 0.987(0.00019))or controls (Control λ(se) = 
1.08(0.00043)). (Figure 12.2)   
 
  
Figure 12.1 – Assessing population stratification by identity by state (IBS) 
using PLINK and R. Average principal components 1 and 3 and 2 and 3 
identified two outlying subjects, an additional 11 outliers were identified 







Figure 12.2 – Quantile-Quantile (QQ plot) (excluding poorly clustering 







12.2 Association testing 
In total after quality control measures, the case-control analysis included 
299,869 SNP in 870 cases of RRD and 1,968 controls.  
Case control analysis was performed using both PLINK and the GENABEL 
software in R. A Cochrane-Armitage trend test with 1 degree of freedom was 
performed with Bonferroni adjusted p-values for genome wide significance. 
Over 200 SNPs were significant on first analysis. Because of the large 
number of associated polymorphisms, we suspected an error in the analysis 
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and compared allele frequencies of these highly associated SNPS in both 
cases and our controls with previous available genotyped databases 
(Orkney, Vis, CEU populations on HapMap). We found a large discrepancy 
between the RRD case genotypes and standard population frequencies and 
came to the conclusion that clustering for the RRD genotypes using the 
standard Illumina algorithm was not optimal for the genotypes, and the case 
genotypes were re-clustered based upon more appropriate thresholds for the 
genotypic data.  
After re-clustering the raw data, the second pass case-control association 
analyses with Bonferroni correction (p-value ≤1.67x 10-7) yielded a total of 
14 SNPs reaching genome wide significance. (Table 11.1) The cluster plots 
of all 14 SNPs were visually inspected using BeadStudio software. In total, 
only two SNPs showed very clear genotype clusters. The remaining 12 SNPs 
showed poor clustering in controls (N=2) or in cases (N=10). Two of these 
12 poorly clustering SNPs, rs10510663 and rs4679072, showed reasonable 
genotype clusters and were located in close proximity on chromosome 3  
(CLASP2 gene). The two SNPs showing unambiguous and clear clustering, 
rs4862110 and rs4957798 were very highly associated with the disease 








































































































Table 12.1 – Identified polymorphism and corrected p-value for association 












17 rs7503953 6082401 A 8.775 1.7E-143 
16 rs11646140 29062981 A 9.706 5.5E-115 
4 rs4862110 1.84E+08 G 4.088 1.31E-86 
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4 rs361147 1.53E+08 C 0.2023 8.35E-73 
19 rs2278902 55507855 A 11.03 4.93E-68 
5 rs4957798 1.08E+08 A 3.499 1.19E-66 
6 rs9500256 58416914 A 0.2797 2.25E-52 
4 rs1390266 20987259 C 2.061 8.32E-16 
7 rs4722094 22098406 G 1.771 2.01E-13 
13 rs1923886 46321292 G 0.6533 1.83E-07 
20 rs3848693 53866611 A 1.501 1.6E-05 
3 rs2319335 1.49E+08 G 1.469 0.000109 
4 rs10009073 1.36E+08 G 0.3746 0.000235 
3 rs10510663 35534244 G 1.873 0.000385 
3 rs4679072 33549244 G 0.7276 0.007878 
18 rs2174896 72370842 G 0.7444 0.05445 
23 rs12557693 12688352 G 1.562 0.05785 
Table 12.2 – SNPs and Bonferroni adjusted p-values after accounting for 
variables age and gender in the logistic regression analysis.  
 
Covariates of age and gender were added to form a logistic regression model 
of the case and control genotypes, with disease status as the binary 
outcome measure. There were significant age and gender effects that 
diminished the strength of association at the top observed SNP loci. (see 




12.3 Single Nucleotide Polymorphisms - rs4862110 and 
rs4957798 
The two strongest associations after covariate analysis and excluding 
poor or ambiguous genotype clustering were, rs4862110 and rs4957798, 
located on chromosomes 4 and 5. Both rs4862110 and rs4957798 were in 
HWE in both cases (p=0.78 and 0.94) and controls (p=0.45 and 0.15). Case 
genotype frequencies were 0.47 and 0.5 for the heterozygous C/T genotype 
for rs4862110 and rs4957798 respectively, compared to control C/T 
genotype frequencies of 0.28, yielding adjusted p-values for association of 
8.02 x 10-109 and 7.46 x 10-81. Control genotypes were similar to HapMap 
CEU and other unpublished data (C/T genotype frequency ~0.3).  
Because of the large discrepancy noted, we verified these SNP loci in 
our cases by re-typing them using TaqMan (Applied Biosciences) PCR 
genotyping. PCR genotyping was performed successfully, there were no false 
calls and the overall call rate was >98% (Figure 12.3). Table 12.3 highlights 
the large disagreement in measured allele frequencies for these SNP loci 







Figure 12.3abcd – Illumina Genomestudio(a+b; top left and top right) and 
TaqMan PCR(c+d; bottom left and bottom right) allelic discrimination plot of 













Call Illumina Call 
TaqMan PCR 
Call 
C/C Genotype 211(23.1%) 32(3.5%) 279(30.6%) 588(64.5%) 
C/T Genotype 456(50%) 253(27.7%) 436(47.8%) 286(31.4%) 
T/T Genotype 224(24.6%) 610(66.9%) 170(18.6%) 26(2.9%) 
Undetermined 21(2.3%) 17(1.9%) 27(3%) 12(1.3%) 
Table 12.3 – Comparative distribution of measured genotypes for SNPs 






Processing of these samples was examined to try and determine why 
this large discrepancy was noted. There was no sample mis-match, all DNA 
samples passed standard quality control checks, and there were no array 
associated processing errors. Both SNP loci genotyped very well, with clear 
clusters and a high call rate and there was no significant difference in 
genotypic counts between the 10 processing batches used for the cases 
(Pearson Goodness of fit test, p=0.302 for rs4862110 and p=0.182 for 
rs4957798).  
 I contacted the manufacturers regarding these results and they have 
advised me that due to new beadpool changes between the Infinium HD and 
Infinium II products, a small number of loci (<0.01%) appear to show 
discordant clustering. They recommend excluding the following 31 SNP loci 
from any analyses using the Human610-quad, 1M-duo and CNV370-Quad 
version 3 : rs8027714, rs209445, rs9956700, rs1036819, rs10041162, 
rs2254715, rs1455311, rs2887022, rs3980714, rs6568006, rs2221705, 
rs7300686, rs9572312, rs12039194, rs10871678, rs1975920, rs7137203, 
rs2236479, rs11076556, rs1447826, rs2074127, rs3021387, rs12824182, 
rs6797523, rs777854, rs1549343,rs12582135, rs1810636, rs16883961, 
rs666101and rs3733746. However, this may not be an exhaustive list as the 
identified loci were absent and other potentially unidentified SNP variants 
may demonstrate this discrepancy. This finding emphasises the importance 
of verifying associated polymorphisms using different genotyping technology 
prior to further resource investment(McCarthy et al. 2008b; McCarthy et al. 
2008a) and also raises potential compatibility issues when comparing 
genotypes between newer release platforms and older models by the same 
manufacturer. Excluding these false positive associations, no individual SNPs 






Figure 12.4 - Manhattan plot (excluding poorly clustering SNPs) after 
adjustment for age and gender 
12.4 Imputation 
Prediction of missing genotypes at un-typed SNPs in the combined 
case/control sets was carried out using the IMPUTE program and subsequent 
analysis carried out via SNPTEST. This was performed by Dr Mirna Kirin. An 
LD threshold of r2>0.97 was used. Due to poor concordance between typed 
and imputed SNPs, we did not select any imputed SNPs for stage 2 
































enic 0.113 0.10 5 G T 0.8913 0.04 44.75 
2.24E-
11* 
rs4954847 LRP1B 0.125 0.12 2 A G 0.1253 0.06 39.64 
3.04E-
10* 
rs4670165 vitrin 0.360 0.36 2 A C 0.6389 0.42 26.31 
2.90E-
07* 










0.231 0.18 15 A G 0.8161 0.25 20.28 
6.68E-
06 
  Table 12.4 - Statistical summary of imputed case/control SNPs. Asterix 
highlights SNPs reaching genome wide significance. (g) genotyped; (i) 
imputed 
12.5 Selection of Stage 2 Single Nucleotide 
Polymorphisms  
For stage 2 genotyping we selected the most statistically significant  4,541 
SNPs (~1%) from the first stage case control comparison as well as 1,440 
SNPs chosen to tag 17 genes (versican/CSPG2, OPTC, LAMC1, LAMB1, 
LAMA1, KCNJ13, HAS1, HAPLN1, FZD4, FN1, FBN1,  COL9A1, COL6A1, 
COL4A4, COL2A1, COL11A1, COL11A2) that are thought to have a putative 
biological role in RRD or have been proven to be implicated in syndromic 
RRD development. In total, 4,235 SNPs were available for analysis in cases 
(N= 1,072) and controls (N=2,920).  
 12.5.1  Candidate gene selection 
I conducted a thorough literature search on PubMed, Medline, HuGE and 
Online Mendelian Inheritance in Man(OMIM) for all genes implicated in the 
pathogenesis of RRD and related syndromes. As well as genes previously 
associated with the phenotype, I selected genes of known function whose 
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end products or biological pathways may potentially be involved in RRD 
pathogenesis. (see Table 12.5) I used the UCSC Genome Browser and the 
HapMap Geonome Browser to select the genes. The largest RefSeq genes 
were selected. The genes were visualised and a 10kb region around the 
gene was examined to determine LD patterns. A force inclusion SNP list was 
created by selecting known functional coding SNPs in the region and non-
synonymous coding SNPs. This list was attached to the tagging algorithm 
and tagsSNPs were selected for each gene using QuickSNP v1.1, with a MAF 
of >0.05, r2 of 0.8 and included a 10kb flanking region around the gene. LD 
was visualised using Haploview with regional genomic data dumps from the 
HapMap phase II database. 
 
HUGO Full/other name Chr 
COL2A1 Collagen II 12q13.11-
q13.2 
COL4A4 Collagen IV 2q36-q37 
COL6A1 Collagen VI 21q22.3 
COL9A1 Collagen IX 6q13 
COL11A1 STL2/Collagen XI (alpha 1 pp) 1p21 
COL11A2 STL3/Collagen XI (alpha 2 pp) 6p21.3 
FBN1 Fibrillin 1 15q21.1 
FN1 Fibronectin 1 2q34 
FZD4 Frizzled Drosophilia Homolog 4 11q14-q21 
HAPLN1 Hyaluronan and proteoglycan link protein 1 5q14.3 
HAS1 Hyaluronan synthetase 1 19q13.3-
q13.4 
KCNJ13 SVD/Potassium inwardly-rectifying channel, 2q37 
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subfamily J, member 13 
LAMA1 Laminin alpha 1 18p11.31 
LAMB1 Laminin beta1 7q31.1-
q31.3 
LAMC1 Laminin gamma 1 1q31 
OPTC Opticin precursor 1q32.1 
VERSICAN/C
SPG2 
Chondroitin sulfate proteoglycan-2 5q12-q14 
Table 12.5 - A summary of the selected candidate genes tagged in stage 2 
genotyping 
12.6 Association testing - Stage 2 
Individually, no SNP reached genome wide significance. A meta 
analysis of the different cohorts was was performed. Inverse variance 
weighted fixed and random effects meta-analysis was done using 
METAL software.(Willer et al. 2010) To do this, a reference allele is 
assigned to each SNP (all studies are aligned to the same reference 
allele) and its z -statistic is calculated. Based on this an overall z-
statistic and p-value are calculated for each SNP from a weighted 
sum of the individual statistics. Standard errors were used to 
calculate the effect size weights. After meta analysis of the Dutch 
(N=264), English (N=687) and Scottish (N=121) replication cohorts, 
one SNP achieved genome wide statistical significance. (rs11637235, 
p=1.21E-05) The significance threshold was set at p<1.3e-05 given 
the numbers of SNPs followed-up for replication, and after correcting 
for correlated SNPs. rs11637235 is located in chr 15, in the DUT 
gene, in close proximity to FBN1, which was a selected candidate 
gene. However this SNP was not significantly associated in the 
original stage 1 Scottish discovery analysis. A meta analysis of the 
replication cohorts (Dutch, English and Scottish) together with the 
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original Scottish RRD cases demonstrated that 5 SNPs reached the 
significance threshold of 1.3e-05, with one SNP reaching genome 
wide significance. (Table 12.6) rs12960119 is located in the SS18 
gene, which is thought to function as a transcriptional co-activator. It 
has been found to co-localize with the actin cytoskeleton in cultured 
cells and RNAi ablation of either isoform markedly impairs the 
formation of stress fibers and focal adhesions making this a good 
candidate gene for RRD.(Kim et al. 2009)  
Ch
r SNP A1 A2 Effect OR StdE 
P-
value Direction 
18 rs12960119 a g -0.37 0.69 0.07 
1.58E
-07 --- 
1 rs267738 a c 0.23 1.27 0.05 
6.70E
-06 +++ 
4 rs955943 a g 0.43 1.54 0.09 
9.90E
-06 +++ 
10 rs7097067 a g 0.50 1.65 0.11 
1.28E
-05 -++ 
5 rs1074463 a g 0.26 1.31 0.06 
1.28E
-05 +++ 
8 rs2045084 a g -0.18 0.83 0.04 
1.54E
-05 --- 
21 rs8132771 a g 0.34 1.43 0.08 
1.96E
-05 +++ 
Table 12.6 - Five SNPs achieved the significance threshold, and 1 
SNP reached genome wide significance- rs12960119 located within 
the SS18 gene (p=1.58e-07)  
 
Based on the results from stage 2 meta-analysis, the top 6 
statistically significant SNPs were genotyped in an additional 846 
samples from London and compared against the genotype counts 
from 2,737 samples derived from the National Blood Sample control 
database. rs7097067 was not genotyped as the direction of the effect 
was not the same in all 3 cohorts.  We did not get replication of the 
genome wide significant SNP (rs12960119), however we did find that 
241 
 
3 SNPs had nominal or close to nominal significant p-value. (0.05) 
(Table 12.7 and Figure 12.5) 
 
Table 12.7 - Highlights the empirical p-value of SNPs replicated in 
an additional 846 cases and 2,737 control samples. One SNP 




Figure 12.5 - Demonstrates the direction and odds ratio of 









SNP A1 A2 BETA EMPp EMPp_SE 
rs267738 C A -0.1706 0.0344 0.0807 
rs955943 A G 0.1904 0.2202 0.1553 
rs1074463 A G -0.0717 0.4434 0.0935 
rs2045084 G A 0.1269 0.0477 0.0641 
rs12960119 G A 0.1092 0.3312 0.1132 
rs8132771 A G 0.2401 0.0562 0.1257 





The three SNPs reaching nominal significance after meta-analysis are: 
rs267738, rs8132771, rs2045084. rs267738 falls in the gene rich area.  
rs8132771 falls between TIAM1 gene and SOD1 and rs2045084 tags the 
TSTA3 gene. At present we are conducting pathway analysis using GRAIL to 
determine the likelihood of an underlying common pathway.(Raychaudhuri 
et al. 2009) In addition, we will use the software GCTA(Yang et al. 2010), to 
estimate the proportion of the underlying liability’s variance that was 
explained collectively by the variants tested to further demonstrate a genetic 
basis to RRD risk captured by the SNP array used. 
In conclusion, our study was designed to identify common genetic variants 
of moderate to large effect that may have a role in RRD.  We have identified 
3 SNPs reaching genome wide significance after meta-analysis. Although our 
study supports a heritability to RRD, with several interesting genomic 
regions for further investigation, additional studies of larger sample size will 










Chapter 13- Conclusions 
13.1 Summary of main findings 
Prior to my research very little was known about the epidemiology and 
clinical associations of RRD in the U.K. There had been no previous studies 
in Scotland and only one report from 2 small regions in England. In 
published genetic literature, very little was known about the heritability of 
RRD and there had been no genetic studies on sporadic RRD.  
Establishing and maintaning the study presented a significant challenge and 
necessitated a considerable level of co-operation between clinicians, nurses, 
healthcare workers and clerical staff. By remaining in constant contact with 
all six vitreoretinal centres in Scotland I was able to recruit over 90% of all 
operated cases in Scotland during the study period. One of the great 
benefits of conducting this work in Scotland was not only the stable 
population structure, but also the highly developed healthcare service, which 
facilitated a very effective recruitment process.     
My research culminated in the establishment of one of the largest clinical 
and DNA databases of individuals with primary RRD worldwide. By 
expanding collaborative efforts with other researchers, I was able to develop 
active case recruitment in centres elsewhere in the U.K. and in Europe which 
provided an additional resource for replication of our findings. 
There have been many novel findings from this study that have added to our 
understanding of the nature of RRD. For example, we now know that the 
annual incidence of primary RRD in the UK is 12.05 per 100,000 population, 
which equates to over 7,300 new cases each year. Males are more 
frequently affected in all subtypes and the incidence of RRD shows a strong 
association with socio-economic affluence despite accounting for known risk 
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factors. I have described the clinical characteristics and natural history in 
over 1,200 incident cases  of primary RRD, making this one of the most 
comprehensive reports in published literature. I have reported the frequency 
of multiple retinal breaks, the association between myopia and non-PVD 
RRD, the frequency of lattice degeneration by type of RRD and the extent of 
visual loss in the fellow eye from RRD. My work has established 
contemporary clinical and demographic associations of RRD which create key 
clinical distinctions that may have important implications in the underlying 
pathogenesis of RRD and which are of notable importance in the successful 
surgical management of patients.  
Using the information services division, which manages all hospital episode 
statistics (HES) in Scotland, I demonstrated that the age standardised 
incidence of RRD is rising and the average annual percent increase in RRD 
incidence in Scotland over the 20 years to 2008 was 1.9%. Although 
commonly this rise in RRD may be attributed to a concomitant rise in 
cataract surgery in Western countries, I could demonstrate no significant 
period effect on APC modelling. Examination of the hospital record data from 
Scotland allowed me to assess and report the high accuracy of case capture 
by the information services division.  
 My work was the first in published literature to estimate the genetic 
contribution to RRD. I have established that the risk to a sibling with RRD is 
increased two-fold compared to the general population. This risk increases 
with increasing myopia in the proband, is independent of age and exists for 
non-myopic RRD. The prevalence of RRD among siblings of affected 
individuals is twice that of the standard population. 
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By bringing together researchers from elsewhere in the U.K. and in Europe, I 
co-ordinated and conducted the first genome wide association study of RRD 
in 2,833 RRD cases and 7,871 controls in total. Several of the top signals 
from the analysis have encompassed genes with a documented role in cell 
adhesion or migration, including SS18, TIAM1, TSTA3 and CDH12. This is 
the first major insight into the molecular pathogenesis of this complex 
condition which we hope to investigate further. 
 
13.2 Contribution of this work to the field 
My research has highlighted the incidence, clinical characteristics and natural 
history of RRD in the U.K. This has provided a comprehensive resource 
which functions to inform clinicians on the subtype and frequency of RRD. 
These findings will help provide information for future resource allocation 
and in planning of vitreo-retinal services. I have highlighted a genetic 
component to RRD pathogenesis. Better characterisation of the genetic risk 
of RRD will allow more appropriate targeting of prevention measures for 
individuals as well as for certain population groups. By further exploring the 
specific genetic loci implicated in RRD,  I hope to improve the scientific 
knowledge of the fundamental molecular basis of RRD. This in turn will 
afford a potential for rational development of novel agents which may have 
a role in prevention or treatment of RRD.  
13.3 Future research 
Having established the largest prospectively recruited database of 
individuals with primary RRD in the U.K., I am presently performing a 
national surgical outcome audit to ensure that standards of clinical care in 
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Scotland are comparable to expected international standards. This clinical 
database provides the potential for further long term evaluation of the 
natural history of the condition and for further characterisation of the risk to 
the second eye. By establishing and expanding our international 
collaborations, I expect to be in a strong position to replicate our findings in 
other populations and to move forward to re-sequencing and functional 






















Checklist of incidence studies 
    Score 
1) Definition of RRD   0  No            
     1  Yes (Not clear)                     
    4  Yes (Clear)   
         
 
2) Type of Study  8   Prospective   
    4  ICD coding/Review of Medical Records 
    2  Survey or Questionnaire 
 
 
3) Study Population 
- Demography  1  Present  
   0  Absent  
 
 
- Case selection criteria  
   0   No                        
    1   Yes (Not clear)  
    4   Yes (Clear)  
   
 
 
4) Incidence   1  RRD Subtype incidence rates 
    1  Age specific incidence rates 
















Retinal Detachment Epidemiology Data Sheet 
 
 
Centre Number              Study Number                               (office use)        
                 
CHI number: ________________     Initials: __ __     Maiden name: 
_________________                        
Postcode: __________              Tel: ________________    
Date of Birth: __ __ / __ __ / __ __ __ __          
Date of Attendance ___ /___ /___ 
Sex :   Male              Female   
Route of referral   Self            GP            Optician              A&E           Other   
 
Presenting Symptoms Yes        No 
Floaters    Duration _____   (days) 
Flashes        Duration _____   (days) 
Shadow         Duration _____   (days) 
Loss of central vision         Duration _____   (days) 
Other           ________________________ Duration _____   (days) 
 
Trauma    None           Blunt           Penetrating          Other       specify __________-
_______Date ___/___/___    
 
Refraction        Myopia        Emmetropia           Hypermetropia           Not known       
  
Please complete or 





Axial Length(mm)                 Right ______    NK               Left ______    NK 
 
Dioptres (Spherical equivalent) Right ______  NK         Left ______    NK 
 
Past Medical History          Yes            No           if yes: Diagnosis 
____________________________________ 
 
Ocular History               Yes         No 
Previous ophthalmic disease          if yes: Diagnosis 
__________________________________ 
Previous intraocular surgery            if yes: Type ______________________   
Date ___/___/___  
                 Type ______________________   
Date ___/___/___ 
Features of Sticklers               if yes specify:     
        Yes       No  
Sensorineural deafness                    
 Arthropathy 
 Other  
             Yes          No 
Complicated cataract Sx with vitreous loss                 
YAG                                           Date ___/___/___ 
 
                                          Yes         No                             Yes        No 
Previous retinal prophylaxis                     Detached eye                          Fellow eye             
    To lattice peripheral retinal degeneration  Cryo                                Cryo             
          Laser          Laser 
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    To retinal breaks         Cryo                                  Cryo             
  
                                                                              Laser                                    Laser 
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Centre Number                    Study Number                          (office use)     
     
Family History        Ethnicity 
                                                                       Yes         No      Not Known    White 
FHx of retinal detachment                                  Black-African 
Members affected: Grandparent        Black-other
                 Parent                            Indian        
         Sibling          Pakistani 
         Other relatives        Chinese
  
                        Other                         
         __________ 
Parental consanguinity           
          
Affected eye       Right                   Left   
 
Lens                            Phakic  Pseudophakic  Aphakic           Phakic  Pseudophakic Aphakic
           
                     




                                    
 
 
Fundus                                 
Macula          On   Bisected             Off                      
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Intra-Ocular Pressure (IOP)    ______                  ______ 
    
                Yes         No               Yes         No 
Retinal Schisis         
  
Breaks (numbers)                                                    ______                                        ______ 
Round hole         
   
Horse-shoe tear        
  
Giant tear         
  
Dialysis           
Disinsertion 
  Yes         No 
PVR                         Grade     A  B  C 
Clock hours of detachment     ______      ______ 
Vitreous Partially detached 
       Detached       
  
  Optically empty       
  
  Haemorrhage       
  
  Membranous deposits   
Peripheral retinal degeneration      
  
Posterior lattice degeneration  
                                       Yes       No 





Centre   Study Number 
      Dr. Danny Mitry 
      Department of Public Health 
      University of Edinburgh 
      Teviot Place 
Date      Edinburgh  
Dear 
I would like to thank you for taking part in the Scottish Retinal Detachment 
Study.  
Your participation has been immensely valuable and has provided important 
information about the natural history and epidemiology of retinal detachment 
which will help in the planning of Ophthalmology services in Scotland.  
As part of the study, we are trying to determine how common retinal 
detachment is in families and if this condition can be inherited. To help inform 
us, we have attached a brief questionnaire requesting information about the 
size of your family and if a member of your family has had a retinal 
detachment. We encourage you to complete the questionnaire, although you 
may opt out below if you wish. For your reassurance, all the information you 
provide is stored anonymously in the University of Edinburgh and is used for 
research purposes only. 
We would be very grateful if you could take a moment to complete the 
attached questionnaire and return it in the stamped self-addressed envelope 
provided.  
Many thanks again for your patience and participation 
Best wishes, 
_______________ 
 Dr. Danny Mitry (Principal Study Co-ordinator) 
 
If you do not wish to complete the questionnaire, please tick this box      and 





Centre   Study Number 
Please complete this page and return it in the stamped envelope provided 
             YES   NO  
       (please tick the box) 
 Has anyone in your family had a retinal detachment?                                       
IF YES,  
which member(s) were affected:    
Father    Mother  
Brother   Sister  
     
Half-Brother   Half-Sister 
       
Son    Daughter 
   
Paternal Aunt   Maternal Aunt 
  
Paternal Uncle  Maternal Uncle 
   
Paternal Grandfather  Maternal Grandfather 
      
Paternal 1st Cousin  Maternal 1st Cousin  
 
If a brother or sister have been affected, please indicate their birth order in the 
family (ie. If they are the first born or eldest, please enter 1. If they are second 
born or second eldest, please enter 2. If they are third eldest, please enter 3. 
Etc.) :_____ 
 
      Number 
In total in your family:      
 
How many brothers do you have?  _____  
 
How many sisters do you have?  _____  
 
How many sons do you have?  _____ 
 




      Paternal   Maternal
   
 
How many Aunts do you have?  _____   _____ 
 
How many Uncles do you have?  _____   _____ 
 
How many 1st Cousins do you have?  _____   _____ 
 
If known, what is your height _____ metres or ____ foot/inches and weight 
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